96. クローン病 Disease details / Clinical trials / Drug dev / DR info

0,25 MG RPC1063
   Celgene International II Sarl (CISII) awholly owned subsidiary of Celgene Corporation
      2015   Phase 2   EUCTR2015-002025-19-HU   Canada;Hungary;Italy;Poland;Ukraine;United States
0.25 MG RPC1063
   Celgene International II Sàrl (CIS II), a wholly owned subsidiary of Celgene Corporation
      2016   Phase 2   EUCTR2015-002025-19-PL   Canada;Hungary;Poland;Ukraine;United States
0114-0006B
   Novo Nordisk A/S
      2013   -   EUCTR2012-002432-93-SK   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2013   -   EUCTR2012-002432-93-PL   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2013   -   EUCTR2012-002432-93-CZ   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2013   -   EUCTR2012-002432-93-BG   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2012   -   EUCTR2012-002432-93-HU   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2012   -   EUCTR2012-002432-93-ES   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
10 MG
   GIULIANI
      2013   -   EUCTR2011-002640-27-DE   Germany;Italy
100 MG
   Shikamura Mitsuhiro
      2023   Phase 3   JPRN-jRCT2071230036   China;Greece;Hungary;Italy;Japan;Korea;Poland
      2022   Phase 3   JPRN-jRCT2071210031   Australia;Belgium;Bosnia;China;Croatia;Czech Republic;Germany;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russia;Slovakia;Spain;Ukraine;United Kingdom;United States
   UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
      2016   Phase 4   EUCTR2016-002061-54-IT   Italy
100% pomegranate juice
   IRCCS Azienda Ospedaliero-Universitaria di Bologna
      2017   -   NCT03000101   Italy
1000 IU D3
   Cedars-Sinai Medical Center
      2018   Early Phase 1   NCT03615378   United States
18F-FDG and 68GA-fapi PET/CT
   Peking Union Medical College Hospital
      2020   Phase 2   NCT04502303   -
1MG RPC1063
   Celgene International II Sarl (CISII) awholly owned subsidiary of Celgene Corporation
      2015   Phase 2   EUCTR2015-002025-19-HU   Canada;Hungary;Italy;Poland;Ukraine;United States
   Celgene International II Sàrl (CIS II), a wholly owned subsidiary of Celgene Corporation
      2016   Phase 2   EUCTR2015-002025-19-PL   Canada;Hungary;Poland;Ukraine;United States
2'-fucosyllactose
   Children's Hospital Medical Center, Cincinnati
      2019   Phase 1/Phase 2   NCT03847467   United States
23-valent polysaccharide pneumococcal vaccine
   Cedars-Sinai Medical Center
      2005   -   NCT00829595   United States
   Kyunghee University Medical Center
      2011   Phase 4   NCT01505855   Korea, Republic of
25 MG ontamalimab
   Shire
      2018   Phase 3   NCT03283085   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
331731-18-1
   ALLERGAN LIMITED
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2013-004034-15-IT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004034-15-GB   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004034-15-FR   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004034-15-DK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2013-004034-15-DE   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2013-004034-15-BE   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2013-001746-33-FR   Austria;Belgium;Canada;Denmark;European Union;France;Germany;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2015   Phase 3   EUCTR2013-001746-33-BE   Austria;Belgium;Canada;Denmark;European Union;France;Germany;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2015   Phase 3   EUCTR2010-020137-10-LT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004034-15-SK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004034-15-HU   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2014   Phase 3   EUCTR2013-004034-15-ES   Austria;Canada;Czech Republic;Denmark;European Union;France;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2014   Phase 3   EUCTR2013-004034-15-AT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2014   Phase 3   EUCTR2013-001746-33-SK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-NL   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-IT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   -   EUCTR2013-001746-33-HU   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Hungary;Israel;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-ES   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-DK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-DE   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Hungary;Israel;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-AT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2012   Phase 3   EUCTR2010-020137-10-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-020137-10-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-SE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-020137-10-GB   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-DE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
   AbbVie Farmacéutica S.L.U.
      2014   Phase 4   EUCTR2013-004781-34-ES   Spain
   AbbVie GK
      -   -   EUCTR2015-004121-13-Outside-EU/EEA   Japan
   Abbott Deutschland GmbH & Co. KG
      -   -   EUCTR2014-004560-38-Outside-EU/EEA   Japan
      -   -   EUCTR2014-004531-39-Outside-EU/EEA   Japan
   Abbott GmbH & Co. K.G.
      2009   Phase 3   EUCTR2007-006494-90-GB   Belgium;Czech Republic;United Kingdom
   Abbott GmbH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
   Allergan Ltd.
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-RO   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2018-004346-42-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2022   Phase 2;Phase 3   EUCTR2018-004346-42-FR   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-SK   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-HU   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-CZ   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-DE   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Astrazeneca AB
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Boehringer Ingelheim International GmbH
      2017   Phase 3   EUCTR2016-000612-14-HR   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-GR   Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-GB   Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-DE   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000612-14-CZ   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
   CHU Amiens Picardie
      2021   Phase 3   EUCTR2021-002047-29-FR   France
   Fundació Clínic per a la Recerca Biomèdica
      2013   Phase 3   EUCTR2012-001723-12-ES   Spain
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   GETECCU
      2011   -   EUCTR2011-000885-36-ES   Spain
   Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)
      2012   -   EUCTR2011-003966-34-ES   Spain
      2011   Phase 3   EUCTR2011-003966-34-BE   Belgium;Spain
   JANSSEN CILAG INTERNATIONAL NV
      2018   Phase 3   EUCTR2017-004209-41-IT   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Janssen-Cilag International N.V.
      2018   Phase 3   EUCTR2017-004209-41-PL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-FR   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Janssen-Cilag International NV
      2018   Phase 3   EUCTR2017-004209-41-NL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-GB   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-CZ   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   PIBD-Net
      2017   Phase 3   EUCTR2016-000522-18-DE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDNet
      2018   Phase 4   EUCTR2016-000522-18-CZ   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      2018   Phase 4   EUCTR2016-000522-18-BE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      2017   Phase 4   EUCTR2016-000522-18-NL   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      -   Phase 4   EUCTR2016-000522-18-FR   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDnet (Pediatric Inflammatory Bowel Disease Network)
      -   Phase 4   EUCTR2016-000522-18-PL   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   Radboud University Medical Centre
      2017   Phase 4   EUCTR2016-003321-42-NL   Netherlands
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   University Hospital Southampton NHS Foundation Trust
      2019   Phase 4   EUCTR2018-004967-30-GB   United Kingdom
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany
4-aminosalicylic acid
   Jacobus Pharmaceutical
      2007   Phase 2   NCT00417690   Israel;United States
4-aminosalicylic acid extended release granules
   Jacobus Pharmaceutical
      2007   Phase 2   NCT00495521   Israel;United States
40 MG
   Department of Internal Medicine, School of Medicine, Keio University
      2013   -   JPRN-UMIN000009596   Japan
      2011   Phase 4   JPRN-UMIN000005146   Japan
   Department of Lower Gastroenterology, Hyogo College of Medicine
      2012   Phase 4   JPRN-UMIN000006882   Japan
   Fukuoka University Chikushi Hospital
      2016   -   JPRN-UMIN000023871   Japan
   GIULIANI
      2013   -   EUCTR2011-002640-27-DE   Germany;Italy
   Janssen Scientific Affairs, LLC
      2018   Phase 3   NCT03464136   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Kenji Watanabe
      2010   -   JPRN-UMIN000005762   Japan
      2010   -   JPRN-UMIN000005761   Japan
   Nagoya University Gradeate School of Medicine Department of Gastroenterology
      2012   Phase 2   JPRN-UMIN000007514   Japan
   Tangdu Hospital, Fourth Military Medical University
      2023   Phase 1   ChiCTR2300074787   China
   Toho University Medical Center Sakura Hospital
      2016   -   JPRN-UMIN000024566   Japan
   Tokyo Medical & Dental University Gastroenterology
      2013   -   JPRN-UMIN000010524   Japan
40 MG MSB11022
   Fresenius Kabi SwissBioSim GmbH
      2019   Phase 1   NCT04018599   United States
5-aminolevulinic acid
   University Hospital, Akershus
      2019   Phase 1/Phase 2   NCT04164849   Norway
5-aminosalicyl acid
   Dr. Falk Pharma GmbH
      2007   -   EUCTR2004-001213-34-GB   Czech Republic;United Kingdom
5-aminosalicylic acid
   Ferring Laegemidler A/S
      2005   -   EUCTR2005-002472-15-SE   Sweden
   Lower GI disease, Hyogo College of Medicine
      2007   Phase 2,3   JPRN-UMIN000004427   Japan
5-HTP
   University Hospital, Ghent
      2018   Phase 2   NCT03574948   Belgium
5000 IU D3
   Cedars-Sinai Medical Center
      2018   Early Phase 1   NCT03615378   United States
549-0261/F02-01
   F. Hoffmann-La Roche Ltd
      2018   Phase 1   EUCTR2017-003649-10-GB   Belgium;Germany;Poland;Spain;United Kingdom
      2018   Phase 1   EUCTR2017-003649-10-DE   Belgium;Germany;Poland;Spain;United Kingdom;United States
      2018   Phase 1   EUCTR2017-003649-10-BE   Belgium;Germany;Poland;Spain;United Kingdom
      -   Phase 1   EUCTR2017-003649-10-PL   Belgium;Germany;Poland;Spain;United Kingdom
   Roche Farma S.A. (Soc unipersonal) que realiza el ensayo en España y que actúa como represntante de FHoffmann-La Roche
      2018   Phase 1   EUCTR2017-003649-10-ES   Belgium;Germany;Poland;Spain;United Kingdom;United States
6 mercaptopurine
   Indiana University
      2015   -   NCT02413047   United States
   Tel-Aviv Sourasky Medical Center
      2012   Phase 3   NCT01629628   Israel
6-[(methyl-4-nitro-1H-imidazol-5-YL)thio]-1H-purine
   Centocor B.V.
      2005   -   EUCTR2004-002815-10-SE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-GB   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-ES   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DK   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-AT   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
6-mercaptopurine
   Lower GI disease, Hyogo College of Medicine
      2007   Phase 2,3   JPRN-UMIN000004427   Japan
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   University of Edinburgh
      2007   Phase 4   EUCTR2006-005800-15-GB   United Kingdom
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands
6-MP
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands
75 MG ontamalimab
   Shire
      2018   Phase 3   NCT03283085   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
80 MG DR-6MP
   Teva GTC
      2011   Phase 2   NCT01433432   Israel
99MTC-S-hynic certolizumab pegol
   Ghent University Hospital
      2012   Phase 3   EUCTR2009-017998-37-BE   Belgium
A fixed-dose combination OF 95 MG clarithromycin, 45 MG rifabutin, and 10 MG clofazimine
   RedHill Biopharma Limited
      2017   Phase 3   NCT03009396   Canada;Czechia;Israel;New Zealand;Poland;Serbia;United States
A-1293543.74
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2015   Phase 2   EUCTR2014-003240-12-IT   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2014-003240-12-SK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-PL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-NO   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-NL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-HU   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-ES   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-DK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-DE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-BE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
AB1010
   AB Science
      2015   Phase 2;Phase 3   EUCTR2012-004222-25-GR   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;India;Italy;Morocco;Poland;Romania;Russian Federation;Slovakia;Spain;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-004222-25-SK   Belgium;Czech Republic;France;Greece;India;Morocco;Slovakia;Spain;Tunisia
      2013   Phase 3   EUCTR2012-004222-25-BE   Belgium;Canada;Central African Republic;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Romania;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
Abatacept
   Bristol-Myers Squibb
      2006   Phase 3   NCT00406653   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;India;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Puerto Rico;South Africa;Spain;Switzerland;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2008   -   EUCTR2006-003371-13-PL   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2008   Phase 3   EUCTR2006-003371-13-IE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2008   -   EUCTR2006-003371-13-CZ   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-NL   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-IT   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-GB   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003371-13-FR   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-DK   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003371-13-DE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-BE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
ABBV-066
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2020   Phase 3   EUCTR2020-002674-26-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 3   EUCTR2020-002674-26-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-003191-50-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-003190-17-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001834-15-DE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2016-003191-50-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003190-17-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2014   Phase 2   EUCTR2013-002902-29-DE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
ABBV-154
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2022   Phase 2   EUCTR2021-002869-18-IT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom;United States
   AbbVie
      2022   Phase 2   NCT05068284   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2022   Phase 2   EUCTR2021-002869-18-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-GR   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-ES   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
ABBV-382
   AbbVie
      2024   Phase 2   NCT06548542   Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Singapore;Slovakia;Slovenia;Spain;Switzerland;United Kingdom;United States
Abbvie care 2.0
   AbbVie
      2016   -   NCT02750800   Hungary
ABR-215062 sodium salt
   Teva Pharmaceutical Industries Ltd.
      2008   -   EUCTR2008-004276-49-NL   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-GB   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-FR   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-ES   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-BE   Belgium;France;Italy;Netherlands;Spain;United Kingdom
Abrilumab
   Amgen
      2012   Phase 2   NCT01696396   Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Netherlands;Switzerland;United Kingdom;United States
ABT 494 12MG
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2015   Phase 2   EUCTR2014-003240-12-IT   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2014-003240-12-SK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-PL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-NO   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-NL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-HU   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-ES   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-DK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-DE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-BE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
ABT 494 3MG
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2015   Phase 2   EUCTR2014-003240-12-IT   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2014-003240-12-SK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-PL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-NO   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-NL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-HU   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-ES   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-DK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-DE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-BE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
ABT humira
   Abbott GmbH & Co. KG
      2007   -   EUCTR2006-002078-23-SE   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
ABT-494
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2018   Phase 3   EUCTR2017-001240-35-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-IT   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
   AbbVie
      2016   Phase 2   NCT02782663   Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Romania;Slovakia;Spain;United Kingdom;United States
      2015   Phase 2   NCT02365649   Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2020   Phase 3   EUCTR2017-001240-35-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001240-35-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001240-35-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001226-18-SI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001226-18-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001225-41-SI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001225-41-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001225-41-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-LV   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Russian Federation;Serbia;Singapore;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-001240-35-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-LV   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-ES   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Russian Federation;Serbia;Singapore;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-001225-41-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2015-003759-23-NO   Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2015-003759-23-HU   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Puerto Rico;Slovakia;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2015-003759-23-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Netherlands;New Zealand;Puerto Rico;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-SK   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-NL   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-GB   Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-FR   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Puerto Rico;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-ES   Australia;Canada;Israel;New Zealand;Puerto Rico;Spain;United States
      2016   Phase 2   EUCTR2015-003759-23-DK   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-DE   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-BE   Australia;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Netherlands;New Zealand;Puerto Rico;Slovakia;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-SK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-PL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-NO   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-NL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-HU   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-ES   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-DK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-DE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003240-12-BE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;United Kingdom;United States
ABT-874
   Abbott
      2009   -   EUCTR2008-004919-36-SE   Austria;Denmark;Sweden
      2009   -   EUCTR2008-004919-36-DK   Austria;Denmark;Sweden
      2009   -   EUCTR2008-004919-36-BE   Austria;Belgium;Denmark;Sweden
      2009   -   EUCTR2008-004919-36-AT   Austria;Denmark;Sweden
      2007   Phase 2   NCT00562887   Australia;Austria;Belgium;Canada;Denmark;Germany;Puerto Rico;United States
ABX464
   Abivax S.A.
      2022   Phase 2/Phase 3   NCT03905109   Belgium
Accelerated 1 HOUR-infusion
   Asan Medical Center
      2011   Phase 4   NCT01346826   Korea, Republic of
Accelerated 30 minutes-infusion
   Asan Medical Center
      2011   Phase 4   NCT01346826   Korea, Republic of
Acded + modulen
   University Hospital Tuebingen
      2025   Phase 2   NCT06953791   -
Acetaminophen
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
Active comparator
   NImmune Biopharma
      2021   Phase 2   NCT05057273   -
Adalimumab
   ACADEMIC MEDICAL CENTER
      2015   Phase 4   EUCTR2013-002932-25-BE   Belgium;Netherlands
   ALLERGAN LIMITED
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   AbbVie
      2016   -   NCT02750800   Hungary
      2015   Phase 3   NCT02499783   China
      2014   Phase 3   NCT02185014   Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Puerto Rico;Romania;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2014   Phase 4   NCT02148718   Spain
      2014   Phase 3   NCT02065570   Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Puerto Rico;Romania;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2013   Phase 2   NCT02015793   China
      2013   Phase 3   NCT01958827   Japan
      2013   -   NCT01768858   Austria
   AbbVie (prior sponsor, Abbott)
      2011   Phase 3   NCT01235689   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
      2008   Phase 3   NCT00686374   Belgium;Canada;Czech Republic;Czechia;France;Netherlands;Poland;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2013-004034-15-IT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004034-15-GB   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004034-15-FR   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004034-15-DK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2013-004034-15-DE   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2013-004034-15-BE   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2013-001746-33-FR   Austria;Belgium;Canada;Denmark;European Union;France;Germany;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2015   Phase 3   EUCTR2013-001746-33-BE   Austria;Belgium;Canada;Denmark;European Union;France;Germany;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2015   Phase 3   EUCTR2010-020137-10-LT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004034-15-SK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004034-15-HU   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2014   Phase 3   EUCTR2013-004034-15-ES   Austria;Canada;Czech Republic;Denmark;European Union;France;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2014   Phase 3   EUCTR2013-004034-15-AT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2014   Phase 3   EUCTR2013-001746-33-SK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-NL   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-IT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   -   EUCTR2013-001746-33-HU   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Hungary;Israel;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-ES   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-DK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-DE   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Hungary;Israel;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-AT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2012   Phase 3   EUCTR2010-020137-10-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-020137-10-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-SE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-020137-10-GB   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-DE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2009   Phase 3   EUCTR2007-006494-90-CZ   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
   AbbVie Farmacéutica S.L.U.
      2014   Phase 4   EUCTR2013-004781-34-ES   Spain
   AbbVie GK
      2014   Phase 3   JPRN-jRCT2080222376   -
      -   -   EUCTR2015-004121-13-Outside-EU/EEA   Japan
   Abbott
      2007   Phase 2/Phase 3   NCT00445939   Japan
      2007   Phase 2/Phase 3   NCT00445432   Japan
      2007   Phase 3   NCT00427921   United States
      2007   Phase 3   NCT00409682   Belgium;Canada;Czech Republic;France;Italy;Netherlands;Poland;United Kingdom;United States
      2006   Phase 3   NCT00409617   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Norway;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
      2006   Phase 3   NCT00348283   Austria;Belgium;Canada;France;Germany;Italy;Netherlands;Sweden;United States
      2006   Phase 3   NCT00338650   United States
      2004   Phase 3   NCT00195715   Australia;Belgium;Canada;Denmark;France;Germany;Hungary;Italy;Netherlands;Poland;South Africa;Spain;Sweden;United Kingdom;United States
      2004   Phase 3   NCT00105300   Belgium;Canada;France;United States
      2003   Phase 3   NCT00077779   United States
      2002   Phase 2   NCT00055523   United States
   Abbott Deutschland GmbH & Co. KG
      -   -   EUCTR2014-004560-38-Outside-EU/EEA   Japan
      -   -   EUCTR2014-004531-39-Outside-EU/EEA   Japan
   Abbott GmBH Co KG
      2005   -   EUCTR2004-002163-24-IT   Denmark;Germany;Hungary;Italy;Spain;United Kingdom
   Abbott GmBH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
   Abbott GmbH Co.KG
      2006   -   EUCTR2005-005291-32-IT   Austria;Belgium;Germany;Italy;Netherlands;Sweden
   Abbott GmbH & Co. K.G.
      2009   Phase 3   EUCTR2007-006494-90-GB   Belgium;Czech Republic;United Kingdom
      -   -   EUCTR2007-006494-90-Outside-EU/EEA   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
   Abbott GmbH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-020137-10-ES   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2006-004814-41-GB   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2006-004814-41-NL   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2006-004814-41-IT   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2006-004814-41-CZ   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2006-004814-41-BE   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2004-002163-24-GB   Denmark;Germany;Hungary;Italy;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-004814-41-FR   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2006   -   EUCTR2005-005291-32-SE   Austria;Belgium;Germany;Italy;Netherlands;Sweden
      2006   -   EUCTR2005-005291-32-NL   Austria;Belgium;Germany;Italy;Netherlands;Sweden
      2006   -   EUCTR2005-005291-32-DE   Austria;Belgium;Germany;Italy;Netherlands;Sweden
      2006   -   EUCTR2005-005291-32-BE   Austria;Belgium;Germany;Italy;Netherlands;Sweden
      2006   -   EUCTR2005-005291-32-AT   Austria;Belgium;Germany;Italy;Netherlands;Sweden
      2005   -   EUCTR2004-002934-20-BE   Belgium
      2005   -   EUCTR2004-002163-24-DE   Denmark;Germany;Hungary;Italy;Spain;United Kingdom
      2004   -   EUCTR2004-002163-24-SE   Denmark;Germany;Hungary;Italy;Spain;Sweden;United Kingdom
      2004   -   EUCTR2004-002163-24-ES   Denmark;Germany;Hungary;Italy;Spain;Sweden;United Kingdom
      2004   -   EUCTR2004-002163-24-DK   Denmark;Germany;Hungary;Italy;Spain;United Kingdom
      -   -   EUCTR2006-004814-41-Outside-EU/EEA   -
   Abbott GmbH & Co. KG (Abbott)
      2006   -   EUCTR2006-002078-23-NL   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2006-002078-23-FR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
   Abbott GmbH & co. KG
      2004   -   EUCTR2004-002163-24-BE   Belgium;Denmark;Germany;Hungary;Italy;Spain;Sweden;United Kingdom
   Abbott Japan Co., Ltd.
      2007   Phase 2-3   JPRN-jRCT2080220358   -
      2007   Phase 2-3   JPRN-jRCT2080220357   -
   Abbott Laboratories
      2004   -   EUCTR2004-002163-24-HU   Belgium;Denmark;Germany;Hungary;Italy;Spain;Sweden;United Kingdom
   Abbvie Deutschland GmbH & Co. K.G.
      2008   Phase 3   EUCTR2007-006494-90-BE   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
   Academic Medical Center
      2019   Phase 4   EUCTR2018-002064-15-NL   Netherlands
      2013   Phase 4   EUCTR2013-002932-25-NL   Netherlands
   Allergan Ltd.
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-RO   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2018-004346-42-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2022   Phase 2;Phase 3   EUCTR2018-004346-42-FR   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-SK   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-HU   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-CZ   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-DE   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Astrazeneca AB
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Biogen
      2019   -   NCT04089514   Belgium;Germany;Ireland;Italy;Spain;United Kingdom
      2018   -   NCT03662919   France
   Boehringer Ingelheim International GmbH
      2017   Phase 3   EUCTR2016-000612-14-HR   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-GR   Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-GB   Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-DE   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000612-14-CZ   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
   CHU Amiens Picardie
      2021   Phase 3   EUCTR2021-002047-29-FR   France
   Celltrion HealthCare France
      2022   -   NCT05427942   France
   Centre Hospitalier Universitaire de Saint Etienne
      2024   Phase 4   NCT06180382   France
   Children's Hospital Medical Center, Cincinnati
      2019   -   NCT04131504   United States
   Department of Internal Medicine, School of Medicine, Keio University
      2013   -   JPRN-UMIN000009596   Japan
      2011   Phase 4   JPRN-UMIN000005146   Japan
   Department of Lower Gastroenterology, Hyogo College of Medicine
      2012   Phase 4   JPRN-UMIN000006882   Japan
   Foundation for Liver Research
      2008   Phase 3   NCT00736983   Netherlands
   Fukuoka University Chikushi Hospital
      2016   -   JPRN-UMIN000023871   Japan
   Fundació Clínic per a la Recerca Biomèdica
      2013   Phase 3   EUCTR2012-001723-12-ES   Spain
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2017   Phase 4   NCT02994836   Spain
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   GETAID
      2014   Phase 4   EUCTR2013-003199-11-FR   Belgium;France
   GETAID - Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives
      2015   Phase 4   EUCTR2013-003199-11-BE   Belgium;France
   GETECCU
      2011   -   EUCTR2011-000885-36-ES   Spain
   Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
      2012   Phase 3   NCT01564823   Spain
      2012   Phase 3   NCT01562951   Belgium;France;Spain
   Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)
      2012   -   EUCTR2011-003966-34-ES   Spain
      2011   Phase 3   EUCTR2011-003966-34-BE   Belgium;Spain
   Hospital Universitari Vall d'Hebron Research Institute
      2014   -   NCT02539849   Spain
   ISTITUTO CLINICO HUMANITAS
      2009   -   EUCTR2009-011763-37-IT   Italy
   Innovaderm Research Inc.
      2012   Phase 4   NCT01556672   Canada
   Iwate Medical University Kochi Medical School Hospital Keio University School of Medicine
      2016   -   JPRN-UMIN000019958   Japan
   JANSSEN CILAG INTERNATIONAL NV
      2018   Phase 3   EUCTR2017-004209-41-IT   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Jamp Pharma Corporation
      2023   -   NCT05913817   Canada
   Janssen Research & Development, LLC
      2021   Phase 2   NCT04655807   Canada;France;Germany;Italy;Japan;Spain;Sweden;United States
   Janssen Scientific Affairs, LLC
      2018   Phase 3   NCT03464136   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Janssen-Cilag International N.V.
      2018   Phase 3   EUCTR2017-004209-41-PL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-FR   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Janssen-Cilag International NV
      2018   Phase 3   EUCTR2017-004209-41-NL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-GB   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-CZ   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Kenji Watanabe
      2010   -   JPRN-UMIN000005762   Japan
      2010   -   JPRN-UMIN000005761   Japan
   Maastricht University Medical Center
      2019   Phase 4   NCT03917303   Netherlands
   McMaster University
      2018   Phase 4   NCT03059849   -
   Mikami Yohei
      2019   -   JPRN-jRCT1031190056   -
   Nagoya University Gradeate School of Medicine Department of Gastroenterology
      2012   Phase 2   JPRN-UMIN000007514   Japan
   Numaguchi Hirotaka
      2021   Phase 2   JPRN-jRCT2031200406   Canada;France;Germany;Italy;Japan;Spain;United States Of America
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   PIBD-Net
      2017   Phase 4   NCT02852694   France
      2017   Phase 3   EUCTR2016-000522-18-DE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDNet
      2018   Phase 4   EUCTR2016-000522-18-CZ   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      2018   Phase 4   EUCTR2016-000522-18-BE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      2017   Phase 4   EUCTR2016-000522-18-NL   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      -   Phase 4   EUCTR2016-000522-18-FR   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDnet (Pediatric Inflammatory Bowel Disease Network)
      -   Phase 4   EUCTR2016-000522-18-PL   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   Radboud University Medical Centre
      2017   Phase 4   EUCTR2016-003321-42-NL   Netherlands
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   Saitama Medical Center
      2016   -   JPRN-UMIN000022270   Japan
   Saitama Medical Center, Saitama Medical University
      2016   -   JPRN-UMIN000023735   Japan
   Sakura Medical Center,Toho university
      2012   Phase 2   JPRN-UMIN000009284   Japan
   Sakura medical center, Toho university
      2015   -   JPRN-UMIN000032485   Japan
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   Sara Varea
      2014   Phase 3   NCT01986127   Spain
   Schneider Children's Medical Center, Israel
      2015   Phase 4   NCT02256462   Israel
   Takeda
      2024   Phase 4   NCT06045754   Canada;United States
      2017   Phase 4   NCT02764762   Canada;United States
   Tangdu Hospital, Fourth Military Medical University
      2023   Phase 1   ChiCTR2300074787   China
   Tel-Aviv Sourasky Medical Center
      2012   Phase 3   NCT01629628   Israel
   The First Affiliated Hospital of Shantou University Medical College
      2022   -   ChiCTR2200058055   China
   Toho University Medical Center Sakura Hospital
      2016   -   JPRN-UMIN000024566   Japan
   Tohoku University Graduate School of Medicine (Tohoku University Hospital)
      2012   -   JPRN-UMIN000007343   Japan
   UCB Biopharma SRL
      2021   Phase 3   NCT04643483   -
   Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
      2021   Phase 4   ChiCTR2100049326   China
   Universitaire Ziekenhuizen KU Leuven
      2012   -   NCT02450513   Belgium
   University Hospital Southampton NHS Foundation Trust
      2019   Phase 4   EUCTR2018-004967-30-GB   United Kingdom
   University Medical Center Groningen
      2021   Phase 4   NCT04646187   Belgium;Netherlands;Spain
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   University of Alberta
      2009   Phase 4   NCT00972218   Canada
   University of Western Ontario, Canada
      2014   Phase 4   NCT01960426   United States
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany
   Vanderbilt University Medical Center
      2008   Phase 4   NCT00517296   United States
   Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
      2021   Phase 4   ChiCTR2000036845   China
   Yamaguchi University Graduate School of Medicine Department of Gastroenterology and Hepatology
      2011   -   JPRN-UMIN000007047   Japan
   waqqas.afif
      2017   -   NCT03261102   Canada
Adalimumab 40 MG EOW or EW
   Abbott
      2002   Phase 3   NCT01070303   United States
Adalimumab and infliximab
   University Hospital, Ghent
      2011   -   NCT01338740   Belgium
Adalimumab injection
   St Vincent's Hospital Melbourne
      2017   Phase 4   NCT03220841   Australia
Adalimumab PRN
   Peter Higgins
      2013   Phase 3   NCT01674413   United States
Adalimumab-680LT
   University Medical Center Groningen
      2024   Phase 1/Phase 2   NCT06117423   Netherlands
Admsc
   University Hospital, Toulouse
      2024   Phase 1/Phase 2   NCT06636032   France
Adrenomedullin
   First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki
      2016   Phase 1,2   JPRN-UMIN000021421   Japan
   University of Miyazaki
      2018   Phase 2   JPRN-jRCT2080223890   Japan
Adsvf
   ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
      2019   Phase 2   EUCTR2019-001948-21-FR   France
Adult human mesenchymal stem cells
   Mesoblast, Inc.
      2010   Phase 3   NCT01233960   Australia;New Zealand;United States
Advancement plasty
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2013   Phase 3   NCT06441526   Netherlands
AERO-RED 100 MG/ML gotas orales EN solucióN
   Universitary Hospital Príncipe de Asturias
      2021   Phase 4   EUCTR2021-000985-14-ES   Spain
After surgery FOR crohn'S disease, eligible patients will BE randomized 1:1 TO receive oral EXL01
   Madeleine Bezault
      2025   Phase 2   NCT06925061   France
AGMB-129
   Agomab Spain S.L.
      2023   Phase 2   NCT05843578   Austria;Canada;Denmark;Germany;Italy;Poland;Spain;United States
AIN457
   Novartis Pharma Services AG
      2010   Phase 2   EUCTR2009-011621-14-DE   Austria;Germany
      2009   -   EUCTR2009-011621-14-AT   Austria;Germany
      2009   -   EUCTR2008-008359-40-PL   Austria;Germany;Poland
      2009   -   EUCTR2008-008359-40-DE   Austria;Germany;Poland
      2009   -   EUCTR2008-008359-40-AT   Austria;Germany;Poland
   Novartis Pharmaceuticals
      2009   Phase 2   NCT01009281   Austria;Canada;Germany;Poland;United States
      2008   Phase 2   NCT00584740   Canada;Germany;United States
Albendazole
   academic medical centre
      2018   Phase 4   EUCTR2017-001737-85-NL   Netherlands
Albumine humaine
   ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
      2019   Phase 2   EUCTR2019-001948-21-FR   France
Aldesleukin
   Boston Children's Hospital
      2021   Phase 1/Phase 2   NCT04263831   United States
Alemtuzumab
   Northwestern University
      2019   Phase 2   NCT04154735   United States
   Paul Szabolcs
      2012   Phase 1/Phase 2   NCT00692939   United States
Alequel
   Hadassah Medical Organization
      2008   Phase 1/Phase 2   NCT02185183   -
Alfacalcidol
   Nagoya University Hospital
      2017   -   JPRN-UMIN000025961   Japan
   Nakamura Masanao
      2017   Phase 2   JPRN-jRCTs041180126   -
Alicaforsen
   Ionis Pharmaceuticals, Inc.
      2001   Phase 3   NCT00048113   Canada;United States
ALLO-ASC
   Anterogen Co., Ltd.
      2015   Phase 1   NCT02580617   Korea, Republic of
ALLO-ASC-CD
   Anterogen Co., Ltd.
      2016   -   NCT03183661   Korea, Republic of
Allogeneic adipose tissue-derived mesenchymal stem cells expanded
   FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE
      2022   Phase 2   EUCTR2021-006068-26-ES   Spain
Allogeneic bone marrow derived human mesenchymal stem cells
   Joshua M Hare
      2019   Phase 1   NCT02677350   United States
Allogeneic bone marrow transplantation
   Fred Hutchinson Cancer Research Center
      2012   Phase 2   NCT01570348   United States
Allogeneic stem cell therapy
   Northwestern University
      2010   Phase 1/Phase 2   NCT01288053   United States
Allogenic eascs 5 milion cells/ML suspension FOR injection. CX601
   CELLERIX S.A.
      2012   Phase 3   EUCTR2011-006064-43-IT   Austria;Belgium;Germany;Israel;Italy;Netherlands;Spain
Allogenic eascs 5 million cells/ML suspension FOR injection CX601
   TIGENIX S.A.U
      2018   Phase 3   EUCTR2017-000725-12-IT   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
   TiGenix, S.A.U.
      2021   Phase 3   EUCTR2017-000725-12-SE   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2017-000725-12-DK   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000725-12-GB   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000725-12-DE   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-PL   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-HU   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-FR   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-CZ   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-BE   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
Allogenic eascs 5 million cells/ML suspension FOR injection. CX601
   TiGenix S.A.U.
      2012   Phase 3   EUCTR2011-006064-43-DE   Austria;Belgium;France;Germany;Israel;Italy;Netherlands;Spain
   TiGenix, S.A.U.
      2012   Phase 3   EUCTR2011-006064-43-AT   Austria;Belgium;France;Germany;Israel;Italy;Netherlands;Spain
Allogenic mesenchymal stem cell isolated from adipose tissue
   FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE
      2022   Phase 2   EUCTR2021-006068-26-ES   Spain
Allopurinol
   SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
      2018   Phase 4   EUCTR2016-004112-35-SE   Sweden
Allopurinol sandoz 100 MG, tabletten
   Meander Medical Center
      2016   Phase 4   EUCTR2016-001638-84-NL   Netherlands
Allopurinol sodium
   Marianne Kiszka-Kanowitz
      2013   Phase 3   EUCTR2013-001503-37-DK   Denmark
Alofisel
   Millennium Pharmaceuticals, Inc (MPI)
      2020   Phase 4   EUCTR2019-000333-39-FR   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2020   Phase 4   EUCTR2017-002491-10-FR   Austria;Czech Republic;France;Germany;Spain;United Kingdom
      2020   Phase 4   EUCTR2017-002491-10-ES   Austria;Czech Republic;France;Germany;Spain;United Kingdom
   Nantes University Hospital
      2024   -   NCT05974280   France
   Takeda Development Center Americas, Inc
      2020   Phase 3   EUCTR2019-000333-39-BE   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2019   Phase 4   EUCTR2019-000333-39-CZ   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
   Takeda Development Center Americas, Inc.
      2021   Phase 3   EUCTR2020-003193-48-NL   Israel;Italy;Japan;Netherlands;Poland;Spain
      2020   Phase 4   EUCTR2017-002491-10-DE   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      2020   Phase 4   EUCTR2017-002491-10-CZ   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      2020   Phase 4   EUCTR2017-002491-10-AT   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      -   Phase 3   EUCTR2020-003193-48-PL   Israel;Japan;Netherlands;Poland
   TiGenix, S.A.U.
      2021   Phase 3   EUCTR2017-000725-12-SE   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2017-000725-12-DK   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000725-12-GB   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000725-12-DE   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-PL   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-HU   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-CZ   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-BE   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
Also referred TO AS MED2070
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2019-001866-14-IT   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2023   Phase 3   EUCTR2019-001866-14-FR   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2019-001866-14-CZ   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-PL   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-HU   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-DE   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-AT   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Also referred TO AS MEDI2070
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2019-001866-14-IT   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2023   Phase 3   EUCTR2019-001866-14-FR   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2019-001866-14-CZ   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2;Phase 3   EUCTR2018-004346-42-FR   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-PL   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-HU   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-DE   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-AT   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
ALX-0600
   Shire
      2004   Phase 2   NCT00308438   Canada;United States
      2003   Phase 2   NCT00072839   Canada;United States
AMG 139
   AstraZeneca
      2011   Phase 1   NCT01258205   Australia;United States
AMG 181
   Amgen
      2011   Phase 1   NCT01290042   Australia;United States
   Amgen Inc
      2013   Phase 2   EUCTR2012-000529-31-NL   Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Netherlands;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000529-31-HU   Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Netherlands;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000529-31-GB   Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Netherlands;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000529-31-DK   Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Netherlands;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000529-31-DE   Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Netherlands;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000529-31-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Netherlands;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000529-31-BE   Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Netherlands;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000529-31-AT   Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Netherlands;United Kingdom;United States
AMG 827
   Amgen
      2010   Phase 2   NCT01199302   Australia;Belgium;Canada;France;Netherlands;Poland;Spain;United States
   Amgen Inc
      2011   -   EUCTR2010-020881-53-NL   Belgium;Netherlands;Spain
      2011   -   EUCTR2010-020881-53-ES   Belgium;Netherlands;Spain
      2011   Phase 2   EUCTR2010-020881-53-BE   Australia;Belgium;Canada;France;Netherlands;Poland;Spain;United States
      2011   -   EUCTR2010-019544-39-NL   Belgium;France;Netherlands;Spain
      2010   Phase 2   EUCTR2010-019544-39-FR   Belgium;France;Netherlands;Spain
      2010   -   EUCTR2010-019544-39-ES   Belgium;France;Netherlands;Spain
      2010   Phase 2   EUCTR2010-019544-39-BE   Australia;Belgium;Canada;France;Netherlands;Poland;Spain;United States
AMG 827 210 MG
   Amgen
      2010   Phase 2   NCT01150890   Australia;Belgium;Canada;France;Netherlands;Poland;Spain;United States
AMG 827 350 MG
   Amgen
      2010   Phase 2   NCT01150890   Australia;Belgium;Canada;France;Netherlands;Poland;Spain;United States
AMG 827 700 MG
   Amgen
      2010   Phase 2   NCT01150890   Australia;Belgium;Canada;France;Netherlands;Poland;Spain;United States
Amgevita
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
Amgevita 40 MG injektionslösung IM fertigpen
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany
Amgevita 40 MG injektionslösung IN einer fertigspritze
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany
Amgevita 40MG solution FOR injection
   Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
      2019   Phase 4   NCT04131322   Spain
Aminosalicylic acid
   University Medical Center Utrecht
      2009   -   EUCTR2009-011220-62-NL   Netherlands
   University of Vermont
      1995   -   NCT00004423   -
Amoxicillin
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
   Juntendo university school of medicine Department of gastroenterology
      2017   -   JPRN-UMIN000025846   Japan
AN100226
   Elan Pharma Ltd.
      2005   -   EUCTR2004-003839-31-DK   Denmark
Andecaliximab
   Gilead Sciences
      2015   Phase 2   NCT02405442   Australia;Canada;Czech Republic;Czechia;France;Germany;Hungary;Iceland;Italy;New Zealand;Poland;South Africa;Spain;United Kingdom;United States
Andosan
   Oslo University Hospital
      2011   Phase 2/Phase 3   NCT01496053   Norway
Anti TNF
   Carmel Medical Center
      2014   -   NCT01881464   Israel
   University Hospital, Lille
      2017   -   NCT02872506   -
Anti TNF humanized antibody FAB fragment-PEG conjugate
   UCB PHARMA S.A.
      2008   -   EUCTR2007-003239-21-FR   France
Anti TNF therapy including infliximab
   Janssen Biotech, Inc.
      2007   -   NCT00606346   Canada;United States
ANTI-CD3
   NovImmune SA
      2006   Phase 1/Phase 2   NCT00630643   -
ANTI-CD3 monoclonal antibody
   PDL BioPharma, Inc
      2005   -   EUCTR2004-004388-31-DE   Germany
   PDL BioPharma, Inc.
      2005   -   EUCTR2004-004387-72-DE   Germany
   Protein Design Labs, Inc.
      2005   -   EUCTR2004-004387-72-AT   Austria;Germany
ANTI-IL-23 monoclonal antibody
   Allergan Limited
      2017   Phase 2   EUCTR2015-000609-38-GB   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-000609-38-HU   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-000609-38-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-000609-38-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2013   Phase 2   EUCTR2012-004098-26-HU   Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United States
      2013   Phase 2   EUCTR2012-004098-26-FR   Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United States
      2013   Phase 2   EUCTR2012-004098-26-ES   Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United States
      2013   Phase 2   EUCTR2012-004098-26-DE   Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United States
      2013   Phase 2   EUCTR2012-004098-26-CZ   Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United States
   MedImmune Limited
      2016   Phase 2   EUCTR2015-000609-38-CZ   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   MedImmune, Ltd, a wholly owned subsidiary of AstraZeneca UK
      2016   Phase 2   EUCTR2015-000609-38-NL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-000609-38-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-000609-38-BE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
ANTI-IL-6 MAB
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2012   -   EUCTR2011-004763-72-IT   Australia;Austria;Brazil;Canada;Czech Republic;European Union;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2012   -   EUCTR2011-004763-72-NL   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-HU   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-GB   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-DE   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-CZ   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-AT   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
ANTI-IL12/23 or ANTI-IL23 - risankizumab
   University of Calgary
      2023   Phase 4   NCT05928039   Canada
ANTI-IL12/23 or ANTI-IL23 - ustekinumab
   University of Calgary
      2023   Phase 4   NCT05928039   Canada
ANTI-integrin - vedolizumab IV and SC
   University of Calgary
      2023   Phase 4   NCT05928039   Canada
ANTI-interferon-gamma monoclonal antibody
   Facet Biotech
      2002   Phase 2   NCT00072943   Canada;United States
ANTI-interleukin-23 immunoglobulin G2 (IGG2) human monoclonal antibody
   ALLERGAN LIMITED
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2019-001866-14-IT   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Allergan Limited
      2021   Phase 3   EUCTR2019-001866-14-ES   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Allergan Ltd.
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-RO   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2018-004346-42-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2023   Phase 3   EUCTR2019-001866-14-FR   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2019-001866-14-CZ   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2;Phase 3   EUCTR2018-004346-42-FR   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-PL   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-HU   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-DE   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-AT   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-SK   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-HU   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-DE   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2019-001866-14-GB   Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Astrazeneca AB
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
ANTI-interleukin-6 monoclonal antibody
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2012   -   EUCTR2011-004763-72-IT   Australia;Austria;Brazil;Canada;Czech Republic;European Union;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2012   -   EUCTR2011-004763-72-NL   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-HU   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-GB   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-DE   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-CZ   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-AT   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
ANTI-madcam antibody
   Pfizer Inc.
      2013   Phase 2   EUCTR2012-002030-37-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;United Kingdom
   SHIRE HUMAN GENETIC THERAPIES, INC
      2019   Phase 3   EUCTR2017-000617-23-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000575-88-IT   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
   Shire Human Genetic Therapies, Inc.
      2019   Phase 3   EUCTR2017-000617-23-RO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000617-23-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000576-29-GR   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2019   Phase 3   EUCTR2017-000575-88-RO   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000574-11-RO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000574-11-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000576-29-HU   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-ES   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-BE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      -   Phase 3   EUCTR2017-000617-23-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000575-88-CZ   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
ANTI-TNF
   Tohoku University Graduate School of Medicine (Tohoku University Hospital)
      2012   -   JPRN-UMIN000007343   Japan
   University of Maryland, Baltimore
      2011   -   NCT02619552   United States
ANTI-TNF discontinuation: physiological saline solution
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2017   Phase 4   NCT02994836   Spain
ANTI-TNF drug
   Hospices Civils de Lyon
      2022   -   NCT03712826   France
   Schneider Children's Medical Center, Israel
      2019   -   NCT03681652   Israel
ANTI-TNF therapy
   Connecticut Children's Medical Center
      2023   Phase 4   NCT05781152   Canada;United States
   Takeda
      2017   -   NCT03090139   Argentina;China;Colombia;Korea, Republic of;Mexico;Russian Federation;Saudi Arabia;Singapore;Taiwan;Turkey
ANTI-tumour necrosis factor A antibodies
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2013   Phase 3   NCT06441526   Netherlands
Antibiotics
   Hyogo college of medicine
      2014   Phase 2   JPRN-UMIN000013369   Japan
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
   Juntendo university school of medicine Department of gastroenterology
      2017   -   JPRN-UMIN000025846   Japan
   Sichuan Academy of Medical Sciences. Sichuan Provincial People's Hospital
      2023   -   ChiCTR2300069727   China
   St Vincent's Hospital Melbourne
      2022   Phase 1/Phase 2   NCT04970446   Australia
Anticorpo monoclonale anti IL-23
   ASTRAZENECA
      2013   Phase 2   EUCTR2012-004098-26-IT   Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
Anticorpo monoclonale ANTI-IL-23
   MEDIMMUNE, LLC
      2016   Phase 2   EUCTR2015-000609-38-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Antithymocyte immunoglobulin
   WOLFSON DIGESTIVE DISEASES CENTRE
      2007   -   EUCTR2005-003337-40-IT   Italy;United Kingdom
APD334
   ARENA PHARMACEUTICALS, INC.
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-IT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc.
      2022   Phase 2;Phase 3   EUCTR2020-004775-40-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-SK   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-PT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-NO   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-NL   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-LT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-HU   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-GR   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-GB   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-FR   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-ES   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-CZ   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-BG   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals, Inc.
      2017   Phase 2   EUCTR2016-003797-40-DE   Belgium;Germany;United States
      2017   Phase 2   EUCTR2016-003797-40-BE   Belgium;Germany;United States
APD371
   Arena Pharmaceuticals
      2017   Phase 2   NCT03155945   United States
Apheresis catheter placement
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
Apixaban 2.5 milligram
   McMaster University
      2021   Early Phase 1   NCT03935451   Canada
Application OF adalimumab
   Gerhard Rogler
      2009   -   NCT01012570   Switzerland
AR401959 L-arginine
   ARENA PHARMACEUTICALS, INC.
      2020   Phase 2   EUCTR2019-002895-14-IT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc.
      2022   Phase 2;Phase 3   EUCTR2020-004775-40-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-SK   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-PT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-NO   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-NL   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-LT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-HU   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-GR   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-GB   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-FR   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-ES   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-CZ   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-BG   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
Artesunate
   Sanjay Gandhi Postgraduate Institute of Medical Sciences
      2021   Phase 2   NCT04713631   India
Ascs: adipose derived stem cells
   CELLERIX S.A.
      2009   -   EUCTR2008-004286-25-DE   Austria;Belgium;Czech Republic;Germany;Netherlands;Spain
      2009   -   EUCTR2008-004286-25-BE   Austria;Belgium;Czech Republic;Germany;Netherlands;Spain
Aspirin 81MG EC TAB
   Stefan Holubar MD MS FACS, FASCRS
      2024   Phase 3   NCT05104229   United States
AST-120
   Ocera Therapeutics, Inc.
      2007   -   EUCTR2005-005363-28-HU   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2007   -   EUCTR2005-005363-28-AT   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   Phase 3   EUCTR2005-005363-28-GB   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-DE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-BE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
ATG
   Paul Szabolcs
      2012   Phase 1/Phase 2   NCT00692939   United States
   Stanford University
      2025   Phase 1/Phase 2   NCT06986382   United States
ATH-063
   Athos Therapeutics Inc
      2023   Phase 1   NCT05807971   Australia
Atorvastatin
   Region Skåne
      2006   -   EUCTR2005-000496-17-SE   Sweden
   Skane University Hospital
      2006   Phase 2   NCT00454545   Sweden
Autologous adipose derived stromal vascular fraction
   ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
      2019   Phase 2   EUCTR2019-001948-21-FR   France
Autologous CD34-selected peripheral blood stem cells transplant
   Paul Szabolcs
      2012   Phase 1/Phase 2   NCT00692939   United States
Autologous mesenchymal stromal cell
   Emory University
      2012   Phase 1   NCT01659762   United States
Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population
   TxCell
      2014   Phase 2   EUCTR2014-001295-65-IT   Austria;Belgium;Germany;Italy
      2014   Phase 2   EUCTR2014-001295-65-DE   Austria;Belgium;Germany;Italy
      2014   Phase 2   EUCTR2014-001295-65-BE   Austria;Belgium;Germany;Italy
      2014   Phase 2   EUCTR2014-001295-65-AT   Austria;Belgium;Germany;Italy
Autologous stem cell transplant
   Aaron Etra
      2017   Phase 2   NCT03219359   United States
Autologous stem cell transplantation
   Northwestern University
      2005   Phase 2   NCT00271947   United States
AVB-114
   Avobis Bio, LLC
      2024   -   NCT06509828   -
      2021   Phase 2   NCT04847739   United States
AZA
   Children's Memorial Health Institute, Poland
      2008   Phase 3   NCT01559142   Poland
   Merck Sharp & Dohme Corp.
      2003   Phase 3   NCT00796250   -
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands
AZA capsules
   Centre Hospitalier Universitaire, Amiens
      2021   Phase 3   NCT05040464   France
Azathioprin
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2010-020137-10-LT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2010-020137-10-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-020137-10-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-SE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-020137-10-GB   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-DE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
   Abbott GmbH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-020137-10-ES   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
   PIBD-Net
      2017   Phase 3   EUCTR2016-000522-18-DE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDNet
      2018   Phase 4   EUCTR2016-000522-18-CZ   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
Azathioprin-ratiopharm 25 MG
   Abbott GmBH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Azathioprine
   AbbVie (prior sponsor, Abbott)
      2011   Phase 3   NCT01235689   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2010-020137-10-LT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2010-020137-10-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-020137-10-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-SE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-020137-10-GB   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-DE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
   Abbott GmbH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-020137-10-ES   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
   Academic Medical Center, department of Gastroenterology and hepatology
      2008   -   EUCTR2008-001131-35-NL   Netherlands
   CHU Amiens Picardie
      2021   Phase 3   EUCTR2021-002047-29-FR   France
   Centocor B.V.
      2005   -   EUCTR2004-002815-10-SE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-GB   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-ES   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DK   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-AT   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
   Children's Memorial Health Institute, Poland
      2008   Phase 3   NCT01559142   Poland
   Department of Gastroenterology and Hepatology, Kyoto University Hospital
      2011   -   JPRN-UMIN000005689   Japan
   Department of Gastroenterology, Nanfang Hospital, Southern Medical University
      2016   -   ChiCTR1800020305   China
   Department of Internal Medicine, School of Medicine, Keio University
      2013   -   JPRN-UMIN000009596   Japan
      2011   Phase 4   JPRN-UMIN000005146   Japan
   Dr. Falk Pharma GmbH
      2002   Phase 3   NCT00946946   Austria;Germany
   Erasmus Medical Center
      2015   Phase 4   NCT02517684   Belgium;Denmark;Finland;Italy;Netherlands;Poland
      2013   Phase 4   NCT01880307   Italy;Netherlands
   GETAID
      2018   Phase 4   EUCTR2014-002311-41-NL   Belgium;France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-SE   France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-DE   Australia;France;Germany;Netherlands;Sweden;United Kingdom
      2014   -   EUCTR2014-002311-41-FR   France;Sweden;United Kingdom
   Gastroenterology Research of America
      2013   Phase 3   NCT01817972   United States
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2005   Phase 4   NCT00546546   France
   Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
      2012   Phase 3   NCT01564823   Spain
   Indiana University
      2015   -   NCT02413047   United States
   Jinling Hospital, China
      2009   -   NCT01015391   China
   Marianne Kiszka-Kanowitz
      2013   Phase 3   EUCTR2013-001503-37-DK   Denmark
   Massachusetts General Hospital
      2005   Phase 3   NCT00098111   United States
   Novartis Pharma Services AG
      2005   Phase 2   EUCTR2005-001148-22-SK   Slovakia
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   PIBD-Net
      2017   Phase 3   EUCTR2016-000522-18-DE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDNet
      2018   Phase 4   EUCTR2016-000522-18-CZ   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      2018   Phase 4   EUCTR2016-000522-18-BE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      2017   Phase 4   EUCTR2016-000522-18-NL   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      -   Phase 4   EUCTR2016-000522-18-FR   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDnet (Pediatric Inflammatory Bowel Disease Network)
      -   Phase 4   EUCTR2016-000522-18-PL   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
      2018   Phase 4   EUCTR2016-004112-35-SE   Sweden
   Schneider Children's Medical Center, Israel
      2019   -   NCT03681652   Israel
   Shanghai Research Institute of Acupuncture and Meridian
      2016   Phase 1 study   ChiCTR-IIR-16007751   China
   Sixth Affiliated Hospital, Sun Yat-sen University
      2023   Phase 4   NCT05813860   -
      2021   -   NCT04761952   -
      2017   Phase 3   NCT03185611   China
   Tokyo Medical & Dental University Gastroenterology
      2013   -   JPRN-UMIN000010524   Japan
   Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
      2021   Phase 4   ChiCTR2100049326   China
   University of Edinburgh
      2015   -   EUCTR2014-002311-41-GB   Belgium;France;Germany;Sweden;United Kingdom
   Zhu Weiming
      2018   -   NCT04160325   China
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands
Azathioprine (AZA) caps
   Centocor Ortho Biotech Services, L.L.C.
      2005   Phase 3   NCT00094458   Austria;Belgium;Canada;Denmark;France;Germany;Greece;Israel;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;United States
Azathioprine + infliximab
   Nantes University Hospital
      2023   -   NCT05584228   -
Azathioprine - ratiopharm 50 MG
   Abbott GmBH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Azathioprine / 6 mercaptopurine
   PIBD-Net
      2017   Phase 4   NCT02852694   France
Azathioprine IN case OF endoscopic recurrence
   Universitaire Ziekenhuizen Leuven
      2005   Phase 2   NCT02247258   Belgium;Czech Republic;Greece
Azathioprine individualised dose
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
      2005   Phase 2   NCT00113503   Canada;United States
Azathioprine or adalimumab and infliximab
   Tokyo Medical and Dental University
      2014   Phase 3   NCT02332356   Japan
Azathioprine or mesalazine
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2002   Phase 3   NCT00976690   France
Azathioprine or methotrexate
   Prof. Arie Levine
      2013   Phase 4   NCT01802593   Israel
Azathioprine weight-based dose
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
      2005   Phase 2   NCT00113503   Canada;United States
Azathioprine+enteral nutrition
   Jinling Hospital, China
      2012   -   NCT01823042   China
Azatioprina
   GETECCU
      2011   -   EUCTR2011-000885-36-ES   Spain
Azatioprina aspen - 50 compresse
   UMBERTO I - POLICLINICO DI ROMA
      2017   Phase 4   EUCTR2016-000522-18-IT   Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Poland;United Kingdom
AZD7798
   AstraZeneca
      2024   Phase 2   NCT06681324   Belgium;Italy;Netherlands;Poland;Sweden;United Kingdom
      2024   Phase 2   NCT06450197   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;France;Germany;Hungary;Italy;Japan;Malaysia;Mexico;Netherlands;Poland;Romania;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;Vietnam
      2024   Phase 1   NCT06432764   Sweden
      2023   Phase 1   NCT06053424   Sweden
      2022   Phase 1   NCT05452304   United Kingdom
AZD9056
   AstraZeneca AB
      2006   -   EUCTR2005-002319-26-HU   Austria;Belgium;Germany;Hungary
      2006   -   EUCTR2005-002319-26-AT   Austria;Belgium;Germany;Hungary
      2005   -   EUCTR2005-002319-26-DE   Austria;Belgium;Germany;Hungary
      2005   -   EUCTR2005-002319-26-BE   Austria;Belgium;Germany;Hungary
Azithromycin
   Amsterdam UMC
      2020   Phase 2   EUCTR2019-004219-29-NL   Canada;Israel;Netherlands;United States
   Centro Hospitalar de São João E.P.E.
      2013   Phase 3   EUCTR2012-005226-29-PT   Belgium;Canada;Israel;Netherlands;Poland;Portugal;United States
   Erasmus MC
      2014   -   EUCTR2012-005226-29-PL   Belgium;Canada;Israel;Netherlands;Poland;Portugal;United States
   University of North Carolina, Chapel Hill
      2021   Phase 2   NCT04186247   Canada;Israel;Netherlands;United States
   Wolfson Medical Center
      2013   Phase 3   EUCTR2012-005226-29-BE   Belgium;Canada;Israel;Netherlands;Poland;Portugal;United States
      -   -   EUCTR2012-005226-29-NL   Canada;Israel;Netherlands;United States
Azithromycin + metronidazole
   Prof. Arie Levine
      2012   Phase 4   NCT01596894   Israel
Azithromycin pill
   Rambam Health Care Campus
      2023   Phase 2   NCT05599347   Israel
B. theta
   4D Pharma
      2015   Phase 1   EUCTR2014-005666-29-GB   United Kingdom
Bacteriophage preparation
   Intralytix, Inc.
      2019   Phase 1/Phase 2   NCT03808103   United States
Bacteriotherapy
   David Suskind
      2012   Phase 1   NCT01757964   United States
Bacteroides thetaiotaomicron
   4D Pharma
      2015   Phase 1   EUCTR2014-005666-29-GB   United Kingdom
Beta carotene from dunaliella algae
   Bnai Zion Medical Center
      2002   Phase 3   NCT00275418   Israel
Betamethasone
   The Sixth Affiliated Hospital of Sun Yat-sen University
      2019   -   ChiCTR1900023696   China
Bezlotoxumab
   David Binion, MD
      2021   Phase 4   NCT04626947   United States
BI 655066
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2014   Phase 2   EUCTR2013-002902-29-DE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
BI 655066 10 MG/ML
      2014   Phase 2   EUCTR2013-002902-29-IE   Belgium;Canada;France;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
      2013   Phase 2   EUCTR2013-002902-29-GB   Belgium;Canada;France;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2015-001834-15-NL   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Spain;United States
      2015   Phase 2   EUCTR2015-001834-15-DE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001834-15-BE   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Spain;United States
   Boehringer Ingelheim España, S.A.
      2015   Phase 2   EUCTR2015-001834-15-ES   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Spain;United States
      2014   Phase 2   EUCTR2013-002902-29-ES   Belgium;Canada;France;Ireland;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
   Boehringer Ingelheim bv
      2015   Phase 2   EUCTR2013-002902-29-NL   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
   SCS Boehringer Ingelheim Comm.V
      2014   Phase 2   EUCTR2013-002902-29-BE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
BI 655066 90 MG/ML
      2014   Phase 2   EUCTR2013-002902-29-IE   Belgium;Canada;France;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
      2013   Phase 2   EUCTR2013-002902-29-GB   Belgium;Canada;France;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2015-001834-15-NL   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Spain;United States
      2015   Phase 2   EUCTR2015-001834-15-DE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001834-15-BE   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Spain;United States
   Boehringer Ingelheim España, S.A.
      2015   Phase 2   EUCTR2015-001834-15-ES   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Spain;United States
      2014   Phase 2   EUCTR2013-002902-29-ES   Belgium;Canada;France;Ireland;Korea, Republic of;Netherlands;Spain;United Kingdom;United States
   Boehringer Ingelheim bv
      2015   Phase 2   EUCTR2013-002902-29-NL   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
   SCS Boehringer Ingelheim Comm.V
      2014   Phase 2   EUCTR2013-002902-29-BE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
BI 655130
   BOEHRINGER-INGELHEIM ITALIA S.P.A.
      2021   Phase 2   EUCTR2020-005770-99-IT   Aruba;Australia;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim
      2021   Phase 2   EUCTR2020-005770-99-NL   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2019-001673-93-BE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2020   Phase 2   EUCTR2019-001673-93-AT   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim AB
      2021   Phase 2   EUCTR2020-005770-99-SE   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim B.V
      2021   Phase 2   EUCTR2020-005770-99-DK   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim BV
      2022   Phase 2   EUCTR2019-001673-93-DK   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2020   Phase 2   EUCTR2017-003090-34-DK   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim Ltd
      2021   Phase 2   EUCTR2020-005770-99-IE   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim Netherlands BV
      2019   Phase 2   EUCTR2017-003090-34-NL   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim Norway KS
      2022   Phase 2   EUCTR2020-005770-99-NO   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2020   Phase 2   EUCTR2019-001673-93-DE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2019   Phase 2   EUCTR2017-003090-34-DE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim Portugal, Lda
      2021   Phase 2   EUCTR2020-005770-99-PT   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim RCV GmbH & Co KG
      2020   Phase 2   EUCTR2019-001673-93-HU   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2019   Phase 2   EUCTR2017-003090-34-HU   Austria;Belgium;Germany;Hungary;Netherlands
      2019   Phase 2   EUCTR2017-003090-34-AT   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim S.A.
      2021   Phase 2   EUCTR2019-001673-93-ES   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   SCS Boehringer Ingelheim Comm.V
      2018   Phase 2   EUCTR2017-003090-34-BE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
BI 695501
   Boehringer Ingelheim
      2016   Phase 3   NCT02871635   Belarus;Bosnia and Herzegovina;Croatia;Czechia;Germany;Greece;Israel;Poland;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
   Boehringer Ingelheim International GmbH
      2017   Phase 3   EUCTR2016-000612-14-HR   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-GR   Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-GB   Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-DE   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000612-14-CZ   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
BI 706321
   BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      2021   Phase 2   EUCTR2020-004527-16-IT   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;United States
   Boehringer Ingelheim
      2021   Phase 2   NCT04978493   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
   Boehringer Ingelheim International GmbH
      2023   Phase 2   EUCTR2020-004527-16-NL   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2020-004527-16-DK   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2020-004527-16-DE   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2021   Phase 2   EUCTR2020-004527-16-PL   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United States
      2021   Phase 2   EUCTR2020-004527-16-BE   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;United States
BI-peglyte
   University of Manitoba
      2024   Phase 4   NCT06298461   Canada
BI706321
   Boehringer Ingelheim International GmbH
      2023   Phase 2   EUCTR2020-004527-16-NL   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2020-004527-16-DK   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2020-004527-16-DE   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2021   Phase 2   EUCTR2020-004527-16-PL   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United States
      2021   Phase 2   EUCTR2020-004527-16-BE   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;United States
Bibr 796 BS, 20 MG
   Boehringer Ingelheim
      2001   Phase 2   NCT02209792   -
Bibr 796 BS, 5 MG
   Boehringer Ingelheim
      2001   Phase 2   NCT02209792   -
BIF195 capsules
   Hvidovre University Hospital
      2021   -   NCT04842149   Denmark
Bifidobacterium
   Fukui Hirokazu
      2021   -   JPRN-jRCTs031200327   -
Bifidobacterium infantis 35624
   University College Cork
      2002   Phase 2/Phase 3   NCT00510978   Ireland
Biological agents
   Tongji Hospital
      2023   -   NCT06673134   China
Biological drug
   Universitaire Ziekenhuizen KU Leuven
      2022   Phase 4   NCT05169593   Belgium;Italy
Biological samplings
   Hospices Civils de Lyon
      2011   -   NCT02504255   France
Biologics
   Janssen Biotech, Inc.
      2007   -   NCT00606346   Canada;United States
   Sixth Affiliated Hospital, Sun Yat-sen University
      2020   -   NCT05542459   China
Biosimilar
   Fukuoka University Chikushi Hospital
      2021   -   JPRN-UMIN000043165   Japan
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain
   Jamp Pharma Corporation
      2023   -   NCT05913817   Canada
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2018   -   NCT03729674   Canada
   Numaguchi Hirotaka
      2021   Phase 2   JPRN-jRCT2031200406   Canada;France;Germany;Italy;Japan;Spain;United States Of America
   Pfizer
      2019   -   NCT03884439   Japan
Biosimilar infliximab
   Diakonhjemmet Hospital
      2014   Phase 4   NCT02148640   Norway
   University of Toyama
      2017   -   JPRN-UMIN000026330   Japan
Biospecimen collection
   National Cancer Institute (NCI)
      2019   Phase 1   NCT03816345   Canada;United States
Bleomycin
   The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine
      2020   Phase 0   ChiCTR2000031344   China
BLI-1300 high dose
   Braintree Laboratories
      2011   Phase 2   NCT01442363   United States
BLI-1300 LOW dose
   Braintree Laboratories
      2011   Phase 2   NCT01442363   United States
Blood and fecal samples
   Centre Hospitalier Régional d'Orléans
      2023   -   NCT05916274   France
Blood and stools samples
   University Hospital, Lille
      2015   -   NCT02851134   France
Blood draw
   Massachusetts General Hospital
      2023   -   NCT06252493   United States
Blood or saliva sample collection
   Mount Sinai Hospital, Canada
      2022   -   NCT06042387   Canada
Blood sample
   Centre Hospitalier Universitaire, Amiens
      2021   Phase 3   NCT05040464   France
Blood samples
   Hospices Civils de Lyon
      2024   -   NCT06244849   France
Blood sampling
   Centre Hospitalier Universitaire Dijon
      2013   -   NCT02859675   France
Blood sampling from infant
   UCB BIOSCIENCES, Inc.
      2014   Phase 1   NCT02019602   France;Netherlands;Switzerland;United States
Blood sampling from mother
   UCB BIOSCIENCES, Inc.
      2014   Phase 1   NCT02019602   France;Netherlands;Switzerland;United States
Blood sampling from umbilical cord
   UCB BIOSCIENCES, Inc.
      2014   Phase 1   NCT02019602   France;Netherlands;Switzerland;United States
Blue light photopheresis
   University Hospital, Akershus
      2019   Phase 1/Phase 2   NCT04164849   Norway
Blueberry-rich diet
   Universität Duisburg-Essen
      2024   -   NCT06698601   Germany
BMS-188667
   Bristol-Myers Squibb International Corporation
      2008   -   EUCTR2006-003371-13-PL   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2008   Phase 3   EUCTR2006-003371-13-IE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2008   -   EUCTR2006-003371-13-CZ   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-NL   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-IT   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-GB   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003371-13-FR   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-DK   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003371-13-DE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-BE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
BMS-936557
   Bristol-Myers Squibb
      2011   Phase 2   NCT01466374   Belgium;France;Hungary;Israel;Poland;Puerto Rico;South Africa;United States
   Bristol-Myers Squibb International Corporation
      2012   -   EUCTR2011-002981-19-PL   Belgium;France;Hungary;Poland;South Africa;United States
      2012   -   EUCTR2011-002981-19-HU   Belgium;France;Hungary;Poland;South Africa;United States
      2012   -   EUCTR2011-002981-19-BE   Belgium;France;Hungary;Poland;South Africa;United States
BMS-945429
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2012   -   EUCTR2011-004763-72-IT   Australia;Austria;Brazil;Canada;Czech Republic;European Union;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2012   -   EUCTR2011-004763-72-NL   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-HU   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-GB   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-DE   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-CZ   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-004763-72-AT   Australia;Austria;Brazil;Canada;Czech Republic;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
   CSL Behring
      2012   Phase 2   NCT01545050   Australia;Austria;Brazil;Canada;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Singapore;Switzerland;Taiwan;United Kingdom;United States
BMS-986165
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 2   EUCTR2020-004461-40-IT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-IT   Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Hungary;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Spain;Switzerland;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb
      2018   Phase 2   NCT03599622   Australia;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 2   EUCTR2020-004461-40-PT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2020-004461-40-NL   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2020-004461-40-DE   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2017-001976-48-NL   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2017-001976-48-BE   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2019   Phase 2   EUCTR2017-001976-48-PT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2019   Phase 2   EUCTR2017-001976-48-DK   Australia;Belgium;Bouvet Island;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Slovakia;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-GB   Australia;Belgium;Brazil;Canada;China;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb international Corporation
      2020   Phase 2   EUCTR2017-001976-48-FR   Australia;Belgium;Brazil;Canada;China;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2019   Phase 2   EUCTR2017-001976-48-RO   Australia;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Slovakia;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-PL   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-HU   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-ES   Australia;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Mexico;Poland;Romania;Spain;Taiwan;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-DE   Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Spain;Switzerland;Taiwan;United Kingdom;United States
   Walid Elsharkawi
      2022   Phase 2   JPRN-jRCT2031210637   Australia;Belgium;Brazil;Canada;China;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Portugal;Romania;Russia;South Korea;Spain;Switzerland;Taiwan;UK;US
BMS986165
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2018   Phase 2   EUCTR2017-001976-48-IT   Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Hungary;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Spain;Switzerland;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 2   EUCTR2020-004461-40-PT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2020-004461-40-NL   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2020-004461-40-DE   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2017-001976-48-NL   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2019   Phase 2   EUCTR2017-001976-48-DK   Australia;Belgium;Bouvet Island;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Slovakia;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-GB   Australia;Belgium;Brazil;Canada;China;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb international Corporation
      2020   Phase 2   EUCTR2017-001976-48-FR   Australia;Belgium;Brazil;Canada;China;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2019   Phase 2   EUCTR2017-001976-48-RO   Australia;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Slovakia;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-PL   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-HU   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-ES   Australia;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Mexico;Poland;Romania;Spain;Taiwan;United Kingdom;United States
      2018   Phase 2   EUCTR2017-001976-48-DE   Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Spain;Switzerland;Taiwan;United Kingdom;United States
Boulardii
   University Clinic Dr Dragisa Misovic-Dedinje
      2019   -   NCT03941418   -
Brazikumab
   ALLERGAN LIMITED
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2019-001866-14-IT   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Allergan Limited
      2021   Phase 3   EUCTR2019-001866-14-ES   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Allergan Ltd.
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-RO   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2018-004346-42-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2023   Phase 3   EUCTR2019-001866-14-FR   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2019-001866-14-CZ   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2022   Phase 2;Phase 3   EUCTR2018-004346-42-FR   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-PL   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-HU   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-DE   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-001866-14-AT   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-SK   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-HU   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-CZ   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-DE   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2019-001866-14-GB   Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Astrazeneca AB
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Brazikumab high dose
   AstraZeneca
      2018   Phase 2/Phase 3   NCT03759288   Australia;Austria;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Brazikumab induction dose
   AstraZeneca
      2020   Phase 3   NCT03961815   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Brazikumab IV infusion
   Allergan
      2016   Phase 2   NCT02574637   Australia;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
Brazikumab LOW dose
   AstraZeneca
      2018   Phase 2/Phase 3   NCT03759288   Australia;Austria;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Brazikumab maintenance dose
   AstraZeneca
      2020   Phase 3   NCT03961815   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Brazikumab SC injection
   Allergan
      2016   Phase 2   NCT02574637   Australia;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
Breast milk sampling
   UCB BIOSCIENCES, Inc.
      2014   Phase 1   NCT02154425   France;Netherlands;Switzerland;United States
Brepocitinib 25 MG
   Pfizer Inc.
      2018   Phase 2   EUCTR2017-003359-43-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001
      2018   Phase 2   EUCTR2017-003359-43-PL   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
Brepocitinib 5 MG
   Pfizer Inc.
      2018   Phase 2   EUCTR2017-003359-43-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001
      2018   Phase 2   EUCTR2017-003359-43-PL   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
Brepocitinib 5MG
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
BT-11
   Landos Biopharma Inc.
      2022   Phase 2   EUCTR2019-000824-17-AT   Albania;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Moldova, Republic of;Netherlands;North Macedonia;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2021   Phase 2   EUCTR2019-000824-17-SK   Albania;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;North Macedonia;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2021   Phase 2   EUCTR2019-000824-17-HR   Albania;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Moldova, Republic of;Netherlands;North Macedonia;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2021   Phase 2   EUCTR2019-000824-17-BG   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;North Macedonia;Poland;Serbia;Slovakia;Spain;Turkey;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-HU   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
   NImmune Biopharma
      2021   Phase 2   NCT05057273   -
BT-11 1000MG
   Landos Biopharma Inc.
      2020   Phase 2   EUCTR2018-005086-39-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
BT-11 500 MG
   Landos Biopharma Inc.
      2020   Phase 2   EUCTR2018-005086-39-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
BT-11 880 MG
   NImmune Biopharma
      2021   Phase 2   NCT03870334   Bulgaria;Poland;United States
Budenofalk
   Dr. Falk Pharma GmbH
      2007   -   EUCTR2004-001213-34-GB   Czech Republic;United Kingdom
   University Medical Center Utrecht
      2009   -   EUCTR2007-005455-42-NL   Netherlands
Budenofalk 3MG gastro-resistant capsules
   Dr. Falk Pharma GmbH
      2009   -   EUCTR2008-006957-42-SK   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-LV   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-LT   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Romania;Russian Federation;Slovakia;Ukraine
      2009   -   EUCTR2008-006957-42-HU   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-DE   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Romania;Russian Federation;Slovakia;Ukraine
      2009   -   EUCTR2008-006957-42-CZ   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-BG   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
Budenofalk 9MG gastro-resistant granules
   Dr. Falk Pharma GmbH
      2009   -   EUCTR2008-006957-42-SK   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-LV   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-LT   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Romania;Russian Federation;Slovakia;Ukraine
      2009   -   EUCTR2008-006957-42-HU   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-DE   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Romania;Russian Federation;Slovakia;Ukraine
      2009   -   EUCTR2008-006957-42-CZ   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-BG   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
Budesonide
   ASTRAZENECA
      2011   Phase 3   EUCTR2011-003743-22-IT   Canada;Germany;Italy;United States
   AstraZeneca
      2008   Phase 2   JPRN-jRCT2080220544   -
   AstraZeneca AB
      -   -   EUCTR2011-003743-22-DE   Canada;Germany;Italy;Poland;United States
      -   -   EUCTR2011-003742-40-DE   Canada;Germany;Italy;Poland;United States
   AstraZeneca K.K.
      -   Phase 3   EUCTR2014-004132-20-Outside-EU/EEA   Japan
   Dr. Falk Pharma GmbH
      2009   Phase 3   NCT01086553   Germany
      2009   -   EUCTR2008-006957-42-SK   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-LV   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-LT   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Romania;Russian Federation;Slovakia;Ukraine
      2009   -   EUCTR2008-006957-42-HU   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-DE   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Romania;Russian Federation;Slovakia;Ukraine
      2009   -   EUCTR2008-006957-42-CZ   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2009   -   EUCTR2008-006957-42-BG   Bulgaria;Czech Republic;Germany;Hungary;Latvia;Lithuania;Slovakia
      2007   -   EUCTR2004-001213-34-GB   Czech Republic;United Kingdom
      2004   Phase 3   NCT00300118   Germany
      2004   Phase 3   EUCTR2004-001213-34-SK   Czech Republic;Slovakia;United Kingdom
      2004   -   EUCTR2004-001213-34-CZ   Czech Republic;United Kingdom
   Hillel Yaffe Medical Center
      2020   -   NCT04233463   Israel
   Medical University of Warsaw
      2024   Phase 2/Phase 3   NCT06719622   Poland
      2023   Phase 3   EUCTR2020-004168-24-PL   Poland
   Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology
      2018   -   JPRN-UMIN000031839   Japan
   Royal Liverpool & Broadgreen University Hospitals Trust
      2009   Phase 2   EUCTR2008-001137-99-GB   United Kingdom
   Royal Liverpool University Hospital
      2014   Phase 2   NCT01783106   United Kingdom
   Takehara Tetsuo
      2018   Phase 2   JPRN-jRCT1051190043   -
   Tohoku University Hospital, Division of Gastroenterology
      2018   -   JPRN-UMIN000030884   Japan
   University Medical Center Utrecht
      2009   -   EUCTR2007-005455-42-NL   Netherlands
   ZERIA Pharmaceutical Co., Ltd.
      2017   -   JPRN-jRCT1080224091   Japan
Budezonide
   Medical University of Warsaw
      2023   Phase 3   EUCTR2020-004168-24-PL   Poland
Bupivacaine/epinephrine/dexamethasone
   Cedars-Sinai Medical Center
      2018   Phase 4   NCT03723447   United States
Bupropion
   Altschuler, Eric, M.D.
      2005   Phase 2/Phase 3   NCT00126373   United States
BY demand
   Hospital Galdakao-Usansolo
      2020   -   NCT04188990   Spain
C326, IL-6 inhibitory avimer protein
   Avidia
      2006   Phase 1   NCT00353756   Australia
Caffeine
   Takeda
      2016   Phase 4   NCT02760615   United States
Caffeine 100 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Calcio
   ASTRAZENECA AB
      2021   Phase 3   EUCTR2019-001866-14-IT   Austria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Calcitriol
   Atlanta VA Medical Center
      2007   -   NCT00427804   United States
Calcium carbonate
   University of British Columbia
      2012   -   NCT01735461   Canada
Caltrate pill
   Second Affiliated Hospital of Wenzhou Medical University
      2020   Early Phase 1   NCT04276636   China
      2014   -   NCT04606017   China
Cannabidiol
   Meir Medical Center
      2010   Phase 1/Phase 2   NCT01037322   Israel
   University of Illinois at Chicago
      2018   Phase 2/Phase 3   NCT03467620   -
Cannabidiol , synthetic form
   Stero Biotechs Ltd.
      2019   Phase 2   NCT04056442   Israel
Cannabis, medical
   OMNI Medical Services, LLC
      2018   Phase 2   NCT03944447   United States
Capsule endoscopy
   Innovaderm Research Inc.
      2012   Phase 4   NCT01556672   Canada
CC-5013
   Celgene Corporation
      2002   Phase 2   NCT00446433   France;Israel;United Kingdom;United States
CCX282-B
   Amgen
      2006   Phase 2   NCT00306215   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Netherlands;Poland;South Africa;Sweden;United Kingdom
      2004   Phase 2   NCT00102921   United States
   ChemoCentryx, Inc
      2007   -   EUCTR2005-003827-38-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Hungary;Sweden;United Kingdom
      2007   -   EUCTR2005-003827-38-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Hungary;Sweden;United Kingdom
      2007   -   EUCTR2005-003827-38-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Hungary;Sweden;United Kingdom
      2007   -   EUCTR2005-003827-38-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Sweden;United Kingdom
      2007   -   EUCTR2005-003827-38-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Hungary;Sweden;United Kingdom
      2007   -   EUCTR2005-003827-38-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Hungary;Sweden;United Kingdom
      2007   -   EUCTR2005-003827-38-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Hungary;Sweden;United Kingdom
      2006   Phase 2   EUCTR2005-003827-38-GB   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Sweden;United Kingdom
      2006   -   EUCTR2005-003827-38-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Hungary;Sweden;United Kingdom
      2006   -   EUCTR2005-003827-38-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Hungary;Sweden;United Kingdom
CD-C-food
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2020   -   NCT04976491   China
CD7 CAR T-cells
   Zhejiang University
      2022   Early Phase 1   NCT05239702   China
Cded (crohn'S disease exclusion diet) IN addition TO ANTI-TNF therapy
   IRCCS Ospedale San Raffaele
      2025   -   NCT06896305   Italy
Cded+dairy
   Evangelismos Hospital
      2024   -   NCT05606419   Greece
Cded+PEN
   Evangelismos Hospital
      2024   -   NCT05606419   Greece
CDP6038
   UCB BIOSCIENCES GmbH
      2012   -   EUCTR2011-002517-11-HU   Czech Republic;Germany;Hungary;Serbia
      2012   -   EUCTR2011-002517-11-DE   Czech Republic;Germany;Hungary;Serbia
      2012   -   EUCTR2011-002517-11-CZ   Czech Republic;Germany;Hungary;Serbia
      2012   Phase 2   EUCTR2011-002517-11-BG   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Netherlands;Poland;Romania;Serbia
CDP870
   UCB AE
      2006   Phase 3   EUCTR2006-002027-16-GR   Greece
   UCB Celletech
      2008   -   EUCTR2007-001913-41-IT   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
   UCB Celltech
      2008   -   EUCTR2007-002716-26-IT   Austria;Belgium;Czech Republic;Estonia;Finland;Hungary;Italy;Latvia
      2008   -   EUCTR2007-002716-26-EE   Austria;Belgium;Czech Republic;Estonia;Finland;Hungary;Italy;Latvia
      2008   -   EUCTR2007-002716-26-CZ   Austria;Belgium;Czech Republic;Estonia;Finland;Hungary;Italy;Latvia
      2008   -   EUCTR2007-002716-26-BE   Australia;Austria;Belgium;Brazil;Canada;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;New Zealand;Poland;Romania;Russian Federation;Ukraine;United States
      2008   -   EUCTR2007-002716-26-AT   Australia;Austria;Belgium;Brazil;Canada;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;New Zealand;Poland;Romania;Russian Federation;Ukraine;United States
      2008   -   EUCTR2007-001913-41-EE   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2008   -   EUCTR2007-001913-41-DE   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2008   -   EUCTR2007-001913-41-CZ   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2008   -   EUCTR2007-001913-41-BE   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2008   -   EUCTR2007-001913-41-AT   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2007   -   EUCTR2007-002716-26-LV   Austria;Belgium;Czech Republic;Estonia;Finland;Hungary;Italy;Latvia
      2007   -   EUCTR2007-002716-26-HU   Australia;Austria;Belgium;Brazil;Canada;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;New Zealand;Poland;Romania;Russian Federation;Ukraine;United States
      2007   -   EUCTR2007-002716-26-FI   Austria;Belgium;Czech Republic;Estonia;Finland;Hungary;Italy;Latvia
      2007   -   EUCTR2007-001913-41-LV   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2007   -   EUCTR2007-001913-41-HU   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2007   -   EUCTR2007-001913-41-FI   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      -   -   EUCTR2014-004381-24-Outside-EU/EEA   Australia;Canada;New Zealand;United States
   UCB Japan Co., Ltd.
      -   -   EUCTR2014-004400-30-Outside-EU/EEA   Japan
      -   -   EUCTR2014-004399-42-Outside-EU/EEA   Japan
      -   -   EUCTR2014-004354-34-Outside-EU/EEA   Japan
   UCB PHARMA
      2007   -   EUCTR2006-001729-24-IT   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
   UCB PHARMA S.A.
      2008   -   EUCTR2007-003239-21-FR   France
   UCB Pharma
      2008   Phase 3   NCT00552058   Australia;Austria;Belgium;Brazil;Canada;Chile;Czech Republic;Czechia;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2006   Phase 3   NCT00333788   Austria;Belgium;Canada;France;Germany;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2004   Phase 3   NCT00152425   -
      2003   Phase 3   NCT00152490   -
   UCB Pharma S.A
      2007   -   EUCTR2005-003977-25-DE   Belgium;Germany
   UCB Pharma S.A.
      2007   -   EUCTR2006-003871-11-DE   Germany
      2007   -   EUCTR2006-001729-24-SE   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2006-003870-88-DE   Germany
      2006   -   EUCTR2005-004104-37-DE   Austria;Belgium;Germany;Italy;Spain;Sweden;United Kingdom
   UCB Pharma SA
      2007   -   EUCTR2006-001729-24-DE   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2004   Phase 3   NCT00160706   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;New Zealand;Norway;Poland;Russian Federation;Serbia;Singapore;Slovenia;South Africa;Spain;Ukraine;United States
      2004   Phase 3   NCT00160524   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Estonia;Georgia;Germany;Hong Kong;Hungary;Israel;Italy;Latvia;Lithuania;New Zealand;Norway;Poland;Russian Federation;Serbia;Singapore;Slovenia;South Africa;Spain;Sweden;Tunisia;Ukraine;United States
   UCB S.A
      2007   Phase 3   EUCTR2006-001729-24-GB   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-001729-24-AT   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2005-003977-25-BE   Belgium;Germany
   UCB S.A.
      2007   -   EUCTR2006-001729-24-NL   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-001729-24-FR   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-001729-24-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2006-001729-24-BE   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-004104-37-SE   Austria;Belgium;Germany;Italy;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2005-004104-37-GB   Austria;Belgium;Denmark;Germany;Italy;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2005-004104-37-ES   Austria;Belgium;Denmark;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-004104-37-DK   Austria;Belgium;Denmark;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-004104-37-BE   Austria;Belgium;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-004104-37-AT   Austria;Belgium;Germany;Italy;Spain;Sweden;United Kingdom
Celebrex
   University of Pittsburgh
      2003   Phase 4   NCT00177866   United States
Celecoxib
   Southwest Hospital, China
      2024   -   NCT05960864   -
Certican
   Novartis Pharma Services AG
      2005   Phase 2   EUCTR2005-001148-22-SK   Slovakia
Certolizumab
   Baylor College of Medicine
      2011   -   NCT01582568   United States
Certolizumab pegol
   Atlanta Gastroenterology Associates
      2009   Phase 4   NCT01024647   United States
   Gastroenterology Research of America
      2013   Phase 3   NCT01817972   United States
   Shafran Gastroenterology Center
      2015   Phase 4   NCT02597829   United States
      2010   -   NCT01053559   United States
   UCB AE
      2006   Phase 3   EUCTR2006-002027-16-GR   Greece
   UCB BIOSCIENCES, Inc.
      2014   Phase 1   NCT02154425   France;Netherlands;Switzerland;United States
      2014   Phase 1   NCT02019602   France;Netherlands;Switzerland;United States
   UCB Biopharma SRL
      2021   Phase 3   NCT04643483   -
      2018   -   NCT03559660   -
   UCB Celletech
      2008   -   EUCTR2007-001913-41-IT   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
   UCB Celltech
      2009   Phase 2   NCT00899678   Australia;Canada;New Zealand;United States
      2008   -   EUCTR2007-002716-26-IT   Austria;Belgium;Czech Republic;Estonia;Finland;Hungary;Italy;Latvia
      2008   -   EUCTR2007-002716-26-EE   Austria;Belgium;Czech Republic;Estonia;Finland;Hungary;Italy;Latvia
      2008   -   EUCTR2007-002716-26-CZ   Austria;Belgium;Czech Republic;Estonia;Finland;Hungary;Italy;Latvia
      2008   -   EUCTR2007-002716-26-BE   Australia;Austria;Belgium;Brazil;Canada;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;New Zealand;Poland;Romania;Russian Federation;Ukraine;United States
      2008   -   EUCTR2007-002716-26-AT   Australia;Austria;Belgium;Brazil;Canada;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;New Zealand;Poland;Romania;Russian Federation;Ukraine;United States
      2008   -   EUCTR2007-001913-41-EE   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2008   -   EUCTR2007-001913-41-DE   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2008   -   EUCTR2007-001913-41-CZ   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2008   -   EUCTR2007-001913-41-BE   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2008   -   EUCTR2007-001913-41-AT   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2007   -   EUCTR2007-002716-26-LV   Austria;Belgium;Czech Republic;Estonia;Finland;Hungary;Italy;Latvia
      2007   -   EUCTR2007-002716-26-HU   Australia;Austria;Belgium;Brazil;Canada;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;New Zealand;Poland;Romania;Russian Federation;Ukraine;United States
      2007   -   EUCTR2007-002716-26-FI   Austria;Belgium;Czech Republic;Estonia;Finland;Hungary;Italy;Latvia
      2007   -   EUCTR2007-001913-41-LV   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2007   -   EUCTR2007-001913-41-HU   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
      2007   -   EUCTR2007-001913-41-FI   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia
   UCB Japan Co. Ltd.
      2006   Phase 2   NCT00329550   Japan
   UCB PHARMA
      2007   -   EUCTR2006-001729-24-IT   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
   UCB PHARMA S.A.
      2008   -   EUCTR2007-003239-21-FR   France
   UCB Pharma
      2010   Phase 2   NCT01190410   Australia;Canada;United States
      2008   Phase 3   NCT00552058   Australia;Austria;Belgium;Brazil;Canada;Chile;Czech Republic;Czechia;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2007   Phase 3   NCT00358683   -
      2007   Phase 3   NCT00356408   Canada;Germany;United States
      2007   Phase 3   NCT00354367   -
      2007   Phase 3   NCT00307931   Greece
      2006   Phase 3   NCT00333788   Austria;Belgium;Canada;France;Germany;Italy;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2006   Phase 2   NCT00329420   Japan
      2006   Phase 3   NCT00308581   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2006   Phase 3   NCT00297648   Belgium;France;Germany
      2006   Phase 2   NCT00291668   Japan
      2004   Phase 3   NCT00152425   -
      2003   Phase 3   NCT00152490   -
   UCB Pharma S.A
      2007   -   EUCTR2005-003977-25-DE   Belgium;Germany
   UCB Pharma S.A.
      2007   -   EUCTR2006-003871-11-DE   Germany
      2007   -   EUCTR2006-001729-24-SE   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2006-003870-88-DE   Germany
      2006   -   EUCTR2005-004104-37-DE   Austria;Belgium;Germany;Italy;Spain;Sweden;United Kingdom
   UCB Pharma SA
      2007   -   EUCTR2006-001729-24-DE   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2004   Phase 3   NCT00160706   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;New Zealand;Norway;Poland;Russian Federation;Serbia;Singapore;Slovenia;South Africa;Spain;Ukraine;United States
      2004   Phase 3   NCT00160524   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Estonia;Georgia;Germany;Hong Kong;Hungary;Israel;Italy;Latvia;Lithuania;New Zealand;Norway;Poland;Russian Federation;Serbia;Singapore;Slovenia;South Africa;Spain;Sweden;Tunisia;Ukraine;United States
   UCB S.A
      2007   Phase 3   EUCTR2006-001729-24-GB   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-001729-24-AT   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2005-003977-25-BE   Belgium;Germany
   UCB S.A.
      2007   -   EUCTR2006-001729-24-NL   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-001729-24-FR   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-001729-24-ES   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2006-001729-24-BE   Austria;Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-004104-37-SE   Austria;Belgium;Germany;Italy;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2005-004104-37-GB   Austria;Belgium;Denmark;Germany;Italy;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2005-004104-37-ES   Austria;Belgium;Denmark;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-004104-37-DK   Austria;Belgium;Denmark;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-004104-37-BE   Austria;Belgium;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-004104-37-AT   Austria;Belgium;Germany;Italy;Spain;Sweden;United Kingdom
Certolizumab pegol /cimzia
   UCB Celltech
      -   -   EUCTR2014-004381-24-Outside-EU/EEA   Australia;Canada;New Zealand;United States
   UCB Japan Co., Ltd.
      -   -   EUCTR2014-004400-30-Outside-EU/EEA   Japan
      -   -   EUCTR2014-004399-42-Outside-EU/EEA   Japan
      -   -   EUCTR2014-004354-34-Outside-EU/EEA   Japan
Certolizumab pegol 400 MG
   UCB Pharma
      2006   Phase 3   NCT00349752   Belgium;Canada;Germany;United States
Chadox2 HAV
   University of Oxford
      2017   Phase 1   NCT03027193   United Kingdom
Chenodeoxycholic acid
   University Medical Center Utrecht
      2009   -   EUCTR2009-013348-35-NL   Netherlands
Chenodiol
   University Medical Center Utrecht
      2009   -   EUCTR2009-013348-35-NL   Netherlands
Chenofalk
   University Medical Center Utrecht
      2009   -   EUCTR2009-013348-35-NL   Netherlands
Chimeric IGG1 monoclonal antibody
   Centocor B.V.
      2005   -   EUCTR2004-002815-10-SE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-GB   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DK   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DE   Denmark;Germany;Spain;Sweden;United Kingdom
Chlorure DE sodium
   ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
      2019   Phase 2   EUCTR2019-001948-21-FR   France
Cholecalciferol
   Boston Children’s Hospital
      2008   -   NCT00621257   United States
   Jørgen Agnholt
      2013   Phase 3   EUCTR2013-000971-34-DK   Denmark
   University Hospital Birmingham NHS Foundation Trust
      2019   Phase 4   NCT03718182   United Kingdom
   University of California, Los Angeles
      2010   Phase 1   NCT01046773   United States
Cholecalciferol 10,000 IU
   University of Michigan
      2015   Phase 4   NCT02208310   United States
Cholecalciferol 400 IU
   University of Michigan
      2015   Phase 4   NCT02208310   United States
Cholecalciferol concentrate
   Academic Medical Center
      2014   Phase 3   EUCTR2013-002838-20-BE   Belgium;Netherlands
      2013   Phase 3   EUCTR2013-002838-20-NL   Belgium;Netherlands
Cholestagel
   LMU München, Campus Großhadern
      2011   -   EUCTR2009-010727-91-DE   Germany
   University College London
      2009   Phase 2   EUCTR2009-010163-16-GB   United Kingdom
Chondroitin sulfate
   University Hospital Case Medical Center
      2011   Phase 1/Phase 2   NCT01245088   United States
Cimzia
   Milton S. Hershey Medical Center
      2013   Phase 4   NCT01696942   United States
   UCB BIOSCIENCES GmbH
      2008   Phase 3   NCT00552344   Australia;Austria;Belgium;Brazil;Canada;Chile;Czech Republic;Czechia;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;New Zealand;Poland;Romania;Russian Federation;Ukraine;United States
   UCB BIOSCIENCES, Inc.
      2009   -   NCT00844285   United States
Cimzia 200 MG solution FOR injection
   Ghent University Hospital
      2012   Phase 3   EUCTR2009-017998-37-BE   Belgium
Ciprofloxacin
   Assistance Publique - Hôpitaux de Paris
      2015   Phase 2   NCT02620007   France
   Children's Hospital of Philadelphia
      2018   Phase 2   NCT03476317   United States
   European Group for Blood and Marrow Transplantation (EMBT)
      2006   -   EUCTR2005-003337-40-GB   United Kingdom
   Foundation for Liver Research
      2008   Phase 3   NCT00736983   Netherlands
   Mount Sinai Hospital, Canada
      2006   Phase 2   NCT00257699   Canada
   Royal Liverpool University Hospital
      2014   Phase 2   NCT01783106   United Kingdom
   University of North Carolina, Chapel Hill
      2008   Phase 2   NCT00609973   United States
   University of Pennsylvania
      2016   Phase 2   NCT02765256   United States
Ciprofloxacin hydrochloride
   Royal Liverpool & Broadgreen University Hospitals Trust
      2009   Phase 2   EUCTR2008-001137-99-GB   United Kingdom
Clarithromycin
   RedHill Biopharma Ltd.
      2019   Phase 3   EUCTR2016-005199-90-SK   Australia;Canada;Czech Republic;Israel;New Zealand;Poland;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-SK   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-CZ   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-BG   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2015   Phase 3   EUCTR2015-001179-36-PL   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2015   Phase 3   EUCTR2014-004108-31-HU   Belgium;Czech Republic;Germany;Hungary;Ireland;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-004108-31-CZ   Czech Republic;Hungary;Ireland;Russian Federation;Ukraine;United Kingdom
   Royal Liverpool University Hospital
      2000   Phase 3   NCT00269386   United Kingdom
Clinimacs® TCR A/ß reagent KIT and clinimacs® CD19 system
   Stanford University
      2025   Phase 1/Phase 2   NCT06986382   United States
Clofarabine
   Stanford University
      2025   Phase 1/Phase 2   NCT06986382   United States
Clofazimine
   RedHill Biopharma Ltd.
      2019   Phase 3   EUCTR2016-005199-90-SK   Australia;Canada;Czech Republic;Israel;New Zealand;Poland;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-SK   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-CZ   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-BG   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2015   Phase 3   EUCTR2015-001179-36-PL   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2015   Phase 3   EUCTR2014-004108-31-HU   Belgium;Czech Republic;Germany;Hungary;Ireland;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-004108-31-CZ   Czech Republic;Hungary;Ireland;Russian Federation;Ukraine;United Kingdom
Cnto 1275
   Centocor BV
      2009   -   EUCTR2008-000649-77-NL   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-000649-77-GB   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-000649-77-FR   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-000649-77-ES   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-000649-77-DE   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-000649-77-BE   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2008-000649-77-AT   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
CNTO1275
   JANSSEN CILAG INTERNATIONAL NV
      2019   Phase 3   EUCTR2018-002629-51-IT   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-IT   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-IT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002918-43-IT   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2016   Phase 2   EUCTR2016-000634-21-IT   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
   JANSSEN-CILAG INTERNATIONAL N.V.
      2011   -   EUCTR2010-022759-42-IT   Australia;Brazil;Bulgaria;Canada;Croatia;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-IT   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;South Africa;Spain;United Kingdom;United States
   Janssen-Cilag International N.V.
      2020   Phase 3   EUCTR2018-002629-51-GB   Austria;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-SE   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-FR   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-002629-51-ES   France;Germany;Netherlands;Spain;Sweden;United States
      2018   Phase 3   EUCTR2017-004209-41-PL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-FR   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2016-002918-43-SK   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2018   Phase 3   EUCTR2016-002918-43-DK   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-SE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-PT   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-NL   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-GB   Belgium;Germany;Netherlands;Portugal;Spain;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-FR   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-ES   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-DE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-BE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 1   EUCTR2016-001956-22-PL   Belgium;Canada;France;Germany;Poland;United States
      2017   Phase 1   EUCTR2016-001956-22-DE   Belgium;Canada;France;Germany;Poland;United States
      2017   Phase 1   EUCTR2016-001956-22-BE   Belgium;Canada;France;Germany;Poland;United States
      2012   Phase 3   EUCTR2010-022760-12-NL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022760-12-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022758-18-BE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-IS   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-IE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-HU   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-GB   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-FR   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-ES   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-DK   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-DE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-CZ   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-BG   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-AT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-NL   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-IS   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-HU   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022759-42-GB   Australia;Brazil;Bulgaria;Canada;Croatia;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-ES   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-DE   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-BG   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-IS   Austria;Belgium;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Italy;Spain;United Kingdom
      2011   -   EUCTR2010-022758-18-IE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-HU   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022758-18-GB   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022758-18-ES   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-DK   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-DE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-CZ   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-AT   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      -   Phase 1   EUCTR2016-001956-22-FR   Belgium;Canada;France;Germany;Poland;United States
   Janssen-Cilag International NV
      2022   Phase 3   EUCTR2020-004457-76-HU   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-DE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-BE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004457-76-PL   Argentina;Belgium;France;Germany;Hungary;Japan;Poland;Russian Federation;Turkey;United States
      2021   Phase 3   EUCTR2019-004225-24-HU   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004225-24-DE   Belgium;Germany;Hungary;Japan;Poland;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004225-24-BE   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002629-51-CZ   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-NL   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-AT   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-PT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-GB   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2016-000634-21-FR   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-NL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-GB   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-CZ   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-PL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-NL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LV   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-HR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-GR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-FR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-DE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Georgia;Germany;Greece;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-CZ   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-BE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-AT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000634-21-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-GB   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-PL   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-Outside-EU/EEA   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-GB   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
CNTO148
   JANSSEN CILAG INTERNATIONAL NV
      2022   Phase 2   EUCTR2021-003314-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Janssen-Cilag International NV
      2023   Phase 2   EUCTR2021-003314-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Singapore;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
CNTO1959
   JANSSEN CILAG INTERNATIONAL NV
      2023   Phase 3   EUCTR2022-002389-33-IT   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Serbia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-IT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-IT   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-IT   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-IT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
   Janssen-Cilag International NV
      2023   Phase 3   EUCTR2022-002389-33-HU   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Serbia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2022-002389-33-FR   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Serbia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2022-002389-33-BE   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Serbia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-PT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-PL   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-NO   Austria;Belgium;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-AT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Singapore;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-PT   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-GR   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-FR   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-DE   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2020-006165-11-DE   Australia;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-PL   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-NL   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-HU   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-SK   Australia;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-PL   Australia;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-NL   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-HR   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-ES   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-BE   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-PT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-GB   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-SK   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-PL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-NL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LV   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-HR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-GR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-FR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-DE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Georgia;Germany;Greece;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-CZ   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-BE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-AT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2021-006282-37-NL   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-006282-37-BE   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
Coffee
   University Hospital Heidelberg
      2010   -   NCT01231217   Germany
Colecalciferol
   Academic Medical Center
      2013   Phase 3   EUCTR2013-002838-20-NL   Belgium;Netherlands
   Imperial College London
      2008   Phase 4   NCT00672763   United Kingdom
Colesevelam
   Florian Beigel
      2010   Phase 4   NCT01203254   Germany
   LMU München, Campus Großhadern
      2011   -   EUCTR2009-010727-91-DE   Germany
Colonoscopy
   Affiliated Hospital of Nanjing University of Chinese Medicine(Jiangsu Provincial Hospital of Traditional Chinese Medicine)
      2024   -   ChiCTR2400087778   China
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
   The First Affiliated Hospital of Soochow University
      2024   -   ChiCTR2400085723   China
Colovit capsule
   University Medical Center Groningen
      2021   -   NCT04913467   Netherlands
Comparator
   AbbVie
      2021   -   NCT04846959   United States
   Scott Lee
      2008   Phase 2   NCT00603616   United States
Computed tomography
   Jonsson Comprehensive Cancer Center
      2016   Early Phase 1   NCT02925351   United States
Contrast enhanced ultrasound
   University of Michigan
      2015   Phase 1/Phase 2   NCT02061163   United States
   Yonsei University
      2020   Phase 4   NCT04660136   Korea, Republic of
Contrast media, magnetic resonance
   Massachusetts General Hospital
      2023   -   NCT06252493   United States
Control diet
   University of Alberta
      2020   -   NCT03950336   Canada
   Universität Duisburg-Essen
      2024   -   NCT06698601   Germany
Conventional treatment
   Department of Surgery 2,Tokyo Women's Medical University
      2012   -   JPRN-UMIN000009631   Japan
   Peking Union Medical College Hospital
      2020   -   NCT05386290   China
   Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
      2021   Phase 4   ChiCTR2100049326   China
Coolonic biopsies
   Centre Hospitalier Régional d'Orléans
      2023   -   NCT05916274   France
COQ10
   University of Pennsylvania
      2024   Early Phase 1   NCT06419335   United States
Cortecosteroid
   Children's Hospital Medical Center, Cincinnati
      2005   Phase 2   NCT00109473   United States
Corticosteroid
   Jinling Hospital, China
      2014   Phase 4   NCT02056418   China
   Yale University
      2015   Phase 4   NCT02392286   United States
Cosmofer 50MG/ML solution FOR infusion or injection
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom
CP-461
   Astellas Pharma Inc
      2002   Phase 2   NCT00042055   United States
CP-690,550
   PFIZER
      2008   -   EUCTR2008-003571-45-IT   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Spain;United Kingdom
   Pfizer
      2012   Phase 2   NCT01470599   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Ukraine;United States
      2012   Phase 2   NCT01393899   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Ukraine;United States
      2011   Phase 2   NCT01393626   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2008   Phase 2   NCT00615199   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Slovakia;South Africa;Spain;United Kingdom;United States
   Pfizer Limited, Ramsgate Road,Sandwich,Kent CT13 9NJ
      2009   -   EUCTR2008-003571-45-GB   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Spain;United Kingdom
   Pfizer Ltd, Ramsgate Road,Sandwich,Kent CT13 9NJ
      2009   -   EUCTR2008-003571-45-CZ   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-003571-45-SK   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;United Kingdom
      2008   -   EUCTR2008-003571-45-NL   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2008-003571-45-HU   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-003571-45-FR   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;United Kingdom
      2008   -   EUCTR2008-003571-45-BE   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Spain;United Kingdom
   Pfizer S.A
      2008   Phase 2   EUCTR2008-003571-45-ES   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;United Kingdom
CP-690,550-10
   Pfizer Inc
      2012   Phase 2   EUCTR2011-003622-27-CZ   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2013   Phase 2   EUCTR2011-003622-27-NL   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2013   Phase 2   EUCTR2011-003622-27-HR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2013   Phase 2   EUCTR2011-003622-27-AT   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-003622-27-SE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-003622-27-HU   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-003622-27-GR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-003622-27-ES   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-003622-27-BG   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
      2012   Phase 2   EUCTR2011-003622-27-DE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;Netherlands Antilles;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc.
      2012   Phase 2   EUCTR2011-001754-28-CZ   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-CZ   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc.235 East 42nd Street, New York, NY 10017
      2013   Phase 2   EUCTR2011-001754-28-HR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2013   -   EUCTR2011-001733-16-HR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-NL   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-HU   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-GR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-ES   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-001754-28-BG   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-AT   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-NL   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-HU   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;Norway;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-GR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-BG   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-AT   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2011   -   EUCTR2011-001754-28-SE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2011   -   EUCTR2011-001733-16-SE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2011   -   EUCTR2011-001733-16-ES   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc.235 East 42nd Street, New York, NY 10017, USA
      2012   Phase 2   EUCTR2011-001754-28-DE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-DE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
CPSI-2364
   Ferring Pharmaceuticals
      2009   Phase 1   NCT00950105   United States
Crohn'S disease
   Affiliated Hospital of Nanjing University of Chinese Medicine(Jiangsu Provincial Hospital of Traditional Chinese Medicine)
      2024   -   ChiCTR2400087778   China
   Ferring Pharmaceuticals
      2005   Phase 4   NCT00225810   Czech Republic
   Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
      2024   -   ChiCTR2500096063   China
   The Affiliated Hospital of Qingdao University
      2023   -   ChiCTR2300073620   China
   The First Affiliated Hospital of Soochow University
      2024   -   ChiCTR2400085723   China
Crohn'S disease exclusion diet
   Assistance Publique - Hôpitaux de Paris
      2022   Phase 2/Phase 3   NCT05284136   France;Netherlands
   Hospital Italiano de Buenos Aires
      2021   -   NCT05034458   Argentina
   Meyer Children's Hospital IRCCS
      2023   -   NCT06324513   Italy
   Wolfson Medical Center
      2022   -   NCT04779762   Israel
Crohns disease exclusion diet + PEN
   Prof. Arie Levine
      2016   -   NCT02231814   Israel
Crown
   Prometheus Laboratories
      2016   Phase 2   NCT02793778   United States
CT-P13
   CELLTRION INC.
      2019   Phase 3   EUCTR2019-001087-30-IT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   CMC Ambroise Paré
      2024   Phase 3   NCT06274294   France
   Celltrion
      2019   Phase 3   NCT03945019   Poland;United States
      2016   Phase 1   NCT02883452   Korea, Republic of
      2014   Phase 3   NCT02096861   United States
   Celltrion, Inc
      2020   Phase 3   EUCTR2019-001087-30-RO   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-SK   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-PL   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-LV   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-HU   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-HR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-GR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-FR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-ES   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-DE   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-CZ   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-BG   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-AT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   Celltrion, Inc.
      2014   Phase 3   EUCTR2013-004497-10-RO   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-NL   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-IT   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-HU   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-GB   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-ES   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-DK   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-BE   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Erasmus Medical Center
      2015   Phase 4   EUCTR2014-005702-37-NL   Netherlands
   Fukuoka University Chikushi Hospital
      2021   -   JPRN-UMIN000043165   Japan
   Ishida Tetsuya
      2020   Phase 3   JPRN-jRCT2031200117   Austria;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Japan;Latvia;Poland;Spain;US
   Pfizer
      2015   -   NCT02539368   Belgium;Czech Republic;Czechia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom
CTLA4IG
   Bristol-Myers Squibb International Corporation
      2008   -   EUCTR2006-003371-13-PL   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2008   Phase 3   EUCTR2006-003371-13-IE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2008   -   EUCTR2006-003371-13-CZ   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-NL   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-GB   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003371-13-FR   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-DK   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003371-13-DE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-BE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
Curcuma longa rhizoma
   CHU de Clermont-Ferrand
      2014   Phase 3   EUCTR2014-000261-51-FR   France
Curcumin
   Hamamatsu South Hospital, Centre for Gastroenterology and Inflammatory Bowel Disease Research
      2014   -   JPRN-UMIN000015770   Japan
   Sanjay Gandhi Postgraduate Institute of Medical Sciences
      2021   Phase 2   NCT04713631   India
   Seattle Children's Hospital
      2009   Phase 1   NCT00889161   United States
   University Hospital, Clermont-Ferrand
      2014   Phase 3   NCT02255370   France
CX401
   CELLERIX S.A.
      2009   -   EUCTR2008-004286-25-DE   Austria;Belgium;Czech Republic;Germany;Netherlands;Spain
      2009   -   EUCTR2008-004286-25-BE   Austria;Belgium;Czech Republic;Germany;Netherlands;Spain
CX601
   MILLENNIUM PHARMACEUTICALS, INC.
      2019   Phase 4   EUCTR2019-000333-39-IT   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
   Millennium Pharmaceuticals, Inc (MPI)
      2020   Phase 4   EUCTR2019-000333-39-FR   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2020   Phase 4   EUCTR2017-002491-10-FR   Austria;Czech Republic;France;Germany;Spain;United Kingdom
      2020   Phase 4   EUCTR2017-002491-10-ES   Austria;Czech Republic;France;Germany;Spain;United Kingdom
   Shikamura Mitsuhiro
      2021   Phase 3   JPRN-jRCT2033200314   Israel;Italy;Japan;Netherlands;Poland;Spain
   Takeda Development Center Americas, Inc
      2020   Phase 3   EUCTR2019-000333-39-BE   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2019   Phase 4   EUCTR2019-000333-39-CZ   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
   Takeda Development Center Americas, Inc.
      2021   Phase 3   EUCTR2020-003193-48-NL   Israel;Italy;Japan;Netherlands;Poland;Spain
      2020   Phase 4   EUCTR2017-002491-10-DE   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      2020   Phase 4   EUCTR2017-002491-10-CZ   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      2020   Phase 4   EUCTR2017-002491-10-AT   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      -   Phase 3   EUCTR2020-003193-48-PL   Israel;Japan;Netherlands;Poland
   Takeda Pharmaceutical Company Limited
      2019   Phase 3   JPRN-jRCT1080224084   Japan
   TiGenix, S.A. Unipersonal
      2012   Phase 3   EUCTR2011-006064-43-NL   Austria;Belgium;France;Germany;Israel;Italy;Netherlands;Spain
      2012   Phase 3   EUCTR2011-006064-43-BE   Austria;Belgium;France;Germany;Israel;Italy;Netherlands;Spain
   TiGenix, S.A.U.
      2017   Phase 3   EUCTR2017-000725-12-ES   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
   Tigenix S.A.U.
      2017   Phase 3   NCT03279081   Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Puerto Rico;Spain;Sweden;United Kingdom;United States
      2009   Phase 1/Phase 2   NCT01372969   Spain
Cyclophosphamide
   Aaron Etra
      2017   Phase 2   NCT03219359   United States
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
   European Group for Blood and Marrow Transplantation (EMBT)
      2006   -   EUCTR2005-003337-40-GB   United Kingdom
   Fred Hutchinson Cancer Research Center
      2012   Phase 2   NCT01570348   United States
   Northwestern University
      2019   Phase 2   NCT04154735   United States
   Paul Szabolcs
      2012   Phase 1/Phase 2   NCT00692939   United States
   Tr1X, Inc.
      2025   Phase 1/Phase 2   NCT06721962   United States
   WOLFSON DIGESTIVE DISEASES CENTRE
      2007   -   EUCTR2005-003337-40-IT   Italy;United Kingdom
Cyclophosphamide monohydrate
   Barts Health NHS Trust
      2017   Phase 3   EUCTR2017-002545-30-GB   United Kingdom
Cyltezo
   Boehringer Ingelheim International GmbH
      2017   Phase 3   EUCTR2016-000612-14-HR   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-DE   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000612-14-CZ   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
CYS
   Antaros Medical
      2024   Early Phase 1   NCT06562361   Sweden
Cytochrome P450 (CYP) substrates
   AbbVie
      2020   Phase 1   NCT04254783   Germany;Israel;United States
Cytoxan
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
D-cura
   Academic Medical Center
      2014   Phase 3   EUCTR2013-002838-20-BE   Belgium;Netherlands
D9421-C
   AstraZeneca
      2012   Phase 3   JPRN-jRCT2080221723   -
   AstraZeneca K.K.
      -   Phase 3   EUCTR2014-004132-20-Outside-EU/EEA   Japan
D9421-C capsule 3 MG
   AstraZeneca
      2012   Phase 3   NCT01514240   Japan
D9421-C, 15MG
   AstraZeneca
      2006   Phase 2   NCT00573469   Japan
D9421-C, 9MG
   AstraZeneca
      2006   Phase 2   NCT00573469   Japan
Darvadstrocel
   Medical University of Vienna
      2018   -   NCT05322057   Austria
   Millennium Pharmaceuticals, Inc (MPI)
      2020   Phase 4   EUCTR2019-000333-39-FR   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2020   Phase 4   EUCTR2017-002491-10-FR   Austria;Czech Republic;France;Germany;Spain;United Kingdom
      2020   Phase 4   EUCTR2017-002491-10-ES   Austria;Czech Republic;France;Germany;Spain;United Kingdom
   Shikamura Mitsuhiro
      2021   Phase 3   JPRN-jRCT2033200314   Israel;Italy;Japan;Netherlands;Poland;Spain
   Takeda
      2021   -   NCT05113095   Japan
      2021   Phase 3   NCT04701411   Israel;Japan;Netherlands;Poland;Spain
      2020   Phase 4   NCT04118088   Austria;Czechia;France;Germany;Israel;Spain
      2019   Phase 3   NCT04075825   Belgium;Czechia;France;Hungary;Israel;Italy;Poland;Spain;United States
      2019   Phase 3   NCT03706456   Japan
   Takeda Development Center Americas, Inc
      2020   Phase 3   EUCTR2019-000333-39-BE   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2019   Phase 4   EUCTR2019-000333-39-CZ   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
   Takeda Development Center Americas, Inc.
      2021   Phase 3   EUCTR2020-003193-48-NL   Israel;Italy;Japan;Netherlands;Poland;Spain
      2020   Phase 4   EUCTR2017-002491-10-DE   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      2020   Phase 4   EUCTR2017-002491-10-CZ   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      2020   Phase 4   EUCTR2017-002491-10-AT   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      -   Phase 3   EUCTR2020-003193-48-PL   Israel;Japan;Netherlands;Poland
   Takeda Pharmaceutical Company Limited
      2019   Phase 3   JPRN-jRCT1080224084   Japan
   TiGenix, S.A.U.
      2021   Phase 3   EUCTR2017-000725-12-DK   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
DB adalimumab 40 MG EOW
   Abbott
      2002   Phase 3   NCT00055497   United States
DB adalimumab 40 MG EW
   Abbott
      2002   Phase 3   NCT00055497   United States
DB-3Q
   Direct Biologics, LLC
      2025   Phase 2   NCT06918808   -
Decortin 20 MG
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2010-020137-10-LT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2010-020137-10-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-020137-10-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
   Abbott GmBH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Decortin 5 MG
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2010-020137-10-LT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2010-020137-10-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-020137-10-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
   Abbott GmBH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Dehydroepiandrosterone
   Inflabloc Pharmaceuticals
      2005   Phase 2   NCT00106314   Canada;United States
Dekristol 20.000 IE
   Jørgen Agnholt
      2013   Phase 3   EUCTR2013-000971-34-DK   Denmark
Delayed release 6 mercaptopurine
   Teva GTC
      2010   Phase 1/Phase 2   NCT01094613   Israel
      2008   Phase 1   NCT00774982   Israel
Delayed release 6MP or calcitriol VS. purinethol
   Teva GTC
      2006   Phase 1/Phase 2   NCT00287170   Israel
Denosumab
   University of Manitoba
      2015   Phase 1/Phase 2   NCT02321280   Canada
Deucravacitinib
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 2   EUCTR2020-004461-40-IT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb
      2021   Phase 2   NCT04877990   Australia;Brazil;Canada;China;Czechia;Germany;Hungary;Italy;Japan;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Taiwan;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 2   EUCTR2020-004461-40-PT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2020-004461-40-NL   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2020-004461-40-DE   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States
   Walid Elsharkawi
      2022   Phase 2   JPRN-jRCT2031210637   Australia;Belgium;Brazil;Canada;China;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Portugal;Romania;Russia;South Korea;Spain;Switzerland;Taiwan;UK;US
Dexa scan
   University of Texas Southwestern Medical Center
      2006   -   NCT00286689   United States
Dexametasone sodium phosphate
   EryDel S.p.A.
      -   Phase 2   EUCTR2018-004763-31-IT   Italy
Dexamethasone
   Erydel
      2009   Phase 3   NCT01277289   Italy;Romania;Spain
   University of Saskatchewan
      2022   Phase 1/Phase 2   NCT05432934   Canada
Dexamethasone sodium phosphate 250 MG/ 10 ML
   ERYDEL S.P.A.
      2009   -   EUCTR2008-007329-38-IT   Italy;Spain
      2009   -   EUCTR2008-007329-38-ES   Italy;Spain
Dextromethorphan
   Takeda
      2016   Phase 4   NCT02760615   United States
Dextromethorphan 30 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Dhea
   Inflabloc Pharmaceuticals
      2005   Phase 2   NCT00106314   Canada;United States
Diet 1
   University of Washington
      2017   -   NCT03012542   United States
Diet 2
   University of Washington
      2017   -   NCT03012542   United States
Dietary therapy
   Rush University Medical Center
      2006   Phase 1/Phase 2   NCT00343642   United States
Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride MON
   Italfarmaco S.p.A.
      2005   Phase 2   EUCTR2004-004854-19-SK   Slovakia
Dietician designed diet
   St Vincent's Hospital Melbourne
      2022   Phase 1/Phase 2   NCT04970446   Australia
Diflucan
   Cliniques Universitaires Saint Luc
      2008   -   EUCTR2008-003167-39-BE   Belgium
Digestible maltodextrin
   University of Alberta
      2021   -   NCT04804046   Canada
Diphenhydramine
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
Dipyridamole
   Guangzhou Women and Children's Medical Center
      2021   Phase 0   ChiCTR2100048717   China
DLX105
   Delenex Therapeutics AG
      2012   Phase 2   NCT01624376   Switzerland
Doxycycline
   Royal Liverpool University Hospital
      2014   Phase 2   NCT01783106   United Kingdom
Doxycycline hyclate
   Royal Liverpool & Broadgreen University Hospitals Trust
      2009   Phase 2   EUCTR2008-001137-99-GB   United Kingdom
E-device
   UCB Biopharma S.P.R.L.
      2017   Phase 3   NCT03357471   United States
E6011
   EA Pharma Co., Ltd.
      2019   Phase 2   NCT03733314   Czechia;Hungary;Japan;Poland;Russian Federation
      2019   Phase 2   EUCTR2018-002109-70-HU   Czech Republic;Hungary;Japan;Poland
      2019   Phase 2   EUCTR2018-002109-70-CZ   Czech Republic;Czechia;Hungary;Japan;Poland;Russian Federation
   Eisai Inc.
      2014   Phase 1   NCT02249078   -
E6011 10 MG/KG
   EA Pharma Co., Ltd.
      2014   Phase 1/Phase 2   NCT02039063   Japan
E6011 15 MG/KG
   EA Pharma Co., Ltd.
      2014   Phase 1/Phase 2   NCT02039063   Japan
E6011 2 MG/KG
   EA Pharma Co., Ltd.
      2014   Phase 1/Phase 2   NCT02039063   Japan
E6011 5 MG/KG
   EA Pharma Co., Ltd.
      2014   Phase 1/Phase 2   NCT02039063   Japan
Early biologic therapy
   Zagazig University
      2024   Early Phase 1   NCT06511921   Egypt
Early faecal calprotectin dosage
   University Hospital, Clermont-Ferrand
      2025   -   NCT06972901   France
EB8018
   Enterome
      2018   Phase 1   NCT03709628   Austria;France;Germany;Italy
   Millennium Pharmaceuticals, Inc (a wholly owned subsidiary
      2020   Phase 2   EUCTR2019-000886-19-FR   France;Germany;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000886-19-GB   Austria;France;Germany;Netherlands;United Kingdom;United States
   Millennium Pharmaceuticals, Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited)
      2020   Phase 2   EUCTR2019-000886-19-NL   Austria;France;Germany;Netherlands;United Kingdom;United States
      2020   Phase 2   EUCTR2019-000886-19-AT   Austria;France;Germany;Netherlands;United Kingdom;United States
   Takeda Development Center Americas,Inc.
      2019   Phase 2   EUCTR2019-000886-19-DE   Austria;France;Germany;Netherlands;United Kingdom;United States
Ebetrex 15 MG = 0,75 ML, oplossing voor injectie IN voorgevulde injectiespuit 20 MG/ML
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
Ebfahf-2
   Icahn School of Medicine at Mount Sinai
      2023   Phase 1   NCT03992469   United States
EEN
   Duzce University
      2021   Phase 3   NCT04921033   Turkey
   Shanghai Tenth People's Hospital
      2023   Phase 4   ChiCTR2300075237   China
   Sun Yat-sen University
      2013   -   NCT02887287   China
   The Second Hospital of Nanjing Medical University
      2016   -   NCT02897661   China
EEN intervention group
   Shaare Zedek Medical Center
      2020   -   NCT04239248   Israel
Efalizumab
   Merck Serono International S.A.
      2009   -   EUCTR2007-001377-28-PT   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-NL   Austria;France;Germany;Netherlands;Portugal
      2008   Phase 4   EUCTR2007-001377-28-FR   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-DE   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-AT   Austria;France;Germany;Netherlands;Portugal
Efmarodocokin alfa
   Genentech, Inc.
      2018   Phase 2   EUCTR2017-004997-32-IE   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
EGG albumen powder
   Lument AB
      2019   Phase 2   EUCTR2019-002093-32-SE   Sweden
EGG white protein
   Lument AB
      2019   Phase 2   EUCTR2019-002093-32-SE   Sweden
Eicosapentaenoic acid
   Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
      2014   -   NCT02179372   Italy
Emea/H/C/000240
   Santeon
      2015   Phase 4   EUCTR2015-001954-14-NL   Netherlands
Emea/H/C/002576
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
Emea/H/C/002778
   Department of medical gastroenterology, Herlev Hospital
      2016   Phase 4   EUCTR2012-002702-51-NO   Denmark;Finland;Norway;Sweden
Empagliflozin
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 1   NCT05078879   United States
Endoscopic balloon dilatation
   St Vincent's Hospital Melbourne
      2017   Phase 4   NCT03220841   Australia
Endoxan baxter
   WOLFSON DIGESTIVE DISEASES CENTRE
      2007   -   EUCTR2005-003337-40-IT   Italy;United Kingdom
Entecavir
   Saitama Medical University
      2016   -   JPRN-UMIN000020029   Japan
Enteral nutrition
   Hôpital Necker-Enfants Malades
      2005   Phase 4   NCT00265772   France
   Jinling Hospital, China
      2014   Phase 4   NCT02056418   China
      2012   -   NCT01823029   China
   Shanghai Tenth People's Hospital
      2023   Phase 4   ChiCTR2300075237   China
   Sixth Affiliated Hospital, Sun Yat-sen University
      2016   -   NCT02998827   -
   Tongji Hospital
      2023   -   NCT06673134   China
   Zhu Weiming
      2012   -   NCT01820247   China
Enteral nutrition biscuits
   Ping An
      2024   -   NCT06362863   -
Enteral nutritional suspension
   Wei Zhou
      2024   -   NCT06587178   China
Entocort
   ASTRAZENECA
      2011   Phase 3   EUCTR2011-003743-22-IT   Canada;Germany;Italy;United States
   AstraZeneca K.K.
      -   Phase 3   EUCTR2014-004132-20-Outside-EU/EEA   Japan
   Padagis LLC
      2011   Phase 3   NCT01453946   Canada;Germany;Italy;Poland;United States
      2011   Phase 3   NCT01444092   Canada;Germany;Italy;Poland;United States
Entocort CR
   Royal Liverpool & Broadgreen University Hospitals Trust
      2009   Phase 2   EUCTR2008-001137-99-GB   United Kingdom
Entocort® kapseln
   AstraZeneca AB
      -   -   EUCTR2011-003743-22-DE   Canada;Germany;Italy;Poland;United States
      -   -   EUCTR2011-003742-40-DE   Canada;Germany;Italy;Poland;United States
Entyvio
   AMC MEDICAL RESEARCH B.V.
      2017   Phase 3   EUCTR2015-000555-24-IT   France;Italy;Netherlands;Spain
   Academic Medical Center Amsterdam
      2016   Phase 4   EUCTR2015-000555-24-NL   France;Italy;Netherlands;Spain
      2016   Phase 4   EUCTR2015-000555-24-FR   France;Netherlands;Spain
      2016   Phase 4   EUCTR2015-000555-24-ES   Netherlands;Spain
   Academic Medical Center, Gastroenterology
      2017   Phase 4   EUCTR2014-005376-29-HU   Belgium;Hungary;Netherlands
      2015   -   EUCTR2014-005376-29-NL   Netherlands
      2015   Phase 4   EUCTR2014-005376-29-BE   Belgium;Netherlands
   FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
      2016   Phase 4   EUCTR2015-003270-32-IT   Italy
   TAKEDA DEVELOPMENT CENTER AMERICAS INC.
      2021   Phase 3   EUCTR2020-004301-31-IT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2015-000481-58-IT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003509-13-IT   Belgium;Canada;Czech Republic;Hungary;Italy;Poland;United States
   Takeda Development Center Americas, Inc.
      2023   Phase 3   EUCTR2021-000630-34-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-GR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HU   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004301-31-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-LT   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-HU   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-ES   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-Outside-EU/EEA   Australia;Canada;China;Israel;Japan;Korea, Republic of;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004301-31-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004301-31-Outside-EU/EEA   Australia;Belgium;Canada;China;Croatia;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2020-004301-31-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
   Takeda Development Centre Americas Inc.
      2018   Phase 2   EUCTR2017-002182-21-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Americas, Ltd.
      2017   Phase 2   EUCTR2017-002182-21-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe Limited
      2017   Phase 4   EUCTR2016-000678-40-BG   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-LV   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-HU   Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-EE   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-CZ   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda Development Centre Europe Ltd
      2015   Phase 3   EUCTR2014-003509-13-PL   Belgium;Canada;Czech Republic;Hungary;Poland;United States
      2015   Phase 3   EUCTR2014-003509-13-HU   Belgium;Canada;Czech Republic;Hungary;Poland;United States
      2015   Phase 3   EUCTR2014-003509-13-CZ   Belgium;Canada;Czech Republic;Hungary;Poland;United States
      2015   Phase 3   EUCTR2014-003509-13-BE   Belgium;Canada;Czech Republic;Hungary;Poland;United States
   Takeda Development Centre Europe, Ltd.
      2018   Phase 2   EUCTR2017-002231-41-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002182-21-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002182-21-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 4   EUCTR2015-000852-12-BE   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-NL   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-GB   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-FR   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-ES   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2   EUCTR2017-002231-41-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Washington University School of Medicine
      2018   Phase 4   NCT03142321   United States
Epanova
   Tillotts Pharma AG
      2003   Phase 3   NCT00613197   Belgium
      2002   Phase 3   NCT00074542   Canada;United States
ERB-041
   Wyeth is now a wholly owned subsidiary of Pfizer
      2004   Phase 1   NCT00245947   -
Ergocalciferol
   Boston Children’s Hospital
      2008   -   NCT00621257   United States
ERY-DEX
   ERYDEL S.P.A.
      2009   -   EUCTR2008-007329-38-IT   Italy;Spain
      2009   -   EUCTR2008-007329-38-ES   Italy;Spain
Erythropoietin
   Jinling Hospital, China
      2012   -   NCT01823029   China
Eskazole
   academic medical centre
      2018   Phase 4   EUCTR2017-001737-85-NL   Netherlands
Esketamine
   Jinling Hospital Affiliated to c University
      2020   Phase 4   NCT05506787   China
Etiprednol dicloacetate
   Teva Branded Pharmaceutical Products R&D, Inc.
      2002   Phase 2   NCT00035503   Canada;United States
Etrasimod
   Pfizer
      2020   Phase 3   NCT04173273   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   Samia Hassan El-Shishtawy
      2021   Phase 2/Phase 3   NCT05033340   -
Etrasimod L-arginine
   ARENA PHARMACEUTICALS, INC.
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-IT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Arena Pharmaceuticals Inc.
      2022   Phase 2;Phase 3   EUCTR2020-004775-40-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2020-004775-40-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Thailand;Türkiye;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-SK   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-PT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-NO   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-NL   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-LT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-HU   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-GR   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-GB   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-FR   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-ES   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-CZ   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002895-14-BG   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Norway;Peru;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
Etrolizumab
   F. HOFFMANN - LA ROCHE LTD.
      2016   Phase 3   EUCTR2014-003855-76-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003824-36-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Italy;Korea, Democratic People's Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   F. Hoffmann-La Roche Ltd
      2018   Phase 1   EUCTR2017-003649-10-GB   Belgium;Germany;Poland;Spain;United Kingdom
      2018   Phase 1   EUCTR2017-003649-10-DE   Belgium;Germany;Poland;Spain;United Kingdom;United States
      2018   Phase 1   EUCTR2017-003649-10-BE   Belgium;Germany;Poland;Spain;United Kingdom
      2015   Phase 3   EUCTR2014-003855-76-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-003855-76-FR   Argentina;Australia;Brazil;Canada;Estonia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003855-76-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-003824-36-RO   Argentina;Australia;Austria;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003824-36-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003824-36-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 1   EUCTR2017-003649-10-PL   Belgium;Germany;Poland;Spain;United Kingdom
   Hoffmann-La Roche
      2018   Phase 1   NCT03478956   Belgium;Germany;Poland;Spain;United Kingdom;United States
      2015   Phase 3   NCT02403323   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Luxembourg;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   NCT02394028   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Luxembourg;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   Roche Farma S.A en nombre de F. Hoffmann-La Roche Ltd
      2015   -   EUCTR2014-003824-36-ES   Argentina;Australia;Austria;Brazil;Canada;Estonia;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;New Zealand;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United States
   Roche Farma S.A. (Soc unipersonal) que realiza el ensayo en España y que actúa como represntante de FHoffmann-La Roche
      2018   Phase 1   EUCTR2017-003649-10-ES   Belgium;Germany;Poland;Spain;United Kingdom;United States
   Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
      2015   Phase 3   EUCTR2014-003855-76-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
EU/1/03/268/002
   LMU München, Campus Großhadern
      2011   -   EUCTR2009-010727-91-DE   Germany
EU/1/99/116/003
   Academic Medical Center, department of Gastroenterology and hepatology
      2008   -   EUCTR2008-001131-35-NL   Netherlands
EUA with seton placement IF necessary
   Vanderbilt University Medical Center
      2008   Phase 4   NCT00517296   United States
EUS
   Vanderbilt University Medical Center
      2008   Phase 4   NCT00517296   United States
Everolimus
   Novartis Pharma Services AG
      2005   Phase 2   EUCTR2005-001148-22-SK   Slovakia
Exclusion diet
   Columbia University
      2012   Phase 2   NCT01647412   United States
   Hospital Universitario Virgen de la Arrixaca
      2025   -   NCT06933264   Spain
   National Nutrition and Food Technology Institute
      2024   -   NCT06353633   -
Exclusive enteral nutrition
   Children's Hospital of Fudan University
      2017   -   NCT03755583   China
   Erasmus Medical Center
      2015   Phase 4   NCT02517684   Belgium;Denmark;Finland;Italy;Netherlands;Poland
   General Hospital of Eastern Millitary Command
      2024   -   ChiCTR2400087670   China
   McMaster University
      2018   Phase 4   NCT03833596   Canada
   Tel-Aviv Sourasky Medical Center
      2020   Phase 3   NCT04398836   Israel
   Xiang Gao
      2024   -   NCT06912815   China
Exclusive enteral nutrition therapy
   Jinling Hospital, China
      2013   -   NCT02233062   China
Exclusive enteral nutrition treatment group
   Sixth Affiliated Hospital, Sun Yat-sen University
      2013   -   NCT05815355   -
EXL01
   Exeliom Biosciences
      2023   Phase 1   NCT05542355   Belgium;Poland
Exoflo
   Direct Biologics, LLC
      2023   Phase 1/Phase 2   NCT05836883   United States
      2023   Phase 1   NCT05130983   United States
Expanded allogenic adipose-derived adult stem cells
   Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
      2009   Phase 1/Phase 2   NCT00999115   Spain
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs
   Millennium Pharmaceuticals, Inc (MPI)
      2020   Phase 4   EUCTR2019-000333-39-FR   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2020   Phase 4   EUCTR2017-002491-10-FR   Austria;Czech Republic;France;Germany;Spain;United Kingdom
      2020   Phase 4   EUCTR2017-002491-10-ES   Austria;Czech Republic;France;Germany;Spain;United Kingdom
   Takeda Development Center Americas, Inc
      2020   Phase 3   EUCTR2019-000333-39-BE   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2019   Phase 4   EUCTR2019-000333-39-CZ   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
   Takeda Development Center Americas, Inc.
      2021   Phase 3   EUCTR2020-003193-48-NL   Israel;Italy;Japan;Netherlands;Poland;Spain
      2020   Phase 4   EUCTR2017-002491-10-DE   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      2020   Phase 4   EUCTR2017-002491-10-CZ   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      2020   Phase 4   EUCTR2017-002491-10-AT   Austria;Czech Republic;Czechia;France;Germany;Israel;Spain
      -   Phase 3   EUCTR2020-003193-48-PL   Israel;Japan;Netherlands;Poland
   TiGenix S.A.U.
      2012   Phase 3   EUCTR2011-006064-43-DE   Austria;Belgium;France;Germany;Israel;Italy;Netherlands;Spain
   TiGenix, S.A. Unipersonal
      2012   Phase 3   EUCTR2011-006064-43-BE   Austria;Belgium;France;Germany;Israel;Italy;Netherlands;Spain
   TiGenix, S.A.U.
      2021   Phase 3   EUCTR2017-000725-12-SE   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2021   Phase 3   EUCTR2017-000725-12-DK   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000725-12-GB   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000725-12-DE   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-PL   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-HU   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-FR   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-ES   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-CZ   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-BE   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2011-006064-43-AT   Austria;Belgium;France;Germany;Israel;Italy;Netherlands;Spain
Expanded human allogenic mesenchymal adult stem cells extracted from adiposetissue (eascs)
   MILLENNIUM PHARMACEUTICALS, INC.
      2019   Phase 4   EUCTR2019-000333-39-IT   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
Extracorporeal photopheresis
   Mallinckrodt
      2004   Phase 2   NCT00221026   Austria;Belgium;Germany;United States
Faecal microbiota transplantation
   Odense University Hospital
      2023   Phase 2   NCT04924270   Denmark
   St Vincent's Hospital Melbourne
      2018   -   NCT03477032   Australia
FAT stem cell
   Nantes University Hospital
      2024   -   NCT05974280   France
FE 999301
   University Hospital Schleswig-Holstein (UKSH)
      2016   Phase 2   EUCTR2016-000205-36-DE   Germany
Feasibility OF BETA-hydroxybutyrate supplementation TO reduce inflammation IN patients with crohn'S
   University of Texas at Austin
      2024   Phase 1/Phase 2   NCT06351124   United States
Fecal microbial transplant
   Seattle Children's Hospital
      2015   Phase 1/Phase 2   NCT02272868   United States
Fecal microbial transplantation
   Beth Israel Deaconess Medical Center
      2013   Phase 1   NCT01847170   United States
   Stony Brook University
      2017   Early Phase 1   NCT03267238   United States
Fecal microbiota
   ASSISTANCE PUBLIQUE -HOPITAUX DE PARIS (AP-HP)
      2019   Phase 3   EUCTR2019-003816-29-FR   France
   Fujita Health University School of Medicine Department of Gastroenterology
      2018   Phase 1,2   JPRN-UMIN000033127   Japan
   Ohmiya Naoki
      2019   Phase 2   JPRN-jRCTs041190021   -
   University of Minnesota
      2022   Phase 1   NCT05248191   United States
Fecal microbiota transplant
   Boston Medical Center
      2015   Phase 2   NCT02417974   United States
   Judith Kelsen
      2015   Phase 1   NCT02636517   United States
   Stacy A. Kahn
      2017   Phase 1/Phase 2   NCT02330211   United States
      2015   Phase 1/Phase 2   NCT02330653   United States
   University of Alberta
      2017   Phase 2   NCT03078803   Canada
      2014   Phase 1/Phase 2   NCT02199561   Canada
Fecal microbiota transplantation
   Assistance Publique - Hôpitaux de Paris
      2021   Phase 3   NCT04997733   France
   Children's Mercy Hospital Kansas City
      2014   Phase 1   NCT02108821   United States
   Chinese University of Hong Kong
      2022   -   NCT05611866   Hong Kong
      2019   -   NCT04014413   Hong Kong
   Federal Research and Clinical Center of Physical-Chemical Medicine
      2018   -   NCT04011943   Russian Federation
   Gulhane Military Medical Academy
      2015   Phase 3   NCT02575040   Turkey
   Ohmiya Naoki
      2018   Phase 2-3   JPRN-jRCTs041190022   -
   Shiga University of Medical Science
      2016   -   JPRN-UMIN000024633   Japan
   Stanford University
      2022   Phase 1   NCT03747718   United States
   Tampere University Hospital
      2021   -   NCT04637438   Finland
   Tongji Hospital
      2023   -   NCT06673134   China
      2020   -   NCT05321758   China
Ferric carboxy maltose
   Shield Therapeutics
      2016   Phase 3   NCT02680756   Belgium;France;Germany;Hungary;Spain;United States
Ferric carboxymaltose
   Vifor Inc.
      2008   Phase 3   NCT00810030   Austria;Russian Federation
Ferric maltol
   Shield Therapeutics
      2016   Phase 3   NCT02680756   Belgium;France;Germany;Hungary;Spain;United States
Ferrous sulphate
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom
   Queen Mary University of London
      2011   Phase 4   NCT01991314   United Kingdom
FFP104
   Fast Forward Pharmaceuticals
      2016   Phase 1/Phase 2   NCT02465944   Belgium;Netherlands
   Fast Forward Pharmaceuticals, B.V.
      2016   Phase 2   EUCTR2015-001678-17-NL   Belgium;Netherlands
      2015   Phase 2   EUCTR2015-001678-17-BE   Belgium;Netherlands
Fibrin glue injection IN fistula
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2003   Phase 3   NCT00723047   Belgium;France
Filgotinib
   GILEAD SCIENCES INCORPORATED
      2018   Phase 3   EUCTR2016-002763-34-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-001367-36-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
   Galapagos NV
      2017   Phase 3   NCT02914600   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-SK   Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-NO   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2016   Phase 3   NCT02914561   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002857-32-PL   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   -   EUCTR2013-002857-32-HU   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   Phase 2   EUCTR2013-002857-32-GB   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   Phase 2   EUCTR2013-002857-32-DE   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   Phase 2   EUCTR2013-002857-32-CZ   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   -   EUCTR2013-002857-32-BE   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
   Gilead Sciences
      2018   Phase 1   NCT03417778   Germany;New Zealand;United States
      2017   Phase 2   NCT03077412   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   NCT03046056   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Spain;Ukraine;United Kingdom;United States
   Gilead Sciences, Inc.
      2018   Phase 2   EUCTR2016-003179-23-BE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2016-003179-23-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2016-003153-15-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2016-003153-15-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-PL   Austria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-FR   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-PL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-GB   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
Filgrastim
   Barts Health NHS Trust
      2017   Phase 3   EUCTR2017-002545-30-GB   United Kingdom
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
   European Group for Blood and Marrow Transplantation (EMBT)
      2006   -   EUCTR2005-003337-40-GB   United Kingdom
FILM-coated tablet
   4SC AG
      2010   -   EUCTR2008-005903-25-BG   Bulgaria;Germany
      2009   -   EUCTR2008-005903-25-DE   Bulgaria;Germany
   AB Science
      2015   Phase 2;Phase 3   EUCTR2012-004222-25-GR   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;India;Italy;Morocco;Poland;Romania;Russian Federation;Slovakia;Spain;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-004222-25-SK   Belgium;Czech Republic;France;Greece;India;Morocco;Slovakia;Spain;Tunisia
      2013   Phase 3   EUCTR2012-004222-25-BE   Belgium;Canada;Central African Republic;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Romania;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2018   Phase 3   EUCTR2017-001226-18-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   ALFA WASSERMANN
      2011   -   EUCTR2011-002821-24-IT   Italy
   AbbVie Deutschland GmbH & Co. KG
      2020   Phase 3   EUCTR2017-001240-35-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001240-35-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001240-35-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001226-18-SI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001226-18-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001225-41-SI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001225-41-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-LV   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Alfa Wassermann S.p.A.
      2008   -   EUCTR2007-001014-17-DE   France;Germany;Hungary;Italy
      2007   Phase 2   EUCTR2007-001014-17-HU   France;Germany;Hungary;Italy
      2007   Phase 2   EUCTR2007-001014-17-FR   France;Germany;Hungary;Italy
   BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      2021   Phase 2   EUCTR2020-004527-16-IT   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;United States
   Boehringer Ingelheim International GmbH
      2023   Phase 2   EUCTR2020-004527-16-NL   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2020-004527-16-DK   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2020-004527-16-DE   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
      2021   Phase 2   EUCTR2020-004527-16-PL   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United States
      2021   Phase 2   EUCTR2020-004527-16-BE   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;United States
   CELGENE CORPORATION
      2017   Phase 3   EUCTR2015-001924-40-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-IT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-001693-18-IT   Italy
   Celgene Corporation
      2017   Phase 3   EUCTR2015-001963-37-FI   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001925-18-FI   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-LV   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-FI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-LV   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-GR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-GB   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Oman;Pakistan;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-ES   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-DK   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-BG   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-SK   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-SE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-LV   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-HU   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-HR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-GR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-GB   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-ES   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-DK   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-DE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-BG   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-BE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-AT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001963-37-EE   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001925-18-EE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-001925-18-NO   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-001924-40-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   GILEAD SCIENCES INCORPORATED
      2018   Phase 3   EUCTR2016-002763-34-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-001367-36-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
   Galapagos NV
      2017   Phase 3   EUCTR2016-002763-34-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-SK   Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-NO   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002857-32-PL   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   -   EUCTR2013-002857-32-HU   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   Phase 2   EUCTR2013-002857-32-GB   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   Phase 2   EUCTR2013-002857-32-DE   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   Phase 2   EUCTR2013-002857-32-CZ   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   -   EUCTR2013-002857-32-BE   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
   Gilead Sciences, Inc.
      2018   Phase 2   EUCTR2016-003179-23-BE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2016-003179-23-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2016-003153-15-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2016-003153-15-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-PL   Austria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-FR   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-PL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-GB   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Janssen-Cilag International NV
      2020   Phase 2   EUCTR2019-003335-37-DE   Argentina;Germany;Italy;Poland;Russian Federation;United States
   LMU München, Campus Großhadern
      2011   -   EUCTR2009-010727-91-DE   Germany
   Millennium Pharmaceuticals, Inc (a wholly owned subsidiary
      2020   Phase 2   EUCTR2019-000886-19-FR   France;Germany;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000886-19-GB   Austria;France;Germany;Netherlands;United Kingdom;United States
   Millennium Pharmaceuticals, Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited)
      2020   Phase 2   EUCTR2019-000886-19-NL   Austria;France;Germany;Netherlands;United Kingdom;United States
      2020   Phase 2   EUCTR2019-000886-19-AT   Austria;France;Germany;Netherlands;United Kingdom;United States
   Otsuka Pharmaceutical Development & Commercialization, Inc.
      -   Phase 2   EUCTR2019-000176-41-DE   Canada;Germany;Hungary;Italy;Poland;Russian Federation;Ukraine;United States
   Pfizer Inc
      2012   Phase 2   EUCTR2011-003622-27-CZ   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2013   Phase 2   EUCTR2011-003622-27-NL   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2013   Phase 2   EUCTR2011-003622-27-HR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2013   Phase 2   EUCTR2011-003622-27-AT   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-003622-27-SE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-003622-27-HU   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-003622-27-GR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-003622-27-ES   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-003622-27-BG   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
      2012   Phase 2   EUCTR2011-003622-27-DE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;Netherlands Antilles;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc.
      2012   Phase 2   EUCTR2011-001754-28-CZ   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-CZ   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc.235 East 42nd Street, New York, NY 10017
      2013   Phase 2   EUCTR2011-001754-28-HR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2013   -   EUCTR2011-001733-16-HR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-NL   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-HU   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-GR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-ES   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-001754-28-BG   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-AT   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-NL   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-HU   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;Norway;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-GR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-BG   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-AT   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2011   -   EUCTR2011-001754-28-SE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2011   -   EUCTR2011-001733-16-SE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2011   -   EUCTR2011-001733-16-ES   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Norway;Romania;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc.235 East 42nd Street, New York, NY 10017, USA
      2012   Phase 2   EUCTR2011-001754-28-DE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-DE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Reistone Biopharma Company Limited
      2019   Phase 2   EUCTR2018-003303-19-PL   China;Poland;Ukraine;United States
   Salix Pharmaceuticals, Inc.
      2015   Phase 3   EUCTR2014-001645-24-DE   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
   Takeda Development Center Americas,Inc.
      2019   Phase 2   EUCTR2019-000886-19-DE   Austria;France;Germany;Netherlands;United Kingdom;United States
   Toray Industries Inc
      2012   -   EUCTR2011-000854-44-LV   Bulgaria;Czech Republic;Hungary;Latvia;Norway;Poland;Sweden
      2012   -   EUCTR2011-000854-44-CZ   Belgium;Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
      2012   -   EUCTR2011-000854-44-BG   Belgium;Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
      2011   -   EUCTR2011-000854-44-SE   Belgium;Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
      2011   -   EUCTR2011-000854-44-PL   Bulgaria;Czech Republic;Hungary;Latvia;Norway;Poland;Sweden
      2011   Phase 2   EUCTR2011-000854-44-NO   Belgium;Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
      2011   Phase 2   EUCTR2011-000854-44-BE   Belgium;Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
      -   -   EUCTR2011-000854-44-NL   Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
   Toray Industries, Inc.
      2011   -   EUCTR2011-000854-44-HU   Bulgaria;Czech Republic;Hungary;Latvia;Norway;Poland;Sweden
   UMBERTO I - POLICLINICO DI ROMA
      2017   Phase 4   EUCTR2016-000522-18-IT   Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Poland;United Kingdom
   University College London
      2009   Phase 2   EUCTR2009-010163-16-GB   United Kingdom
   University College London / University College London Hospitals NHS Foundation Trust
      2006   -   EUCTR2006-002494-48-GB   United Kingdom
   Ventyx Biosciences, Inc.
      2023   Phase 2   EUCTR2022-003365-38-SK   Australia;Brazil;Bulgaria;Canada;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Slovakia;United States
      2023   Phase 2   EUCTR2022-003365-38-PL   Australia;Brazil;Bulgaria;Canada;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Slovakia;United States
      2023   Phase 2   EUCTR2022-003365-38-LT   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
      2023   Phase 2   EUCTR2022-003365-38-IT   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
      2023   Phase 2   EUCTR2022-003365-38-HU   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
      2023   Phase 2   EUCTR2022-003365-38-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Slovakia;Spain;United States
      -   Phase 2   EUCTR2022-003365-38-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
Fish OIL
   The First Affiliated Hospital of Sun Yat-sen University
      2011   -   ChiCTR-TRC-11001321   China
FITC-adalimumab
   University of Erlangen-Nürnberg Medical School
      2011   Phase 1/Phase 2   NCT01275508   Germany
Flagyl
   GETECCU
      2011   -   EUCTR2011-000885-36-ES   Spain
Flixabi
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   University Southampton Hospital NHS Foundation Trust
      2018   Phase 4   EUCTR2018-001546-33-GB   United Kingdom
Fluconazole
   Children's Hospital of Philadelphia
      2018   Phase 2   NCT03476317   United States
   Cliniques Universitaires Saint Luc
      2008   -   EUCTR2008-003167-39-BE   Belgium
   University Hospital, Lille
      2008   Phase 2   NCT02997059   France
   University of Pennsylvania
      2016   Phase 2   NCT02765256   United States
   Weill Medical College of Cornell University
      2024   Phase 3   NCT06274554   United States
Fludarabine
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
   Northwestern University
      2019   Phase 2   NCT04154735   United States
Fludarabine phosphate
   Barts Health NHS Trust
      2017   Phase 3   EUCTR2017-002545-30-GB   United Kingdom
   Fred Hutchinson Cancer Research Center
      2012   Phase 2   NCT01570348   United States
Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration OF unlabeled vedolizumab
   University Medical Center Groningen
      2020   Phase 1   NCT04112212   Netherlands
Fluorescence molecular imaging procedure without prior administration OF vedolizumab-800CW
   University Medical Center Groningen
      2020   Phase 1   NCT04112212   Netherlands
Fluorine F 18 clofarabine
   Jonsson Comprehensive Cancer Center
      2016   Early Phase 1   NCT02925351   United States
FMT
   Assistance Publique - Hôpitaux de Paris
      2021   Phase 3   NCT04997733   France
   Boston Medical Center
      2015   Phase 2   NCT02417974   United States
   Children's Hospital Los Angeles
      2017   Phase 1/Phase 2   NCT03194529   United States
   Children's Mercy Hospital Kansas City
      2014   Phase 1   NCT02108821   United States
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
   St Vincent's Hospital Melbourne
      2022   Phase 1/Phase 2   NCT04970446   Australia
   Stacy A. Kahn
      2015   Phase 1/Phase 2   NCT02330653   United States
   University of Alberta
      2017   Phase 2   NCT03078803   Canada
   University of Minnesota
      2022   Phase 1   NCT05248191   United States
   Yanling Wei
      2015   Phase 2   NCT02335281   China
Folacin
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
Folic acid
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
Foralumab
   Tiziana Life Sciences, PLC
      2022   Phase 1   NCT05028946   -
Formula
   Medical University of Warsaw
      2023   Phase 3   EUCTR2020-004168-24-PL   Poland
   National Nutrition and Food Technology Institute
      2024   -   NCT06353633   -
   University Hospital Birmingham
      2008   Phase 4   NCT00609752   United Kingdom
FOS
   Hospital Universitari Vall d'Hebron Research Institute
      2014   -   NCT02539849   Spain
Fosfato sodico DE dexametasona
   ERYDEL S.P.A.
      2009   -   EUCTR2008-007329-38-ES   Italy;Spain
Fosfomycin
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
Freeze dried grape powder
   Case Western Reserve University
      2024   -   NCT05972694   United States
Fully human IGG1 monoclonal antibody specific FOR TL1A
   Teva Branded Pharmaceutical Products R&D, Inc.
      2023   Phase 2   EUCTR2022-002593-89-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
G-CSF
   National Institute of Allergy and Infectious Diseases (NIAID)
      2001   Phase 1   NCT00025805   United States
   Northwestern University
      2019   Phase 2   NCT04154735   United States
   Paul Szabolcs
      2012   Phase 1/Phase 2   NCT00692939   United States
G321605
   Galapagos NV
      2014   -   EUCTR2014-001892-30-HU   Belgium;Czech Republic;France;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine;United Kingdom
      2014   -   EUCTR2014-001892-30-BE   Belgium;Czech Republic;France;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine;United Kingdom
GED-0301
   CELGENE CORPORATION
      2017   Phase 3   EUCTR2015-001924-40-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-IT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-001693-18-IT   Italy
   Celgene
      2017   Phase 3   NCT02974322   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   NCT02685683   Italy
      2016   Phase 3   NCT02641392   Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   NCT02596893   Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;Former Serbia and Montenegro;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 1   NCT02367183   Australia;Canada;Hungary;Slovakia;United States
   Celgene Corporation
      2017   Phase 3   EUCTR2015-001963-37-FI   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001925-18-FI   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-LV   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-FI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-PT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-LV   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-GR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-GB   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Oman;Pakistan;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-ES   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-DK   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-BG   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-SK   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-SE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-PT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-LV   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-HU   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-HR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-GR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-GB   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-ES   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-DK   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-DE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-BG   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-BE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-AT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001963-37-EE   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001925-18-EE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-001925-18-NO   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-001924-40-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   GIULIANI
      2013   -   EUCTR2011-002640-27-DE   Germany;Italy
      2012   -   EUCTR2011-005678-47-IT   Italy
      2011   -   EUCTR2011-002640-27-IT   Germany;Italy
Genetic analysis
   University Hospital, Lille
      2015   -   NCT02851134   France
Genome-wide DNA methylation
   Jinling Hospital, China
      2017   -   NCT03272152   China
Glatiramer acetate
   Tel-Aviv Sourasky Medical Center
      2008   Phase 2   NCT00731172   Israel
Gliolan
   Akershus University Hospital
      2019   Phase 2   EUCTR2018-002422-23-NO   Norway
GLPG0634
   Galapagos NV
      2014   Phase 2   NCT02048618   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   -   EUCTR2013-002857-32-PL   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   -   EUCTR2013-002857-32-HU   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   Phase 2   EUCTR2013-002857-32-GB   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   Phase 2   EUCTR2013-002857-32-DE   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   Phase 2   EUCTR2013-002857-32-CZ   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
      2014   -   EUCTR2013-002857-32-BE   Belgium;Czech Republic;France;Germany;Hungary;Poland;Romania;Russian Federation;United Kingdom
GLPG1205
   Galapagos NV
      2014   -   EUCTR2014-001892-30-HU   Belgium;Czech Republic;France;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine;United Kingdom
      2014   -   EUCTR2014-001892-30-BE   Belgium;Czech Republic;France;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine;United Kingdom
Glucagon
   Massachusetts General Hospital
      2023   -   NCT06252493   United States
Glucocorticoids
   Tongji Hospital
      2023   -   NCT06673134   China
Glucose
   The First Affiliated Hospital of Sun Yat-sen University
      2011   -   ChiCTR-TRC-11001321   China
Glutamine
   All India Institute of Medical Sciences, New Delhi
      2005   Phase 1   NCT00838149   India
Glycan
   GLSMED Learning Health S.A.
      2024   -   NCT06727253   -
Golimumab
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   JANSSEN CILAG INTERNATIONAL NV
      2022   Phase 2   EUCTR2021-003314-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Janssen Research & Development, LLC
      2022   Phase 2   NCT05242471   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
   Janssen Scientific Affairs, LLC
      2013   Phase 4   NCT01804166   United States
   Janssen-Cilag International NV
      2023   Phase 2   EUCTR2021-003314-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Singapore;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Nishikawa Kazuko
      2022   Phase 2   JPRN-jRCT2031220309   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;Norway;Poland;Portugal;Republic Of Lithuania;Serbia;Spain;Switzerland;United Kingdom Of Great Britain
Green TEA
   University Hospital Heidelberg
      2010   -   NCT01231217   Germany
Group 2 ustekinumab 130 MG
   Janssen Research & Development, LLC
      2011   Phase 3   NCT01369342   Australia;Belgium;Brazil;Bulgaria;Canada;Croatia;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   NCT01369329   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Serbia;South Africa;Spain;United Kingdom;United States
Group 3: ustekinumab approximately 6 MG/KG
   Janssen Research & Development, LLC
      2011   Phase 3   NCT01369342   Australia;Belgium;Brazil;Bulgaria;Canada;Croatia;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   NCT01369329   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Serbia;South Africa;Spain;United Kingdom;United States
Growth hormone
   Children's Hospital Medical Center, Cincinnati
      2005   Phase 2   NCT00109473   United States
   Columbia University
      2012   Phase 2   NCT01647412   United States
   University of Texas Southwestern Medical Center
      2006   -   NCT00286689   United States
GS-5745
   GILEAD SCIENCES INCORPORATED
      2015   Phase 2   EUCTR2015-001249-10-IT   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;Italy;South Africa;Spain;United Kingdom;United States
   Gilead Sciences, Inc
      2016   Phase 2   EUCTR2015-001249-10-IS   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;New Zealand;South Africa;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001249-10-HU   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;New Zealand;South Africa;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001249-10-GB   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;Italy;New Zealand;South Africa;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001249-10-ES   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;New Zealand;South Africa;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001249-10-DE   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;New Zealand;South Africa;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001249-10-CZ   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;New Zealand;South Africa;Spain;United Kingdom;United States
GS-6034
   GILEAD SCIENCES INCORPORATED
      2018   Phase 3   EUCTR2016-002763-34-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-001367-36-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
   Galapagos NV
      2017   Phase 3   EUCTR2016-002763-34-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-SK   Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-NO   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Gilead Sciences, Inc.
      2018   Phase 2   EUCTR2016-003179-23-BE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2016-003179-23-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2016-003153-15-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2016-003153-15-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-PL   Austria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-FR   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003179-23-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-PL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-GB   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-DE   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-003153-15-CZ   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002763-34-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001367-36-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
GSK1070806
   University of Birmingham
      2019   Phase 1/Phase 2   NCT03681067   United Kingdom
      2018   Phase 1   EUCTR2018-002001-65-GB   United Kingdom
GSK1605786
   GlaxoSmithKline
      2010   Phase 1   NCT01611805   Australia
GSK1605786 500 MG
   GlaxoSmithKline
      2011   Phase 1   NCT01489943   United States
GSK1605786 capsule
   GlaxoSmithKline
      2013   Phase 1   NCT01827631   China
GSK1605786 chemocentryx: formulation A
   GlaxoSmithKline
      2010   Phase 1   NCT01114607   United States
GSK1605786 GSK direct-fill: formulation C
   GlaxoSmithKline
      2010   Phase 1   NCT01114607   United States
GSK1605786 GSK modified-process: formulation D
   GlaxoSmithKline
      2010   Phase 1   NCT01114607   United States
GSK1605786 GSK tablet: formulation E
   GlaxoSmithKline
      2010   Phase 1   NCT01114607   United States
GSK1605786 GSK: formulation B
   GlaxoSmithKline
      2010   Phase 1   NCT01114607   United States
GSK1605786A
   GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.
      2012   -   EUCTR2010-022384-35-IT   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;New Zealand;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022383-12-IT   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022382-10-IT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;New Zealand;Norway;South Africa;Spain;Sweden;United Kingdom;United States
   GlaxoSmithKline
      2011   Phase 3   NCT01536418   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2011   Phase 3   NCT01318993   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2011   Phase 3   NCT01316939   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   NCT01277666   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
   GlaxoSmithKline Research & Development Limited
      2013   -   EUCTR2010-022383-12-BG   Argentina;Austria;Brazil;Bulgaria;Chile;Czech Republic;Denmark;Estonia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2012   -   EUCTR2010-022383-12-SK   Argentina;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Denmark;Estonia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2012   -   EUCTR2010-022383-12-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022383-12-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022383-12-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022383-12-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2010-022383-12-AT   Argentina;Australia;Austria;Brazil;Bulgaria;Chile;Czech Republic;Denmark;Estonia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2012   -   EUCTR2010-022382-10-SK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022382-10-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2012   -   EUCTR2010-022382-10-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2010-022383-12-SE   Argentina;Austria;Brazil;Bulgaria;Chile;Czech Republic;Denmark;Estonia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-022383-12-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2011   -   EUCTR2010-022383-12-DK   Argentina;Austria;Brazil;Bulgaria;Chile;Czech Republic;Denmark;Estonia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   GlaxoSmithKline Research & Development Ltd
      2013   -   EUCTR2010-022384-35-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2010-022384-35-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2010-022384-35-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022384-35-PL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;United States
      2012   -   EUCTR2010-022384-35-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022384-35-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022384-35-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2010-022384-35-AT   Argentina;Austria;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;New Zealand;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2012   -   EUCTR2010-022383-12-PL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2010-022384-35-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-022384-35-HU   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022384-35-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022384-35-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-022384-35-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2010-022384-35-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022384-35-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022383-12-NO   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2011   -   EUCTR2010-022383-12-HU   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022383-12-GB   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2011   -   EUCTR2010-022383-12-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022383-12-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2010-022382-10-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Italy;Japan;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2010-022382-10-NL   Austria;Belgium;Czech Republic;Denmark;Germany;Hungary;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom
      2011   -   EUCTR2010-022382-10-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Italy;Japan;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022382-10-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Italy;Japan;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2010-022382-10-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Italy;Japan;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2010-022382-10-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Italy;Japan;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022382-10-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Italy;Japan;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom;United States
      2010   -   EUCTR2010-022382-10-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Italy;Japan;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
      -   -   EUCTR2010-022383-12-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      -   Phase 3   EUCTR2010-022382-10-NO   Austria;Belgium;Czech Republic;Denmark;Germany;Hungary;Italy;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
   GlaxoSmithKline Research and Development Limited
      2013   -   EUCTR2011-002817-12-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002817-12-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002817-12-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002817-12-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002817-12-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002817-12-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-002817-12-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002817-12-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-002817-12-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2012   -   EUCTR2011-002817-12-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-002817-12-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002817-12-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
GSK2330811
   GlaxoSmithKline
      2021   Phase 2   NCT04151225   -
Guselkumab
   JANSSEN CILAG INTERNATIONAL NV
      2023   Phase 3   EUCTR2022-002389-33-IT   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Serbia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-IT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-IT   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-IT   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-IT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
   Janssen Pharmaceutical K.K.
      2020   Phase 3   NCT04397263   Japan
      2020   Phase 3   JPRN-jRCT2080225202   none
   Janssen Research & Development, LLC
      2024   Phase 3   NCT06663332   China;Japan;Poland;Spain;Turkey;United States
      2024   Phase 3   NCT05923073   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   NCT05784129   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Serbia;Spain;United Kingdom;United States
      2022   Phase 2   NCT05242471   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
   Janssen-Cilag International NV
      2023   Phase 3   EUCTR2022-002389-33-HU   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Serbia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2022-002389-33-FR   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Serbia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2022-002389-33-BE   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Serbia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-PT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-PL   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-NO   Austria;Belgium;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-AT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Singapore;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-PT   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-GR   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-FR   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-DE   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2020-006165-11-DE   Australia;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-PL   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-NL   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-HU   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-SK   Australia;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-PL   Australia;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-NL   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-HR   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-ES   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-BE   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-PT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-GB   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-SK   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-PL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-NL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LV   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-HR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-GR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-FR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-DE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Georgia;Germany;Greece;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-CZ   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-BE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-AT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2021-006282-37-NL   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-006282-37-BE   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
   Janssen-Cilag Ltd.
      2024   Phase 3   NCT06408935   Australia;Brazil;Canada;Czechia;Germany;Israel;Italy;Poland;Slovakia;Spain;Taiwan
      2022   Phase 3   NCT05347095   Australia;Belgium;Canada;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;United Kingdom;United States
   Nishikawa Kazuko
      2022   Phase 2   JPRN-jRCT2031220309   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;Norway;Poland;Portugal;Republic Of Lithuania;Serbia;Spain;Switzerland;United Kingdom Of Great Britain
   Numaguchi Hirotaka
      2023   Phase 3   JPRN-jRCT2031230352   Australia;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea,Republic Of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;UnitedKingdom Of Great Britain;UnitedStates Of America
      2022   Phase 3   JPRN-jRCT2031220205   Australia;Belgium;Canada;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Netherlands;Poland;Portugal;Republic Of Korea;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;United Kingdom Of Great Britain;United States Of America
   University of California, San Diego
      2013   -   NCT02103361   United States
Guselkumab dose 1
   Hirotaka Numaguchi
      2022   Phase 3   JPRN-jRCT2031210678   Australia;Belarus;Belgium;Bosnia And Herzegovina;Brazil;Canada;China;Croatia;Czechia;France;Germany;Hungary;Italy;Japan;Jordan;Korea;Lithuania;Netherlands;NewZealand;Poland;RussianFederation;Serbia;Slovakia;Spain;Taiwan,Province Of China;Turkey;Ukraine;United Kingdom Of Great Britain;UnitedStates Of America
   Janssen Research & Development, LLC
      2022   Phase 3   NCT05197049   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2/Phase 3   NCT03466411   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, The Former Yugoslav Republic of;Malaysia;Netherlands;New Zealand;North Macedonia;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
Guselkumab dose 2
   Hirotaka Numaguchi
      2022   Phase 3   JPRN-jRCT2031210678   Australia;Belarus;Belgium;Bosnia And Herzegovina;Brazil;Canada;China;Croatia;Czechia;France;Germany;Hungary;Italy;Japan;Jordan;Korea;Lithuania;Netherlands;NewZealand;Poland;RussianFederation;Serbia;Slovakia;Spain;Taiwan,Province Of China;Turkey;Ukraine;United Kingdom Of Great Britain;UnitedStates Of America
   Janssen Research & Development, LLC
      2022   Phase 3   NCT05197049   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2/Phase 3   NCT03466411   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, The Former Yugoslav Republic of;Malaysia;Netherlands;New Zealand;North Macedonia;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
Guselkumab dose 3
   Hirotaka Numaguchi
      2022   Phase 3   JPRN-jRCT2031210678   Australia;Belarus;Belgium;Bosnia And Herzegovina;Brazil;Canada;China;Croatia;Czechia;France;Germany;Hungary;Italy;Japan;Jordan;Korea;Lithuania;Netherlands;NewZealand;Poland;RussianFederation;Serbia;Slovakia;Spain;Taiwan,Province Of China;Turkey;Ukraine;United Kingdom Of Great Britain;UnitedStates Of America
   Janssen Research & Development, LLC
      2022   Phase 3   NCT05197049   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2/Phase 3   NCT03466411   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, The Former Yugoslav Republic of;Malaysia;Netherlands;New Zealand;North Macedonia;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
Guselkumab dose 4
   Janssen Research & Development, LLC
      2018   Phase 2/Phase 3   NCT03466411   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, The Former Yugoslav Republic of;Malaysia;Netherlands;New Zealand;North Macedonia;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
Guselkumab dose 5
   Janssen Research & Development, LLC
      2018   Phase 2/Phase 3   NCT03466411   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, The Former Yugoslav Republic of;Malaysia;Netherlands;New Zealand;North Macedonia;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
Hematopoietic stem cell transplantation
   University of California, Los Angeles
      2014   Phase 0   NCT01932658   United States
Hepatitis A vaccine
   Asan Medical Center
      2011   Phase 4   NCT01341808   Korea, Republic of
Herpes zoster vaccine
   University of Alabama at Birmingham
      2016   Phase 2   NCT02538341   United States
      2013   Phase 2   NCT02538757   United States
Hextend
   Spectrum Health Hospitals
      2007   Phase 3   NCT00467922   United States
High dose TSO
   Dr. Falk Pharma GmbH
      2010   Phase 2   NCT01279577   Germany
High oligosaccharide group
   University of British Columbia
      2015   -   NCT02193750   Australia;Canada
High performance liquid chromatography
   Vanderbilt-Ingram Cancer Center
      2006   -   NCT00897312   -
High serine diet
   University of Michigan
      2021   -   NCT04795960   United States
HIGH-dose cyclophosphamide
   Johns Hopkins University
      2015   Phase 1/Phase 2   NCT01836289   United States
Hladqa1*05A>G screening
   Western University, Canada
      2020   -   NCT04109300   Canada
HM201
   Syneos Health
      2021   Phase 1   NCT05088369   Australia
HMPL-004
   Hutchison Medipharma Limited
      2006   Phase 2   NCT00655733   United States
HMPL004-6599
   Nutrition Science Partners Limited
      2018   Phase 1   NCT03597971   Australia
Hulio
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
HUM291
   PDL BioPharma, Inc
      2005   -   EUCTR2004-004388-31-DE   Germany
   PDL BioPharma, Inc.
      2005   -   EUCTR2004-004387-72-DE   Germany
   Protein Design Labs, Inc.
      2005   -   EUCTR2004-004387-72-AT   Austria;Germany
Human albumin AS macroaggregates
   ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
      2019   Phase 2   EUCTR2019-001948-21-FR   France
Human ANTI-IL-12 antibody
   Centocor BV
      2009   -   EUCTR2008-000649-77-NL   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-000649-77-GB   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-000649-77-FR   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-000649-77-ES   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-000649-77-DE   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-000649-77-BE   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2008-000649-77-AT   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
Human ANTI-IP10 monoclonal antibody
   Bristol-Myers Squibb International Corporation
      2012   -   EUCTR2011-002981-19-PL   Belgium;France;Hungary;Poland;South Africa;United States
      2012   -   EUCTR2011-002981-19-HU   Belgium;France;Hungary;Poland;South Africa;United States
      2012   -   EUCTR2011-002981-19-BE   Belgium;France;Hungary;Poland;South Africa;United States
Human placenta-derived cells PDA001 intravenous infusion
   Celularity Incorporated
      2010   Phase 2   NCT01155362   United States
Human plasma FOR fractionation
   Fundación FISEVI
      2012   -   EUCTR2011-006127-38-ES   Spain
      2012   -   EUCTR2011-004820-37-ES   Spain
Human TH-SC01 cell injection
   Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
      2022   Phase 1/Phase 2   NCT05626023   China
Human umbilical cord mesenchymal stem cells
   Shanghai East Hospital
      2022   -   NCT05262829   China
Humira
   ACADEMIC MEDICAL CENTER
      2015   Phase 4   EUCTR2013-002932-25-BE   Belgium;Netherlands
   ALLERGAN LIMITED
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Abbott GmbH & Co. KG
      2008   -   EUCTR2006-004814-41-NL   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2006-004814-41-IT   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2006-004814-41-CZ   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2006-004814-41-BE   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2004-002163-24-GB   Denmark;Germany;Hungary;Italy;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-004814-41-FR   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
      2006   -   EUCTR2005-005291-32-SE   Austria;Belgium;Germany;Italy;Netherlands;Sweden
      2006   -   EUCTR2005-005291-32-NL   Austria;Belgium;Germany;Italy;Netherlands;Sweden
      2006   -   EUCTR2005-005291-32-DE   Austria;Belgium;Germany;Italy;Netherlands;Sweden
      2006   -   EUCTR2005-005291-32-BE   Austria;Belgium;Germany;Italy;Netherlands;Sweden
      2006   -   EUCTR2005-005291-32-AT   Austria;Belgium;Germany;Italy;Netherlands;Sweden
      2005   -   EUCTR2004-002934-20-BE   Belgium
      2005   -   EUCTR2004-002163-24-DE   Denmark;Germany;Hungary;Italy;Spain;United Kingdom
      2004   -   EUCTR2004-002163-24-SE   Denmark;Germany;Hungary;Italy;Spain;Sweden;United Kingdom
      2004   -   EUCTR2004-002163-24-ES   Denmark;Germany;Hungary;Italy;Spain;Sweden;United Kingdom
      2004   -   EUCTR2004-002163-24-DK   Denmark;Germany;Hungary;Italy;Spain;United Kingdom
      -   -   EUCTR2006-004814-41-Outside-EU/EEA   -
   Abbott GmbH & Co. KG (Abbott)
      -   Phase 3   EUCTR2006-002078-23-SK   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
   Abbott GmbH & co. KG
      2004   -   EUCTR2004-002163-24-BE   Belgium;Denmark;Germany;Hungary;Italy;Spain;Sweden;United Kingdom
   Abbott Laboratories
      2004   -   EUCTR2004-002163-24-HU   Belgium;Denmark;Germany;Hungary;Italy;Spain;Sweden;United Kingdom
   Academic Medical Center
      2019   Phase 4   EUCTR2018-002064-15-NL   Netherlands
      2013   Phase 4   EUCTR2013-002932-25-NL   Netherlands
   Allergan Ltd.
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-RO   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2018-004346-42-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   AstraZeneca
      2018   Phase 2/Phase 3   NCT03759288   Australia;Austria;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2022   Phase 2;Phase 3   EUCTR2018-004346-42-FR   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-SK   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-HU   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-CZ   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-DE   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Astrazeneca AB
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Boehringer Ingelheim
      2016   Phase 3   NCT02871635   Belarus;Bosnia and Herzegovina;Croatia;Czechia;Germany;Greece;Israel;Poland;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
   Boehringer Ingelheim International GmbH
      2017   Phase 3   EUCTR2016-000612-14-HR   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-GR   Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-GB   Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-DE   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000612-14-CZ   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
   CHU Amiens Picardie
      2021   Phase 3   EUCTR2021-002047-29-FR   France
   Department of medical gastroenterology, Herlev Hospital
      2009   Phase 4   EUCTR2009-009926-94-DK   Denmark
   Fundació Clínic per a la Recerca Biomèdica
      2013   Phase 3   EUCTR2012-001723-12-ES   Spain
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain
   GETAID
      2014   Phase 4   EUCTR2013-003199-11-FR   Belgium;France
   GETAID - Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives
      2015   Phase 4   EUCTR2013-003199-11-BE   Belgium;France
   GETECCU
      2011   -   EUCTR2011-000885-36-ES   Spain
   Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)
      2012   -   EUCTR2011-003966-34-ES   Spain
      2011   Phase 3   EUCTR2011-003966-34-BE   Belgium;Spain
   IBD Center LMU Munich
      2008   Phase 4   EUCTR2008-004926-18-DE   Germany
   JANSSEN CILAG INTERNATIONAL NV
      2018   Phase 3   EUCTR2017-004209-41-IT   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Janssen-Cilag International N.V.
      2018   Phase 3   EUCTR2017-004209-41-PL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-FR   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Janssen-Cilag International NV
      2018   Phase 3   EUCTR2017-004209-41-NL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-GB   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-CZ   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Kenji Watanabe
      2010   -   JPRN-UMIN000005762   Japan
      2010   -   JPRN-UMIN000005761   Japan
   Nagoya University Gradeate School of Medicine Department of Gastroenterology
      2012   Phase 2   JPRN-UMIN000007514   Japan
   PIBD-Net
      2017   Phase 3   EUCTR2016-000522-18-DE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDNet
      2018   Phase 4   EUCTR2016-000522-18-BE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      2017   Phase 4   EUCTR2016-000522-18-NL   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      -   Phase 4   EUCTR2016-000522-18-FR   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDnet (Pediatric Inflammatory Bowel Disease Network)
      -   Phase 4   EUCTR2016-000522-18-PL   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   Radboud University Medical Centre
      2017   Phase 4   EUCTR2016-003321-42-NL   Netherlands
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Robarts Clinical Trials
      2015   Phase 4   EUCTR2014-001050-41-DE   Canada;Germany;United Kingdom;United States
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   University Hospital Southampton NHS Foundation Trust
      2019   Phase 4   EUCTR2018-004967-30-GB   United Kingdom
   University Maastricht
      2019   Phase 4   EUCTR2017-004588-11-NL   Netherlands
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   University of Leuven, Division of Gastroenterology
      2007   Phase 4   EUCTR2006-006632-22-BE   Belgium
Humira - 40MG/0.8ML soluz. iniettabile- USO sottocutaneo-flaconcino(vetro) 0.8ML 2 astucci:1 flaconcino+1siringa+1AGO+1adatt.sterile-2tamponi imbevuti alcool
   UMBERTO I - POLICLINICO DI ROMA
      2017   Phase 4   EUCTR2016-000522-18-IT   Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Poland;United Kingdom
Humira 20 MG solution FOR injection IN PRE-filled syringe
   AbbVie Deutschland GmbH & Co. KG
      2009   Phase 3   EUCTR2007-006494-90-CZ   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
   Abbott GmbH & Co. K.G.
      -   -   EUCTR2007-006494-90-Outside-EU/EEA   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
   Abbvie Deutschland GmbH & Co. K.G.
      2008   Phase 3   EUCTR2007-006494-90-BE   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
Humira 40 MG injekcní roztok V predplnené injekcní STRíkacce
   PIBDNet
      2018   Phase 4   EUCTR2016-000522-18-CZ   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
Humira 40 MG solucióN inyectable EN jeringa precargada
   Abbott GmbH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-ES   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
Humira 40 MG solution FOR injection IN PRE-filled PEN
   Abbott GmbH & Co. KG
      2009   -   EUCTR2006-004814-41-GB   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
Humira 40 MG solution FOR injection IN PRE-filled syringe
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2013-004034-15-IT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004034-15-GB   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004034-15-FR   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2013-004034-15-DK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2013-004034-15-DE   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2013-004034-15-BE   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2015   Phase 3   EUCTR2013-001746-33-FR   Austria;Belgium;Canada;Denmark;European Union;France;Germany;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2015   Phase 3   EUCTR2013-001746-33-BE   Austria;Belgium;Canada;Denmark;European Union;France;Germany;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2015   Phase 3   EUCTR2010-020137-10-LT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004034-15-SK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004034-15-HU   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2014   Phase 3   EUCTR2013-004034-15-ES   Austria;Canada;Czech Republic;Denmark;European Union;France;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2014   Phase 3   EUCTR2013-004034-15-AT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Slovakia;Spain;Switzerland;Ukraine;United States
      2014   Phase 3   EUCTR2013-001746-33-SK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-NL   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-IT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   -   EUCTR2013-001746-33-HU   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Hungary;Israel;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-ES   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-DK   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-DE   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Hungary;Israel;Netherlands;Slovakia;Spain;Switzerland;United States
      2014   Phase 3   EUCTR2013-001746-33-AT   Austria;Belgium;Canada;Czech Republic;Denmark;European Union;France;Germany;Hungary;Israel;Italy;Netherlands;Slovakia;Spain;Switzerland;United States
      2012   Phase 3   EUCTR2010-020137-10-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-020137-10-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-SE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-020137-10-GB   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-DE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2009   Phase 3   EUCTR2007-006494-90-CZ   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
   AbbVie Farmacéutica S.L.U.
      2014   Phase 4   EUCTR2013-004781-34-ES   Spain
   Abbott GmbH & Co. K.G.
      2009   Phase 3   EUCTR2007-006494-90-GB   Belgium;Czech Republic;United Kingdom
      -   -   EUCTR2007-006494-90-Outside-EU/EEA   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
   Abbott GmbH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2006-004814-41-GB   Belgium;Czech Republic;France;Italy;Netherlands;United Kingdom
   Abbvie Deutschland GmbH & Co. K.G.
      2008   Phase 3   EUCTR2007-006494-90-BE   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
Humira 40 MG/0.8 ML solution FOR injection
   AbbVie GK
      -   -   EUCTR2015-004121-13-Outside-EU/EEA   Japan
   Abbott Deutschland GmbH & Co. KG
      -   -   EUCTR2014-004560-38-Outside-EU/EEA   Japan
      -   -   EUCTR2014-004531-39-Outside-EU/EEA   Japan
Humira 40MG solution FOR injection
   Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
      2019   Phase 4   NCT04131322   Spain
Humira 40MG/0.4ML PRE-filled syringe
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
Humira 40MG/0.8ML solution FOR injection FOR paediatric USE
   AbbVie Deutschland GmbH & Co. KG
      2009   Phase 3   EUCTR2007-006494-90-CZ   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
   Abbott GmbH & Co. K.G.
      -   -   EUCTR2007-006494-90-Outside-EU/EEA   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
   Abbvie Deutschland GmbH & Co. K.G.
      2008   Phase 3   EUCTR2007-006494-90-BE   Belgium;Canada;Czech Republic;Poland;United Kingdom;United States
Humira PRE-filled PEN
   Abbott GmbH & Co. KG
      2007   -   EUCTR2006-002078-23-SE   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
      2007   -   EUCTR2006-002078-23-PT   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
      2007   -   EUCTR2006-002078-23-GR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-002078-23-FI   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
      2006   -   EUCTR2006-002078-23-ES   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2006-002078-23-DK   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
   Abbott GmbH & Co. KG (Abbott)
      2010   -   EUCTR2006-002078-23-IE   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
      2007   -   EUCTR2006-002078-23-GB   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Slovakia;Sweden;United Kingdom
      2006   -   EUCTR2006-002078-23-NO   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2006-002078-23-NL   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2006-002078-23-FR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2006-002078-23-DE   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
      2006   -   EUCTR2006-002078-23-CZ   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
      2006   -   EUCTR2006-002078-23-BE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2006-002078-23-AT   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom
Humira*SC 2SIR+F 40MG 0,8ML+2T
   Abbott GmBH Co KG
      2005   -   EUCTR2004-002163-24-IT   Denmark;Germany;Hungary;Italy;Spain;United Kingdom
   Abbott GmBH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
   Abbott GmbH Co.KG
      2006   -   EUCTR2005-005291-32-IT   Austria;Belgium;Germany;Italy;Netherlands;Sweden
Hydroxychloroquine
   Royal Liverpool University Hospital
      2014   Phase 2   NCT01783106   United Kingdom
Hydroxychloroquine sulphate
   Royal Liverpool & Broadgreen University Hospitals Trust
      2009   Phase 2   EUCTR2008-001137-99-GB   United Kingdom
Hyperbaric oxygen
   Assaf-Harofeh Medical Center
      2013   -   NCT01828190   Israel
   Daping Hospital, Army Medical University (Third Military Medical University)
      2018   -   ChiCTR1800019958   China
Hypnosis
   University Hospital, Grenoble
      2018   -   NCT03623932   France
ICG-guided bowel perfusion assessment
   Leiden University Medical Center
      2020   Phase 3   NCT04712032   Netherlands
IGG2 antibodies
   EA Pharma Co., Ltd.
      2019   Phase 2   EUCTR2018-002109-70-HU   Czech Republic;Hungary;Japan;Poland
      2019   Phase 2   EUCTR2018-002109-70-CZ   Czech Republic;Czechia;Hungary;Japan;Poland;Russian Federation
IL-23 therapy
   Weill Medical College of Cornell University
      2024   Phase 3   NCT06274554   United States
Ileocecal resection
   University Hospital, Lille
      2017   -   NCT02872506   -
Ileocolonic biopsies
   Hospices Civils de Lyon
      2024   -   NCT06244849   France
Ileocolonoscopy
   Universitaire Ziekenhuizen Leuven
      2005   Phase 2   NCT02247258   Belgium;Czech Republic;Greece
IM90838
   Immunic AG
      2019   Phase 2   EUCTR2018-001895-39-RO   Bulgaria;Croatia;Czech Republic;Czechia;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-NL   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-HR   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-CZ   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-BG   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
Immune ablation and hematopoietic stem cell support
   Richard Burt, MD
      2001   Phase 1   NCT00278577   United States
Immunonutrition
   Istituto Clinico Humanitas
      2020   -   NCT04014517   -
Immunosuppressant
   First Affiliated Hospital, Sun Yat-Sen University
      2005   -   NCT06457035   -
Immunosuppressive agents
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2021   Phase 3   NCT06059989   Netherlands
   Tongji Hospital
      2020   -   NCT05321758   China
Immunosuppressor/tnfalpha
   University Hospital, Grenoble
      2018   -   NCT03623932   France
Immunotherapy
   King's College London
      2022   Phase 1   NCT03185000   United Kingdom
   Tongji Hospital
      2023   -   NCT06673134   China
IMP will BE labeled AS PF-04236921 106MG/vial, clonal SC lyophilized form
   PFIZER INC.
      2012   -   EUCTR2011-000722-30-IT   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
Imraldi
   University Hospital Southampton NHS Foundation Trust
      2019   Phase 4   EUCTR2018-004967-30-GB   United Kingdom
IMU-838
   Immunic AG
      2019   Phase 2   EUCTR2018-001895-39-RO   Bulgaria;Croatia;Czech Republic;Czechia;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-NL   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-HR   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-CZ   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-BG   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
Imuran
   Academic Medical Center, department of Gastroenterology and hepatology
      2008   -   EUCTR2008-001131-35-NL   Netherlands
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
   Centocor B.V.
      2005   -   EUCTR2004-002815-10-SE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-GB   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-ES   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DK   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-AT   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
   Novartis Pharma Services AG
      2005   Phase 2   EUCTR2005-001148-22-SK   Slovakia
   PIBDNet
      2017   Phase 4   EUCTR2016-000522-18-NL   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   University of Edinburgh
      2015   -   EUCTR2014-002311-41-GB   Belgium;France;Germany;Sweden;United Kingdom
Imurel
   CHU Amiens Picardie
      2021   Phase 3   EUCTR2021-002047-29-FR   France
   GETAID
      2018   Phase 4   EUCTR2014-002311-41-NL   Belgium;France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-DE   Australia;France;Germany;Netherlands;Sweden;United Kingdom
      2014   -   EUCTR2014-002311-41-FR   France;Sweden;United Kingdom
   GETECCU
      2011   -   EUCTR2011-000885-36-ES   Spain
   Marianne Kiszka-Kanowitz
      2013   Phase 3   EUCTR2013-001503-37-DK   Denmark
   PIBDNet
      2018   Phase 4   EUCTR2016-000522-18-BE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      -   Phase 4   EUCTR2016-000522-18-FR   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
      2018   Phase 4   EUCTR2016-004112-35-SE   Sweden
Imurel 25 MG
   GETAID
      2015   Phase 4   EUCTR2014-002311-41-SE   France;Germany;Netherlands;Sweden;United Kingdom
Increlex
   Nationwide Children's Hospital
      2008   Phase 2/Phase 3   NCT00764699   United States
Increlex 10MG/ML solution FOR injection
   Greater Glasgow & Clyde NHS
      2011   Phase 2   EUCTR2010-022215-19-GB   United Kingdom
   Queen Mary, University of London
      2008   -   EUCTR2007-004269-16-GB   United Kingdom
Indocyanine green
   Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
      2017   -   ChiCTR-INR-17012532   China
   Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
      2020   Phase 0   ChiCTR2000035737   China
Inflectra
   CELLTRION INC.
      2019   Phase 3   EUCTR2019-001087-30-IT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   CUB- Hopital Erasme
      2016   Phase 4   EUCTR2015-004618-10-BE   Belgium
   Celltrion, Inc
      2020   Phase 3   EUCTR2019-001087-30-RO   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-SK   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-PL   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-LV   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-HU   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-HR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-GR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-FR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-ES   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-DE   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-CZ   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-BG   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-AT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   Department of medical gastroenterology, Herlev Hospital
      2016   Phase 4   EUCTR2012-002702-51-NO   Denmark;Finland;Norway;Sweden
   Erasmus Medical Center
      2015   Phase 4   EUCTR2014-005702-37-NL   Netherlands
   Pfizer
      2018   -   NCT03801928   Canada;United States
   UZ Leuven
      2021   Phase 4   EUCTR2020-004012-10-BE   Belgium
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
Inflectra 100 MG powder FOR concentrate FOR solution FOR infusion
   Santeon
      2015   Phase 4   EUCTR2015-001954-14-NL   Netherlands
Infliximab
   ACADEMIC MEDICAL CENTER
      2015   Phase 4   EUCTR2013-002932-25-BE   Belgium;Netherlands
   AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
      2009   -   EUCTR2008-006484-36-IT   Italy
   Academic Medical Center
      2019   Phase 4   EUCTR2018-002064-15-NL   Netherlands
      2014   -   EUCTR2013-001029-17-NL   Netherlands
      2013   Phase 4   EUCTR2013-002932-25-NL   Netherlands
   Academic Medical Center, department of Gastroenterology and hepatology
      2008   -   EUCTR2008-001131-35-NL   Netherlands
   Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
      2024   Phase 4   NCT06113913   Belgium
   Beth Israel Deaconess Medical Center
      2021   Phase 4   NCT04835506   Canada;United States
   Biogen
      2018   -   NCT03662919   France
   CELLTRION INC.
      2019   Phase 3   EUCTR2019-001087-30-IT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   CENTOCOR
      2010   -   EUCTR2010-018431-18-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;United Kingdom
   CHRU de Lille
      2008   Phase 4   EUCTR2006-004784-58-FR   Belgium;France;Germany;United Kingdom
   CUB- Hopital Erasme
      2016   Phase 4   EUCTR2015-004618-10-BE   Belgium
   Celltrion
      2019   Phase 3   NCT03945019   Poland;United States
   Celltrion, Inc
      2020   Phase 3   EUCTR2019-001087-30-RO   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-SK   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-PL   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-LV   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-HU   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-HR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-GR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-FR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-ES   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-DE   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-CZ   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-BG   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-AT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   Celltrion, Inc.
      2014   Phase 3   EUCTR2013-004497-10-RO   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-NL   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-IT   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-HU   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-GB   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-ES   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-DK   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-BE   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Centocor B.V.
      2005   -   EUCTR2004-002815-10-SE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-GB   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-ES   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DK   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-AT   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
   Centocor BV
      2010   Phase 3   EUCTR2010-018431-18-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;United Kingdom
   Centocor, Inc.
      2003   Phase 3   NCT00207675   -
      2002   -   NCT00261976   Argentina;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
      2000   Phase 3   NCT00207766   -
      2000   Phase 3   NCT00207662   -
   Children's Hospital Medical Center, Cincinnati
      2023   Phase 2/Phase 3   NCT05660746   United States
      2019   -   NCT04131504   United States
   Children's Memorial Health Institute, Poland
      2008   Phase 3   NCT01559142   Poland
   Copenhagen University Hospital at Herlev
      2013   Phase 4   NCT01817426   Denmark;Finland;Norway;Sweden
   Daping Hospital, Army Medical University (Third Military Medical University)
      2018   -   ChiCTR1800019958   China
   Department of Gastroenterology and Hepatology, Kyoto University Hospital
      2011   -   JPRN-UMIN000005689   Japan
   Department of Gastroenterology, Nanfang Hospital, Southern Medical University
      2016   -   ChiCTR1800020305   China
   Department of medical gastroenterology S, Odense University Hospital
      2015   Phase 4   EUCTR2012-002702-51-SE   Denmark;Finland;Norway;Sweden
      2012   Phase 4   EUCTR2012-002702-51-DK   Denmark;Finland;Norway;Sweden
   Department of medical gastroenterology, Herlev Hospital
      2016   Phase 4   EUCTR2012-002702-51-NO   Denmark;Finland;Norway;Sweden
      2015   Phase 4   EUCTR2012-002702-51-FI   Denmark;Finland;Norway;Sweden
   Erasmus Medical Center
      2023   Phase 4   NCT05552287   Netherlands
      2023   Phase 4   EUCTR2022-002648-35-NL   Italy;Netherlands
      2015   Phase 4   NCT02517684   Belgium;Denmark;Finland;Italy;Netherlands;Poland
      2015   Phase 4   EUCTR2014-005702-37-NL   Netherlands
      2013   Phase 4   NCT01880307   Italy;Netherlands
   Ernest Seidman
      2014   -   NCT02453607   Canada
   Fukuoka University Chikushi Hospital
      2021   -   JPRN-UMIN000043165   Japan
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2017   Phase 4   NCT02994836   Spain
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   GETAID
      2021   Phase 4   EUCTR2021-002369-17-FR   Belgium;France;Spain
      2018   Phase 4   EUCTR2014-002311-41-NL   Belgium;France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-SE   France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-DE   Australia;France;Germany;Netherlands;Sweden;United Kingdom
      2014   -   EUCTR2014-002311-41-FR   France;Sweden;United Kingdom
      2012   -   EUCTR2011-003038-14-NL   Netherlands
      2012   Phase 4   EUCTR2011-003038-14-BE   Belgium;Netherlands
   Graduate School of Medical Sciences, Kyushu University
      2009   -   JPRN-UMIN000010293   Japan
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2012   Phase 4   NCT01442025   France
      2005   Phase 3   NCT00571337   Belgium;France
   Hikma Pharmaceuticals LLC
      2018   -   NCT03452501   Saudi Arabia
   Hvidovre University Hospital
      2014   -   NCT02060318   Denmark
   IBD Center, Sapporo Kosei General Hospital
      2014   -   JPRN-UMIN000014006   Japan
   IRCCS Burlo Garofolo
      2018   Phase 3   NCT03221166   Italy
      2017   Phase 3   EUCTR2016-000786-24-IT   Italy
   Ishida Tetsuya
      2020   Phase 3   JPRN-jRCT2031200117   Austria;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Japan;Latvia;Poland;Spain;US
   Janssen Biologics B.V.
      2011   -   EUCTR2010-018431-18-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2011   -   EUCTR2010-018431-18-CZ   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2010   Phase 3   EUCTR2010-018431-18-NL   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2010   Phase 3   EUCTR2010-018431-18-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2010   -   EUCTR2010-018431-18-DE   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2010   -   EUCTR2010-018431-18-BE   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2010   -   EUCTR2010-018431-18-AT   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2009   -   EUCTR2008-005237-30-NL   Canada;Netherlands;Sweden;United States
   Janssen Biologics BV
      2011   -   EUCTR2008-005237-30-SE   Belgium;France;Germany;Hungary;Italy;Netherlands;Sweden;United Kingdom;United States
   Janssen Biotech, Inc.
      2010   Phase 3   NCT01190839   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States
   Janssen Korea, Ltd., Korea
      2007   -   NCT00724529   Korea, Republic of
   Janssen Scientific Affairs, LLC
      2013   Phase 4   NCT01804166   United States
   Johnson & Johnson (China) Investment Ltd.
      2020   -   NCT04312659   China
   Jørgen Agnholt
      2013   Phase 3   EUCTR2013-000971-34-DK   Denmark
   Katholieke Universiteit Leuven
      2011   Phase 4   EUCTR2011-002061-38-BE   Belgium
   Klinikum Westbrandenburg GmbH
      2015   -   NCT02522169   -
   Massachusetts General Hospital
      2019   -   NCT04655729   United States
   Merck Sharp & Dohme Corp.
      2012   -   NCT01349920   Moldova, Republic of;United Kingdom
      2010   -   NCT00988832   United Kingdom
      2006   -   NCT00727298   Germany
      2005   -   NCT00705471   -
      2004   -   NCT00724958   Austria
      2003   Phase 3   NCT00796250   -
      2002   -   NCT00818272   Germany
   Mikami Yohei
      2019   -   JPRN-jRCT1031190056   -
   Mundipharma Pharmaceuticals B.V.
      2016   Phase 4   EUCTR2014-004904-31-BE   Belgium;Netherlands
      2015   Phase 4   EUCTR2014-004904-31-NL   Netherlands
   Nanfang Hospital of Southern Medical University
      2014   -   NCT02088944   -
   Novartis Pharma AG
      2011   -   EUCTR2010-019973-13-DE   Germany;Switzerland
   Novartis Pharmaceuticals
      2011   Phase 2   NCT01355614   Germany;Switzerland
   Oregon Health and Science University
      2010   -   NCT01266785   United States
   Peking Union Medical College Hospital
      2020   -   NCT05386290   China
   Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
      2023   Phase 4   ChiCTR2300070321   China
   Pfizer
      2019   -   NCT03884439   Japan
   Pontificia Universidad Catolica de Chile
      2025   -   NCT06758024   Chile
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Renji Hospital, School of Medicine, Shanghai Jiaotong University
      2020   Phase 0   ChiCTR2000029323   China
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   Saitama Medical University
      2011   -   JPRN-UMIN000006232   Japan
   Saitama Medical center
      2014   -   JPRN-UMIN000012790   Japan
   Samsung Medical Center
      2009   Phase 3   NCT01661257   Korea, Republic of
   Second Affiliated Hospital of Wenzhou Medical University
      2017   -   NCT04272788   China
   Sheba Medical Center
      2005   -   NCT00252369   Israel
   Sichuan Academy of Medical Sciences. Sichuan Provincial People's Hospital
      2023   -   ChiCTR2300069727   China
   Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
      2024   -   ChiCTR2300079034   China
   Sixth Affiliated Hospital, Sun Yat-sen University
      2023   Phase 4   NCT05813860   -
      2021   -   NCT04761952   -
   Taina Sipponen
      2016   Phase 4   EUCTR2016-001278-13-FI   Finland
   Taizhou Mabtech Pharmaceutical Co.,Ltd
      2023   Phase 4   NCT05906576   China
   The First Affiliated Hospital of Sun Yat-sen University
      2019   -   ChiCTR1900026091   China
   The Jikei University School of Medicine Division of Gastroenterology and Hepatology
      2012   Phase 4   JPRN-UMIN000008043   Japan
   Tohoku University Graduate School of Medicine (Tohoku University Hospital)
      2012   -   JPRN-UMIN000007343   Japan
   UMC Utrecht
      2019   Phase 4   EUCTR2019-003068-39-NL   Netherlands
   UZ Leuven
      2021   Phase 4   EUCTR2020-004012-10-BE   Belgium
   University Hospitals Cleveland Medical Center
      2008   -   NCT00791557   United States
   University Medical Center Groningen
      2021   Phase 4   NCT04646187   Belgium;Netherlands;Spain
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   University Southampton Hospital NHS Foundation Trust
      2018   Phase 4   EUCTR2018-001546-33-GB   United Kingdom
   University of Alberta
      2015   -   NCT02847884   Canada
   University of Edinburgh
      2015   -   EUCTR2014-002311-41-GB   Belgium;France;Germany;Sweden;United Kingdom
   University of Leuven
      2008   Phase 4   EUCTR2006-004784-58-DE   Belgium;France;Germany;United Kingdom
      2007   Phase 4   EUCTR2006-004784-58-BE   Belgium;France;Germany;United Kingdom
   University of Leuven Hospitals
      2009   Phase 4   EUCTR2006-004784-58-GB   Belgium;France;Germany;United Kingdom
   University of Pittsburgh
      2005   Phase 4   NCT00688636   United States
   University of Rochester
      2007   Phase 4   NCT00462072   United States
   University of Western Ontario, Canada
      2014   Phase 4   NCT01960426   United States
   Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie
      2013   -   EUCTR2011-001332-29-AT   Austria
   Vanderbilt-Ingram Cancer Center
      2006   -   NCT00897312   -
   Zon MW
      2014   Phase 4   EUCTR2013-002651-15-NL   Netherlands
Infliximab (IFX) infusion
   Centocor Ortho Biotech Services, L.L.C.
      2005   Phase 3   NCT00094458   Austria;Belgium;Canada;Denmark;France;Germany;Greece;Israel;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;United States
Infliximab (remicade): 100 MG OF lyophilized infliximab
   First Department of Medicine, University of Szeged
      2014   -   EUCTR2013-005629-21-HU   Hungary
Infliximab 10 MG/KG
   Centocor, Inc.
      1996   Phase 3   NCT00269841   -
      1995   Phase 2/Phase 3   NCT00269854   -
Infliximab 20 MG/KG
   Centocor, Inc.
      1995   Phase 2/Phase 3   NCT00269854   -
Infliximab 5 MG/KG
   Centocor, Inc.
      1996   Phase 3   NCT00269841   -
      1995   Phase 2/Phase 3   NCT00269854   -
   Clinical Research Group of inflammatory bowel disease in Japan
      2009   Phase 4   JPRN-UMIN000002604   Japan
Infliximab 5 MG/KG body weight infused over 2 hours
   Janssen Inc.
      2012   Phase 4   NCT01181765   Canada
Infliximab 5 MG/KG every 6 weeks
   Merck Sharp & Dohme Corp.
      2008   Phase 4   NCT00752622   Canada
Infliximab 7 MG/KG every 8 weeks
   Merck Sharp & Dohme Corp.
      2008   Phase 4   NCT00752622   Canada
Infliximab and adalimumab
   Regionshospitalet Viborg, Skive
      2009   -   NCT02322008   -
Infliximab and azathioprine combination AT week 0
   Sixth Affiliated Hospital, Sun Yat-sen University
      2017   -   NCT03393247   China
Infliximab and azathioprine combination AT week 14
   Sixth Affiliated Hospital, Sun Yat-sen University
      2017   -   NCT03393247   China
Infliximab and immunosuppressives
   Children's Hospital of Fudan University
      2022   Phase 4   NCT05043870   China
Infliximab infusion
   Centocor Ortho Biotech Services, L.L.C.
      2005   Phase 3   NCT00094458   Austria;Belgium;Canada;Denmark;France;Germany;Greece;Israel;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;United States
   Chiba University Hospital
      2012   Phase 2   JPRN-UMIN000015297   Japan
      2012   Phase 2   JPRN-UMIN000007806   Japan
   Department of Lower Gastroenterology, Hyogo College of Medicine
      2012   Phase 4   JPRN-UMIN000006889   Japan
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2019   Phase 4   NCT03885713   Spain
Infliximab subcutaneous
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2021   Phase 3   NCT06059989   Netherlands
Infliximab therapeutic drug monitoring
   Imelda GI Clinical Research Center
      2018   Phase 4   NCT04775732   Belgium
Infliximab+azathioprine
   Belgian IBD Research Group
      2001   Phase 4   NCT00554710   Belgium
Infliximab, adalimumab, certolizumab pegol
   Oslo University Hospital
      2013   -   NCT02073526   Norway
Infliximab, azathioprine
   Lower GI disease, Hyogo College of Medicine
      2007   Phase 2,3   JPRN-UMIN000004427   Japan
   Sixth Affiliated Hospital, Sun Yat-sen University
      2016   -   NCT02998827   -
Infliximab-biosimilar
   Onze Lieve Vrouwe Gasthuis
      2015   Phase 4   NCT02452151   -
Infliximab-dyyb
   Asan Medical Center
      2023   -   NCT06064864   Korea, Republic of
Infliximab-innovator
   Onze Lieve Vrouwe Gasthuis
      2015   Phase 4   NCT02452151   -
Injection OF iron
   Jinling Hospital, China
      2012   -   NCT01823029   China
Innovator infliximab
   Diakonhjemmet Hospital
      2014   Phase 4   NCT02148640   Norway
Inositol
   National Cancer Institute (NCI)
      2010   Phase 1/Phase 2   NCT01111292   United States
Instillation OF fibrin glue
   Sheba Medical Center
      2005   -   NCT00252369   Israel
Intensify treatment with THE existing drug
   University of Western Ontario, Canada
      2014   Phase 4   NCT01960426   United States
Interferon BETA-1A
   EMD Serono
      2001   Phase 2   NCT00304252   Germany;Italy;Sweden;Switzerland;United Kingdom
Interferon gamma
   Mahidol University
      2024   -   NCT06629194   Thailand
Interleukin 2
   Assistance Publique - Hôpitaux de Paris
      2014   Phase 2   NCT01988506   France
Interleukin-11
   Wyeth is now a wholly owned subsidiary of Pfizer
      2002   Phase 2   NCT00040521   United States
Interleukin-2
   Boston Children's Hospital
      2021   Phase 1/Phase 2   NCT04263831   United States
Intestinal resection
   Nantes University Hospital
      2023   -   NCT05584228   -
   Sakura Medical Center,Toho university
      2012   Phase 2   JPRN-UMIN000009284   Japan
Intestinal surgery FOR crohn'S disease
   Sir Run Run Shaw Hospital
      2019   Phase 4   NCT03901937   China
Intralipid
      2013   -   EUCTR2013-001212-30-NL   Netherlands
   Mayo Clinic
      2018   -   NCT03773237   United States
   Radboud University
      2014   Phase 4   NCT02349594   Netherlands
Intrinsically labelled protein
   University of Nottingham
      2022   -   NCT05572203   United Kingdom
Investigational product
   Telavant, Inc.
      2023   Phase 2   NCT05471492   -
Invita D3
   Academic Medical Center
      2013   Phase 3   EUCTR2013-002838-20-NL   Belgium;Netherlands
Iodine
   The First Affiliated Hospital of Soochow University
      2024   -   ChiCTR2400085723   China
Iron
   Iron Therapeutics (Switzerland) AG
      2012   -   EUCTR2010-023589-39-DE   Austria;Germany;Hungary;United Kingdom
      2011   Phase 3   EUCTR2010-023589-39-GB   Austria;Germany;Hungary;United Kingdom
      2011   -   EUCTR2010-023589-39-AT   Austria;Germany;Hungary;United Kingdom
      -   -   EUCTR2010-023589-39-HU   Austria;Germany;Hungary;United Kingdom
Iron sucrose
   Vifor Inc.
      2008   Phase 3   NCT00810030   Austria;Russian Federation
Iron sulphate 200MG coated tablets
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom
Iron supplement 300-600 MG/DAY
   University Health Network, Toronto
      2002   Phase 2   NCT00152841   Canada
Iron(III)- hydroxide dextran complex
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom
ITF 2357
   ITALFARMACO
      2008   -   EUCTR2007-000189-19-IT   Belgium;Italy;Netherlands
ITF2357
   Italfarmaco
      2007   Phase 1/Phase 2   NCT00792740   Belgium
   Italfarmaco S.p.A.
      2007   -   EUCTR2007-000189-19-NL   Belgium;Italy;Netherlands
      2007   -   EUCTR2007-000189-19-BE   Belgium;Italy;Netherlands
      2005   Phase 2   EUCTR2004-004854-19-SK   Slovakia
Itraconazole
   Montreal Heart Institute
      2022   Phase 2   NCT05049525   Canada
IV saline infusion
   McGill University Health Center
      2004   Phase 3   NCT00798473   Canada
IV tulisokibart
   Merck Sharp & Dohme LLC
      2024   Phase 3   NCT06430801   Australia;Austria;Belgium;Canada;Chile;China;Colombia;Croatia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
J695
   National Institute of Allergy and Infectious Diseases (NIAID)
      2000   Phase 1   NCT00007163   United States
J695, BSF 415977 (formerly LU415977), WAY-165772, A-796874.0
   Abbott
      2009   -   EUCTR2008-004919-36-SE   Austria;Denmark;Sweden
      2009   -   EUCTR2008-004919-36-DK   Austria;Denmark;Sweden
      2009   -   EUCTR2008-004919-36-BE   Austria;Belgium;Denmark;Sweden
      2009   -   EUCTR2008-004919-36-AT   Austria;Denmark;Sweden
JNJ-40346527-AAC
   Provention Bio, Inc.
      2018   Phase 2   EUCTR2017-003017-25-PL   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
      2018   Phase 2   EUCTR2017-003017-25-HU   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
      2018   Phase 2   EUCTR2017-003017-25-ES   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
      2018   Phase 2   EUCTR2017-003017-25-DE   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
      2018   Phase 2   EUCTR2017-003017-25-AT   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
JNJ-64304500
   JANSSEN CILAG INTERNATIONAL NV
      2021   Phase 2   EUCTR2020-002701-26-IT   Canada;France;Germany;Italy;Japan;Spain;Sweden;United States
   Janssen Research & Development, LLC
      2021   Phase 2   NCT04655807   Canada;France;Germany;Italy;Japan;Spain;Sweden;United States
      2016   Phase 2   NCT02877134   Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United Kingdom;United States
   Numaguchi Hirotaka
      2021   Phase 2   JPRN-jRCT2031200406   Canada;France;Germany;Italy;Japan;Spain;United States Of America
JNJ-64304500-AAA
   JANSSEN CILAG INTERNATIONAL NV
      2016   Phase 2   EUCTR2016-000634-21-IT   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
   Janssen-Cilag International NV
      2019   Phase 2   EUCTR2016-000634-21-FR   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000634-21-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-GB   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
JNJ-67864238
   JANSSEN CILAG INTERNATIONAL NV
      2019   Phase 2   EUCTR2019-003335-37-IT   Argentina;Germany;Italy;Poland;Russian Federation;United States
   Janssen Research & Development, LLC
      2019   Phase 2   NCT04102111   Argentina;France;Germany;Italy;Poland;Russian Federation;Ukraine;United States
   Janssen-Cilag International NV
      2020   Phase 2   EUCTR2019-003335-37-DE   Argentina;Germany;Italy;Poland;Russian Federation;United States
JNJ-78934804
   JANSSEN CILAG INTERNATIONAL NV
      2022   Phase 2   EUCTR2021-003314-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Janssen Research & Development, LLC
      2022   Phase 2   NCT05242471   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
   Janssen-Cilag International NV
      2023   Phase 2   EUCTR2021-003314-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Singapore;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Nishikawa Kazuko
      2022   Phase 2   JPRN-jRCT2031220309   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea;Mexico;Netherlands;Norway;Poland;Portugal;Republic Of Lithuania;Serbia;Spain;Switzerland;United Kingdom Of Great Britain
Kanamycin
   Hyogo college of medicine
      2014   Phase 2   JPRN-UMIN000013369   Japan
Kenacort
   University Medical Center Utrecht
      2009   -   EUCTR2007-005455-42-NL   Netherlands
Kleanlyte
   University of Manitoba
      2024   Phase 4   NCT06298461   Canada
Kremezin®, spherical adsorptive carbon
   Ocera Therapeutics, Inc.
      2007   -   EUCTR2005-005363-28-HU   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2007   -   EUCTR2005-005363-28-AT   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   Phase 3   EUCTR2005-005363-28-GB   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-DE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-005363-28-BE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom
L 44
   Lument AB
      2019   Phase 2   EUCTR2019-002093-32-SE   Sweden
L-carnitine
   University of California, San Francisco
      2013   -   NCT01523106   United States
L01BA
   PIBDNet
      2017   Phase 4   EUCTR2016-000522-18-NL   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
L04ab04
   ACADEMIC MEDICAL CENTER
      2015   Phase 4   EUCTR2013-002932-25-BE   Belgium;Netherlands
L04ax01
   CHU Amiens Picardie
      2021   Phase 3   EUCTR2021-002047-29-FR   France
Laboratory biomarker analysis
   Fred Hutchinson Cancer Research Center
      2012   Phase 2   NCT01570348   United States
   Vanderbilt-Ingram Cancer Center
      2006   -   NCT00897312   -
Lactated ringers
   Spectrum Health Hospitals
      2007   Phase 3   NCT00467922   United States
Lactobacillus salivarius UCC118
   University College Cork
      2002   Phase 2/Phase 3   NCT00510978   Ireland
Lactulose/rhamnose solution
   MediBeacon
      2019   Early Phase 1   NCT03962998   United States
LAP TAP bupivacaine/epinephrine
   Cedars-Sinai Medical Center
      2015   -   NCT02538679   -
Laquinimod
   Teva Pharmaceutical Industries
      2010   Phase 2   NCT00737932   Belgium;France;Israel;Italy;Netherlands;Poland;South Africa;Spain;United Kingdom
   Teva Pharmaceutical Industries Ltd.
      2008   -   EUCTR2008-004276-49-IT   Belgium;France;Italy;Netherlands;Spain;United Kingdom
Laquinimod capsules 0.5 MG
   Teva Pharmaceutical Industries Ltd.
      2008   -   EUCTR2008-004276-49-NL   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-GB   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-FR   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-BE   Belgium;France;Italy;Netherlands;Spain;United Kingdom
Laquinimod Cápsulas 0.5 MG
   Teva Pharmaceutical Industries Ltd.
      2008   Phase 2   EUCTR2008-004276-49-ES   Belgium;France;Italy;Netherlands;Spain;United Kingdom
Late biologic therapy
   Zagazig University
      2024   Early Phase 1   NCT06511921   Egypt
LDP-02
   Millennium Pharmaceuticals, Inc.
      2000   Phase 2   NCT00655135   -
Lengthening adalimumab dosing interval
   Radboud University Medical Center
      2017   Phase 4   NCT03172377   Netherlands
Leukapheresis
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
Leukapheresis- collection OF stem cells
   Nationwide Children's Hospital
      2013   Phase 2   NCT02676622   -
Lipitor
   University College London
      2009   Phase 2   EUCTR2009-010163-16-GB   United Kingdom
Liposomal bupivacaine
   Cedars-Sinai Medical Center
      2018   Phase 4   NCT03723447   United States
LMT503
   Lmito Therapeutics Inc.
      2025   Phase 1   NCT05659953   Netherlands
LO4ab02
   ACADEMIC MEDICAL CENTER
      2015   Phase 4   EUCTR2013-002932-25-BE   Belgium;Netherlands
Local injection OF normal saline
   Direct Biologics, LLC
      2023   Phase 1/Phase 2   NCT05836883   United States
Losartan
   Takeda
      2016   Phase 4   NCT02760615   United States
LOW dose naltrexone
   Santa Barbara Cottage Hospital
      2013   Phase 2   NCT01810185   United States
LOW dose TSO
   Dr. Falk Pharma GmbH
      2010   Phase 2   NCT01279577   Germany
LOW fiber diet
   Rhode Island Hospital
      2021   -   NCT05918562   United States
LOW N-6 pufa diet
   University of Alberta
      2020   -   NCT03950336   Canada
LOW serine diet
   University of Michigan
      2021   -   NCT04795960   United States
LOW-dose IL-2 administration
   Nationwide Children's Hospital
      2013   Phase 2   NCT02676622   -
Lumbar puncture
   Shire
      2012   Phase 1   NCT01387594   Austria;Belgium;France;Germany;Netherlands
Lumentin 44
   Lument AB
      2019   Phase 2   EUCTR2019-002093-32-SE   Sweden
Lutikizumab
   AbbVie
      2024   Phase 2   NCT06548542   Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Singapore;Slovakia;Slovenia;Spain;Switzerland;United Kingdom;United States
LY3074828
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2023   Phase 3   EUCTR2022-000811-29-IT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2020-005311-49-IT   Argentina;Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Eli Lilly and Company
      2023   Phase 3   EUCTR2022-000811-29-PT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2022-000811-29-NO   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2022-000811-29-FR   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2022-000811-29-AT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2019-002687-27-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2019-002687-27-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-002687-27-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-002687-27-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-002687-27-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-002687-27-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-002687-27-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002204-84-PL   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Japan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Switzerland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002204-84-NL   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Japan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Switzerland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002204-84-HU   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Japan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Switzerland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002204-84-GB   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Japan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Switzerland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002204-84-CZ   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Japan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Switzerland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002204-84-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Japan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Switzerland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002204-84-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Japan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Switzerland;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2022-000811-29-PL   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2022-000811-29-BE   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2020-005311-49-PL   Argentina;Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;United Kingdom;United States
   Lilly S.A.
      2019   Phase 3   EUCTR2018-004614-18-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Masaki Takeshi
      2024   Phase 3   JPRN-jRCT2051230129   Australia;Austria;Belgium;Brazil;Canada;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;United Kingdom;United States
      2021   Phase 3   JPRN-jRCT2031210210   Japan;United States
Lymphocyte immune globulin
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
Maltodextrin
   Katholieke Universiteit Leuven
      2008   -   NCT01487759   Belgium
   University of Alberta
      2020   -   NCT03950336   Canada
Mango polyphenolics
   Texas A&M University
      2014   -   NCT02227602   United States
Mannitol
   Sanming First Affiliated Hospital of Fujian Medical University
      2014   Phase 4 study   ChiCTR-DDT-14004402   China
Mare´S milk
   University of Jena
      2000   -   NCT00940576   Germany
Masitinib mesylate
   AB Science
      2015   Phase 2;Phase 3   EUCTR2012-004222-25-GR   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;India;Italy;Morocco;Poland;Romania;Russian Federation;Slovakia;Spain;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-004222-25-SK   Belgium;Czech Republic;France;Greece;India;Morocco;Slovakia;Spain;Tunisia
      2013   Phase 3   EUCTR2012-004222-25-BE   Belgium;Canada;Central African Republic;Czech Republic;France;Germany;Greece;Hungary;Italy;Netherlands;Poland;Romania;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States
MB-102
   MediBeacon
      2019   Early Phase 1   NCT03962998   United States
MBF-118 oral capsules
   Medibiofarma S.L.
      2023   Phase 2   NCT05940558   Spain
MDGN-002
   Aevi Genomic Medicine, LLC, a Cerecor company
      2017   Phase 1   NCT03169894   United States
MDX-1100
   Bristol-Myers Squibb International Corporation
      2012   -   EUCTR2011-002981-19-PL   Belgium;France;Hungary;Poland;South Africa;United States
      2012   -   EUCTR2011-002981-19-HU   Belgium;France;Hungary;Poland;South Africa;United States
      2012   -   EUCTR2011-002981-19-BE   Belgium;France;Hungary;Poland;South Africa;United States
Measurement OF serum infliximab and ANTI-infliximab antibodies
   Copenhagen University Hospital at Herlev
      2009   Phase 4   NCT00851565   Denmark
Mecasermin [rdna origin] 10MG/ML solution
   Greater Glasgow & Clyde NHS
      2011   Phase 2   EUCTR2010-022215-19-GB   United Kingdom
MEDI2070
   ASTRAZENECA
      2013   Phase 2   EUCTR2012-004098-26-IT   Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States
   Allergan
      2013   Phase 2   NCT01714726   Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Poland;Spain;United States
   Allergan Limited
      2017   Phase 2   EUCTR2015-000609-38-GB   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-000609-38-HU   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-000609-38-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-000609-38-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-SK   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2021   Phase 2;Phase 3   EUCTR2018-004346-42-HU   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-CZ   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-DE   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 2   EUCTR2012-004098-26-HU   Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United States
      2013   Phase 2   EUCTR2012-004098-26-FR   Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United States
      2013   Phase 2   EUCTR2012-004098-26-ES   Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United States
      2013   Phase 2   EUCTR2012-004098-26-DE   Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United States
      2013   Phase 2   EUCTR2012-004098-26-CZ   Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;United States
   MEDIMMUNE, LLC
      2016   Phase 2   EUCTR2015-000609-38-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   MedImmune Limited
      2016   Phase 2   EUCTR2015-000609-38-CZ   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
   MedImmune, Ltd, a wholly owned subsidiary of AstraZeneca UK
      2016   Phase 2   EUCTR2015-000609-38-NL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-000609-38-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-000609-38-BE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
Medical cannabis
   Eli Sprecher, MD
      2019   -   NCT05578313   Israel
Mediterranean diet
   University of Miami
      2025   Phase 4   NCT06774079   United States
Medium chain triglycerides
   Imperial College London
      2008   Phase 4   NCT00672763   United Kingdom
Medium dose TSO
   Dr. Falk Pharma GmbH
      2010   Phase 2   NCT01279577   Germany
Melatonin
   Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
      2025   -   ChiCTR2500097177   China
Melphalan
   Paul Szabolcs
      2012   Phase 1/Phase 2   NCT00692939   United States
   Stanford University
      2025   Phase 1/Phase 2   NCT06986382   United States
Mensa
   European Group for Blood and Marrow Transplantation (EMBT)
      2006   -   EUCTR2005-003337-40-GB   United Kingdom
Mercaptopurine
   GETAID
      2018   Phase 4   EUCTR2014-002311-41-NL   Belgium;France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-SE   France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-DE   Australia;France;Germany;Netherlands;Sweden;United Kingdom
      2014   -   EUCTR2014-002311-41-FR   France;Sweden;United Kingdom
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   University of Edinburgh
      2015   -   EUCTR2014-002311-41-GB   Belgium;France;Germany;Sweden;United Kingdom
Mesalamine
   Ferring Pharmaceuticals
      2009   Phase 3   NCT00245505   Sweden
   Milton S. Hershey Medical Center
      2013   Phase 4   NCT01696942   United States
Mesalamine, 5-aminosalicylic acid
   Ferring Pharmaceuticals A/S
      2009   -   EUCTR2008-002100-26-GB   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002100-26-FR   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2009   -   EUCTR2008-002100-26-BE   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-002100-26-SE   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-002100-26-DK   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-002100-26-DE   Belgium;Denmark;France;Germany;Sweden;United Kingdom
Mesalazine
   Alimentiv Inc
      2018   Phase 4   EUCTR2018-001382-17-GB   Canada;United Kingdom
   AstraZeneca
      2012   Phase 3   JPRN-jRCT2080221723   -
   AstraZeneca K.K.
      -   Phase 3   EUCTR2014-004132-20-Outside-EU/EEA   Japan
   Dr. Falk Pharma GmbH
      2007   -   EUCTR2004-001213-34-GB   Czech Republic;United Kingdom
      2004   Phase 3   NCT00300118   Germany
      2004   Phase 3   EUCTR2004-001213-34-SK   Czech Republic;Slovakia;United Kingdom
      2004   -   EUCTR2004-001213-34-CZ   Czech Republic;United Kingdom
      2002   Phase 3   NCT00946946   Austria;Germany
   Ferring Laegemidler A/S
      2005   -   EUCTR2005-002472-15-SE   Sweden
   Ferring Pharmaceuticals
      2009   Phase 3   NCT00245505   Sweden
   Ferring Pharmaceuticals A/S
      2009   -   EUCTR2008-002100-26-GB   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002100-26-FR   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2009   -   EUCTR2008-002100-26-BE   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-002100-26-SE   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-002100-26-DK   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-002100-26-DE   Belgium;Denmark;France;Germany;Sweden;United Kingdom
   Peking Union Medical College Hospital
      2020   -   NCT05386290   China
   University Medical Center Utrecht
      2009   -   EUCTR2009-011220-62-NL   Netherlands
   Yanling Wei
      2015   Phase 2   NCT02335281   China
   Zeria Pharmaceutical Co., Ltd.
      2011   Phase 2   JPRN-jRCT2080221421   -
   Zeria Pharmaceutical Co.,LTD
      2005   Phase 3   JPRN-C000000300   Japan
   Zeria Pharmaceutical Co.,LTD.
      2005   Phase 2,3   JPRN-C000000301   Japan
Mesalazine EC 500 MG
   Disphar International B.V.
      2005   Phase 3   EUCTR2004-004083-77-SK   Czech Republic;Slovakia
      2004   -   EUCTR2004-004083-77-CZ   Czech Republic
Mesalazine sustained-release tablets
   Xijing Hospital of Digestive Diseases
      2016   Phase 3   NCT02769494   China
Mesalazine tablets
   AstraZeneca
      2012   Phase 3   NCT01514240   Japan
Mesalazine, tripterygium glycosides
   Zhu Weiming
      2014   Phase 2/Phase 3   NCT02044952   China
Mesenchymal cell and fibroblast injection
   Royan Institute
      2013   Phase 1   NCT01874015   Iran, Islamic Republic of
Mesenchymal cell transplantation
   Royan Institute
      2013   Phase 1   NCT01874015   Iran, Islamic Republic of
Mesenchymal stem cells
   Amy Lightner
      2021   Phase 1   NCT04791878   United States
      2020   Phase 1/Phase 2   NCT04519697   United States
      2020   Phase 1/Phase 2   NCT04519684   United States
      2020   Phase 1/Phase 2   NCT04519671   United States
   CHU-ULg
      2012   Phase 2   EUCTR2011-005966-39-BE   Belgium
   Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2022   Phase 1/Phase 2   NCT05521672   Spain
   Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
      2024   Phase 1   NCT06429241   China
   Leiden University Medical Center
      2010   -   EUCTR2009-015680-14-NL   Netherlands
   The Cleveland Clinic
      2022   Phase 1   NCT05578508   United States
      2021   Phase 1   NCT04073472   United States
   University of Liege
      2013   Phase 1/Phase 2   NCT01540292   Belgium
Mesenchymal stromal cells
   University of Liege
      2018   Phase 1/Phase 2   NCT03901235   Belgium
Mesenchymal stromal cells (MSC) FOR infusion
   R.P.Herrmann
      2010   Phase 2   NCT01090817   Australia
Mesna
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
   European Group for Blood and Marrow Transplantation (EMBT)
      2006   -   EUCTR2005-003337-40-GB   United Kingdom
   Northwestern University
      2019   Phase 2   NCT04154735   United States
   Paul Szabolcs
      2012   Phase 1/Phase 2   NCT00692939   United States
Methacholine challenge test
   Rambam Health Care Campus
      2008   -   NCT01297907   Israel
Methotrexat
   PIBD-Net
      2017   Phase 3   EUCTR2016-000522-18-DE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
Methotrexate
   Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
      2011   -   JPRN-UMIN000005251   Japan
   GETAID
      2018   Phase 4   EUCTR2014-002311-41-NL   Belgium;France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-DE   Australia;France;Germany;Netherlands;Sweden;United Kingdom
      2014   -   EUCTR2014-002311-41-FR   France;Sweden;United Kingdom
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2005   Phase 4   NCT00546546   France
   Indiana University
      2015   -   NCT02413047   United States
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   PIBD-Net
      2017   Phase 4   NCT02852694   France
      2017   Phase 3   EUCTR2016-000522-18-DE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDNet
      2018   Phase 4   EUCTR2016-000522-18-CZ   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      2018   Phase 4   EUCTR2016-000522-18-BE   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      2017   Phase 4   EUCTR2016-000522-18-NL   Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
      -   Phase 4   EUCTR2016-000522-18-FR   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   PIBDnet (Pediatric Inflammatory Bowel Disease Network)
      -   Phase 4   EUCTR2016-000522-18-PL   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom
   Prof. Arie Levine
      2015   Phase 4   NCT02269358   Israel
   Takeda
      2017   Phase 4   NCT02764762   Canada;United States
   University of Edinburgh
      2015   -   EUCTR2014-002311-41-GB   Belgium;France;Germany;Sweden;United Kingdom
   University of North Carolina, Chapel Hill
      2016   Phase 3   NCT02772965   United States
   University of Western Ontario, Canada
      2005   Phase 3   NCT00132899   Canada
Methotrexate - 20 MG/0.8 ML soluzione iniettabile 4 siringhe preriempite monouso DA 1.25 ML
   UMBERTO I - POLICLINICO DI ROMA
      2017   Phase 4   EUCTR2016-000522-18-IT   Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Poland;United Kingdom
Methotrexate disodium
   GETAID
      2015   Phase 4   EUCTR2014-002311-41-SE   France;Germany;Netherlands;Sweden;United Kingdom
Methotrexate injection
   Amsterdam UMC location AMC
      2019   Phase 4   EUCTR2018-003594-95-NL   Netherlands
Methoxsalen
   Therakos
      2005   -   EUCTR2004-002693-37-DE   Germany
      2005   Phase 2   EUCTR2004-002693-37-BE   Austria;Belgium;Germany
      2004   -   EUCTR2004-002693-37-AT   Austria;Germany
Methoxsalen +ECP
   Mallinckrodt
      2004   Phase 2   NCT00221026   Austria;Belgium;Germany;United States
Methyl prednisolone
   European Group for Blood and Marrow Transplantation (EMBT)
      2006   -   EUCTR2005-003337-40-GB   United Kingdom
Methylprednisolone
   Aaron Etra
      2017   Phase 2   NCT03219359   United States
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
   Stanford University
      2022   Phase 1   NCT05587673   United States
Methylprednisolone or budesonide
   Belgian IBD Research Group
      2001   Phase 4   NCT00554710   Belgium
Metoject
   CHU Amiens Picardie
      2021   Phase 3   EUCTR2021-002047-29-FR   France
   GETAID
      2015   Phase 4   EUCTR2014-002311-41-SE   France;Germany;Netherlands;Sweden;United Kingdom
Metotrexat
   GETAID
      2015   Phase 4   EUCTR2014-002311-41-SE   France;Germany;Netherlands;Sweden;United Kingdom
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
Metronidazol
   GETECCU
      2011   -   EUCTR2011-000885-36-ES   Spain
Metronidazole
   Amsterdam UMC
      2020   Phase 2   EUCTR2019-004219-29-NL   Canada;Israel;Netherlands;United States
   Centro Hospitalar de São João E.P.E.
      2013   Phase 3   EUCTR2012-005226-29-PT   Belgium;Canada;Israel;Netherlands;Poland;Portugal;United States
   Erasmus MC
      2014   -   EUCTR2012-005226-29-PL   Belgium;Canada;Israel;Netherlands;Poland;Portugal;United States
   Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
      2012   Phase 3   NCT01564823   Spain
   Hyogo college of medicine
      2014   Phase 2   JPRN-UMIN000013369   Japan
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
   Juntendo university school of medicine Department of gastroenterology
      2017   -   JPRN-UMIN000025846   Japan
   Mount Sinai Hospital, Canada
      2006   Phase 2   NCT00257699   Canada
   S.L.A. Pharma AG
      2007   Phase 1   NCT00774969   United Kingdom
   University of North Carolina, Chapel Hill
      2021   Phase 2   NCT04186247   Canada;Israel;Netherlands;United States
   Wolfson Medical Center
      2013   Phase 3   EUCTR2012-005226-29-BE   Belgium;Canada;Israel;Netherlands;Poland;Portugal;United States
      -   -   EUCTR2012-005226-29-NL   Canada;Israel;Netherlands;United States
Metronidazole oral
   University of Louisville
      2021   Phase 4   NCT04682522   United States
Microbiota
   McMaster Children's Hospital
      2018   Phase 1   NCT03378167   Canada
Midazolam
   Takeda
      2016   Phase 4   NCT02760615   United States
Midazolam 2 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Midazolam 3 MG
   GlaxoSmithKline
      2011   Phase 1   NCT01489943   United States
Milk
   Universitary Hospital Príncipe de Asturias
      2021   Phase 4   EUCTR2021-000985-14-ES   Spain
Mirikizumab
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2023   Phase 3   EUCTR2022-000811-29-IT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2020-005311-49-IT   Argentina;Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Eli Lilly and Company
      2025   Phase 3   NCT06937099   Austria;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Turkey;United States
      2024   Phase 3   NCT05509777   Australia;Austria;Belgium;Brazil;Canada;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2022-000811-29-PT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2022-000811-29-NO   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2022-000811-29-FR   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2022-000811-29-AT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2022   Phase 3   EUCTR2019-002687-27-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2019-002687-27-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   NCT04844606   Austria;Belgium;Brazil;France;Germany;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2019-002687-27-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   NCT04232553   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-002687-27-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-002687-27-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-002687-27-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-002687-27-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-002687-27-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   NCT03926130   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2022-000811-29-PL   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2022-000811-29-BE   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Democratic People's Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2020-005311-49-PL   Argentina;Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;United Kingdom;United States
   Lilly S.A.
      2019   Phase 3   EUCTR2018-004614-18-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Masaki Takeshi
      2024   Phase 3   JPRN-jRCT2051230129   Australia;Austria;Belgium;Brazil;Canada;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;United Kingdom;United States
      2021   Phase 3   JPRN-jRCT2031210210   Japan;United States
MLN0002
   AMC MEDICAL RESEARCH B.V.
      2017   Phase 3   EUCTR2015-000555-24-IT   France;Italy;Netherlands;Spain
   Academic Medical Center Amsterdam
      2016   Phase 4   EUCTR2015-000555-24-NL   France;Italy;Netherlands;Spain
      2016   Phase 4   EUCTR2015-000555-24-FR   France;Netherlands;Spain
      2016   Phase 4   EUCTR2015-000555-24-ES   Netherlands;Spain
   Academic Medical Center, Gastroenterology
      2015   Phase 4   EUCTR2014-005376-29-BE   Belgium;Netherlands
   MILLENNIUM PHARMACEUTICALS, INC.
      2011   -   EUCTR2009-016488-12-IT   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands
      2009   -   EUCTR2008-002783-33-IT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
   Millennium Pharmaceuticals, Inc.
      2011   Phase 3   EUCTR2009-016488-12-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands;Slovakia
      2011   -   EUCTR2009-016488-12-NL   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands
      2011   -   EUCTR2009-016488-12-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;New Zealand;Norway;Poland;Slovakia;South Africa;Turkey;United States
      2011   -   EUCTR2009-016488-12-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands;Slovakia
      2011   Phase 3   EUCTR2009-016488-12-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands;Slovakia
      2011   -   EUCTR2009-016488-12-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;New Zealand;Norway;Poland;Slovakia;South Africa;Turkey;United States
      2010   -   EUCTR2009-016488-12-HU   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands
      2009   Phase 3   EUCTR2008-002784-14-PT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002784-14-MT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-IE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-GR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-FR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-EE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   -   EUCTR2008-002783-33-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-PT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-MT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002783-33-IS   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-IE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-GR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002783-33-GB   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002783-33-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-EE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
      2009   -   EUCTR2008-002783-33-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002783-33-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
      2008   -   EUCTR2008-002783-33-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-002783-33-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
   Shikamura Mitsuhiro
      2023   Phase 3   JPRN-jRCT2071230036   China;Greece;Hungary;Italy;Japan;Korea;Poland
   TAKEDA DEVELOPMENT CENTER AMERICAS INC.
      2021   Phase 3   EUCTR2020-004301-31-IT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
   Takeda Development Center Americas, Inc.
      2023   Phase 3   EUCTR2021-000630-34-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-GR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HU   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-LT   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-HU   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-ES   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-Outside-EU/EEA   Australia;Canada;China;Israel;Japan;Korea, Republic of;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004301-31-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004301-31-Outside-EU/EEA   Australia;Belgium;Canada;China;Croatia;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2020-004301-31-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
   Takeda Development Centre Americas Inc.
      2018   Phase 2   EUCTR2017-002182-21-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Americas, Ltd.
      2017   Phase 2   EUCTR2017-002182-21-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe Limited
      2017   Phase 4   EUCTR2016-000678-40-BG   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-LV   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-HU   Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-EE   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-CZ   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda Development Centre Europe Ltd
      2015   Phase 3   EUCTR2014-003509-13-PL   Belgium;Canada;Czech Republic;Hungary;Poland;United States
      2015   Phase 3   EUCTR2014-003509-13-HU   Belgium;Canada;Czech Republic;Hungary;Poland;United States
      2015   Phase 3   EUCTR2014-003509-13-CZ   Belgium;Canada;Czech Republic;Hungary;Poland;United States
      2015   Phase 3   EUCTR2014-003509-13-BE   Belgium;Canada;Czech Republic;Hungary;Poland;United States
      2009   Phase 3   EUCTR2008-002784-14-IS   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
   Takeda Development Centre Europe Ltd.
      2010   Phase 3   EUCTR2008-002784-14-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2008-002784-14-GB   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-CZ   Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2008   Phase 3   EUCTR2008-002784-14-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe ltd.
      2009   Phase 3   EUCTR2008-002784-14-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe, Ltd.
      2018   Phase 2   EUCTR2017-002231-41-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002182-21-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002182-21-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 4   EUCTR2015-000852-12-BE   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-NL   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-GB   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-FR   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-ES   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      -   Phase 2   EUCTR2017-002231-41-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Pharmaceutical Company Limited
      2014   Phase 3   JPRN-jRCT2080222352   Japan
MLN0002 SC
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2015-000482-31-IT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Montenegro;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-IT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000482-31-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
MLN002
   Takeda Development Centre Europe Limited
      2016   Phase 4   EUCTR2016-000678-40-CZ   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
Mobilization OF stem cells TO prepare FOR leukapheresis
   Nationwide Children's Hospital
      2013   Phase 2   NCT02676622   -
Moderate oligosaccharide group
   University of British Columbia
      2015   -   NCT02193750   Australia;Canada
Modulen
   Duzce University
      2021   Phase 3   NCT04921033   Turkey
   Hillel Yaffe Medical Center
      2020   -   NCT04233463   Israel
Modulen IBD
   Assistance Publique - Hôpitaux de Paris
      2014   -   NCT02201693   France
   Hôpital Necker-Enfants Malades
      2005   Phase 4   NCT00265772   France
Mongersen
   CELGENE CORPORATION
      2017   Phase 3   EUCTR2015-001924-40-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-IT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-001693-18-IT   Italy
   Celgene Corporation
      2017   Phase 3   EUCTR2015-001963-37-FI   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001925-18-FI   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-LV   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-FI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2015-001924-40-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-PT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-LV   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-GR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-GB   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Oman;Pakistan;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-ES   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-DK   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-BG   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001963-37-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-SK   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-SE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-PT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-LV   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-HU   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-HR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-GR   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-GB   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-ES   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-DK   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-DE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-BG   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-BE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001925-18-AT   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001963-37-EE   Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001925-18-EE   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-001925-18-NO   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2015-001924-40-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Monoclonal antibodies
   MILLENNIUM PHARMACEUTICALS, INC.
      2011   -   EUCTR2009-016488-12-IT   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands
Monoclonal antibody ANTI-IGG1
   Boehringer Ingelheim
      2021   Phase 2   EUCTR2019-001673-93-BE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2020   Phase 2   EUCTR2019-001673-93-AT   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim BV
      2022   Phase 2   EUCTR2019-001673-93-DK   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2020   Phase 2   EUCTR2017-003090-34-DK   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim Netherlands BV
      2019   Phase 2   EUCTR2017-003090-34-NL   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2020   Phase 2   EUCTR2019-001673-93-DE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2019   Phase 2   EUCTR2017-003090-34-DE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim RCV GmbH & Co KG
      2020   Phase 2   EUCTR2019-001673-93-HU   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2019   Phase 2   EUCTR2017-003090-34-HU   Austria;Belgium;Germany;Hungary;Netherlands
      2019   Phase 2   EUCTR2017-003090-34-AT   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim S.A.
      2021   Phase 2   EUCTR2019-001673-93-ES   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   SCS Boehringer Ingelheim Comm.V
      2018   Phase 2   EUCTR2017-003090-34-BE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
Monoclonal antibody CA2
   FDA Office of Orphan Products Development
      1996   Phase 3   NCT00004941   -
MORF-057
   Morphic Therapeutic, Inc
      2024   Phase 2   NCT06226883   Austria;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Latvia;Mexico;Poland;Romania;Serbia;Slovakia;Spain;United States
Mosapride
   Department of Gastroenterology, Graduate School of Medicine, Osaka City University
      2012   -   JPRN-UMIN000008199   Japan
Moviprep polvo para solucióN oral
   Universitary Hospital Príncipe de Asturias
      2021   Phase 4   EUCTR2021-000985-14-ES   Spain
Movprep
   Lument AB
      2019   Phase 2   EUCTR2019-002093-32-SE   Sweden
MSC
   CHU-ULg
      2012   Phase 2   EUCTR2011-005966-39-BE   Belgium
   University of Liege
      2013   Phase 1/Phase 2   NCT01540292   Belgium
MSC injection 01
   Sixth Affiliated Hospital, Sun Yat-sen University
      2017   Phase 2/Phase 3   NCT03056664   -
MSC injection 02
   Sixth Affiliated Hospital, Sun Yat-sen University
      2017   Phase 2/Phase 3   NCT03056664   -
MSC treatment 01
   Sixth Affiliated Hospital, Sun Yat-sen University
      2016   Phase 2/Phase 3   NCT02532738   -
MSC treatment 02
   Sixth Affiliated Hospital, Sun Yat-sen University
      2016   Phase 2/Phase 3   NCT02532738   -
MSC-AFP
   Mayo Clinic
      2018   Phase 1   NCT03449069   United States
      2017   Phase 1   NCT03220243   United States
   William A. Faubion, M.D.
      2013   Phase 1   NCT01915927   United States
MT-1303
   Mitsubishi Tanabe Pharma Corporation
      2015   Phase 2   NCT02389790   Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Ukraine
      2015   Phase 2   NCT02378688   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Ukraine
      2014   Phase 1   NCT02148185   Japan
   Mitsubishi Tanabe Pharma Corporation (MTPC)
      2015   Phase 2   EUCTR2014-002557-19-SK   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia
      2015   Phase 2   EUCTR2014-002557-19-PL   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Ukraine
      2015   Phase 2   EUCTR2014-002557-19-NL   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Ukraine
      2015   Phase 2   EUCTR2014-002557-19-IT   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia
      2015   Phase 2   EUCTR2014-002556-77-SK   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Ukraine
      2015   Phase 2   EUCTR2014-002556-77-PL   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Ukraine
      2015   Phase 2   EUCTR2014-002556-77-NL   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Ukraine
      2015   Phase 2   EUCTR2014-002556-77-IT   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia
      2014   Phase 2   EUCTR2014-002557-19-HU   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia
      2014   Phase 2   EUCTR2014-002557-19-CZ   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Ukraine
      2014   Phase 2   EUCTR2014-002556-77-HU   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia
      2014   Phase 2   EUCTR2014-002556-77-CZ   Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Ukraine
MTP-101C
   University of Minnesota
      2025   Phase 2   NCT06631586   United States
MTP-101S
   University of Minnesota
      2025   Phase 2   NCT06631586   United States
MTX
   Centre Hospitalier Universitaire, Amiens
      2021   Phase 3   NCT05040464   France
   Peking Union Medical College Hospital
      2016   -   ChiCTR-OPC-16008655   China
MVA HAV
   University of Oxford
      2017   Phase 1   NCT03027193   United Kingdom
Mycodigest supplement
   Tel-Aviv Sourasky Medical Center
      2018   -   NCT04329481   Israel
Mycophenolate mofetil
   Fred Hutchinson Cancer Research Center
      2012   Phase 2   NCT01570348   United States
Mycophenolic acid
   Fred Hutchinson Cancer Research Center
      2012   Phase 2   NCT01570348   United States
N-3 polyunsaturated fatty acids
   Sixth Affiliated Hospital, Sun Yat-sen University
      2021   -   NCT04761952   -
N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium
   GlaxoSmithKline Research & Development Ltd
      2011   -   EUCTR2010-022382-10-NL   Austria;Belgium;Czech Republic;Denmark;Germany;Hungary;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom
      -   Phase 3   EUCTR2010-022382-10-NO   Austria;Belgium;Czech Republic;Denmark;Germany;Hungary;Italy;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium
   GlaxoSmithKline Research & Development Ltd
      2011   Phase 3   EUCTR2010-022383-12-NO   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2011   Phase 3   EUCTR2010-022383-12-GB   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom
Naltrexone
   Milton S. Hershey Medical Center
      2008   Phase 2   NCT00715117   United States
Naltrexone hydrochloride
   ErasmusMC
      2020   Phase 2   EUCTR2019-000852-32-NL   Netherlands
Naltrexone-HCL
   Milton S. Hershey Medical Center
      2006   Phase 2   NCT00663117   United States
NAP
   TiGenix, S.A.U.
      2021   Phase 3   EUCTR2017-000725-12-SE   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000725-12-GB   Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000725-12-DE   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-PL   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-HU   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-FR   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-CZ   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000725-12-BE   Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
Natalizumab
   Biogen
      2008   Phase 4   NCT00801125   -
      2008   -   NCT00707512   Puerto Rico;United States
      2004   Phase 3   NCT00078611   Canada;United States
      2002   Phase 4   NCT00280956   United States
      2002   Phase 2   NCT00055536   United States
      2002   Phase 2   NCT00055367   United Kingdom;United States
      2002   Phase 3   NCT00032786   -
      2001   Phase 3   NCT00032799   United States
   Elan Pharma Ltd.
      2005   -   EUCTR2004-003839-31-DK   Denmark
Neomycin
   Children's Hospital of Philadelphia
      2018   Phase 2   NCT03476317   United States
   University of Pennsylvania
      2016   Phase 2   NCT02765256   United States
Nessuno
   GILEAD SCIENCES INCORPORATED
      2015   Phase 2   EUCTR2015-001249-10-IT   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;Italy;South Africa;Spain;United Kingdom;United States
Nitazoxanide
   Romark Laboratories L.C.
      2005   Phase 2   NCT00130390   United States
Nivolumab
   Alliance Foundation Trials, LLC.
      2019   Phase 1   NCT03656627   United States
   National Cancer Institute (NCI)
      2019   Phase 1   NCT03816345   Canada;United States
NNC 0142-0000-0002
   Janssen Research & Development, LLC
      2011   Phase 2   NCT01203631   Belgium;Canada;France;Hungary;Israel;Poland;Russian Federation;United States
NNC0114-0006
   Novo Nordisk A/S
      2013   Phase 2   NCT01751152   Bulgaria;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2013   -   EUCTR2012-002432-93-SK   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2013   -   EUCTR2012-002432-93-PL   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2013   -   EUCTR2012-002432-93-CZ   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2013   -   EUCTR2012-002432-93-BG   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2012   -   EUCTR2012-002432-93-HU   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2012   -   EUCTR2012-002432-93-ES   Bulgaria;Czech Republic;Hungary;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
NNC0142-0000-0002
   Novo Nordisk A/S
      2011   -   EUCTR2010-020836-21-PL   Belgium;Canada;European Union;Hungary;Israel;Poland;Russian Federation;United States
      2011   Phase 2   EUCTR2010-020836-21-BE   Belgium;Canada;European Union;Hungary;Israel;Poland;Russian Federation;United States
      2010   -   EUCTR2010-020836-21-HU   Belgium;Hungary;Poland
NNC142-0002
   Novo Nordisk A/S
      2011   -   EUCTR2010-020836-21-PL   Belgium;Canada;European Union;Hungary;Israel;Poland;Russian Federation;United States
      2011   Phase 2   EUCTR2010-020836-21-BE   Belgium;Canada;European Union;Hungary;Israel;Poland;Russian Federation;United States
      2010   -   EUCTR2010-020836-21-HU   Belgium;Hungary;Poland
None AT this time
   Millennium Pharmaceuticals, Inc (a wholly owned subsidiary
      2020   Phase 2   EUCTR2019-000886-19-FR   France;Germany;United Kingdom;United States
Normal diet
   Graduate School of Medical Sciences, Kyushu University
      2009   -   JPRN-UMIN000010293   Japan
   Zhu Weiming
      2018   -   NCT04160325   China
Normal saline
   Fujita Health University School of Medicine Department of Gastroenterology
      2018   Phase 1,2   JPRN-UMIN000033127   Japan
   Seattle Children's Hospital
      2015   Phase 1/Phase 2   NCT02272868   United States
Normix*AD 12CPR RIV 200MG
   ALFA WASSERMANN
      2007   -   EUCTR2007-001014-17-IT   France;Germany;Hungary;Italy
NOW foods L-ornithine capsules
   The Third Xiangya Hospital of Central South University
      2024   -   NCT06455267   China
NSP001
   Provexis Plc
      2009   Phase 2   EUCTR2006-005526-23-GB   United Kingdom
Nutraceutical combination
   Columbia University
      2012   Phase 2   NCT01647412   United States
Nutrition treat
   Jinling Hospital, China
      2011   -   NCT01540942   China
Nutritional dietary intervention
   Hospital Galdakao-Usansolo
      2020   -   NCT04188990   Spain
Nutropinaq 10MG/2ML solution FOR injection
   Greater Glasgow & Clyde NHS
      2011   Phase 2   EUCTR2010-022215-19-GB   United Kingdom
Obefazimod
   Abivax S.A.
      2024   Phase 2   NCT06456593   Belgium;Czechia;France;Germany;Hungary;Italy;Netherlands;Poland;Romania;Slovakia;Spain;United States
OD-07656
   Odyssey Therapeutics
      2024   Phase 1   NCT06206811   Australia
OL adalimumab 40 MG
   Abbott
      2002   Phase 3   NCT00055497   United States
Oligofructose enriched inulin
   Katholieke Universiteit Leuven
      2008   -   NCT01487759   Belgium
Olokizumab
   UCB BIOSCIENCES GmbH
      2012   Phase 2   NCT01635621   Bulgaria;Czech Republic;Germany;Hungary;Poland
      2012   -   EUCTR2011-002517-11-HU   Czech Republic;Germany;Hungary;Serbia
      2012   -   EUCTR2011-002517-11-DE   Czech Republic;Germany;Hungary;Serbia
      2012   -   EUCTR2011-002517-11-CZ   Czech Republic;Germany;Hungary;Serbia
      2012   Phase 2   EUCTR2011-002517-11-BG   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Netherlands;Poland;Romania;Serbia
Omega-3
   Tillotts Pharma AG
      2002   Phase 3   NCT00074542   Canada;United States
Omegaven
      2013   -   EUCTR2013-001212-30-NL   Netherlands
   Radboud University
      2014   Phase 4   NCT02349594   Netherlands
   The First Affiliated Hospital of Sun Yat-sen University
      2011   -   ChiCTR-TRC-11001321   China
Omeprazol
   Medical University of Warsaw
      2023   Phase 3   EUCTR2020-004168-24-PL   Poland
Omeprazole
   Medical University of Warsaw
      2024   Phase 2/Phase 3   NCT06719622   Poland
      2023   Phase 3   EUCTR2020-004168-24-PL   Poland
   Takeda
      2016   Phase 4   NCT02760615   United States
Omeprazole 20 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Omeprazole 40 MG
   GlaxoSmithKline
      2011   Phase 1   NCT01489943   United States
Only 1 ARM: treatment with MSC-AFP
   William A. Faubion, M.D.
      2017   Phase 1   NCT03014219   United States
Ontamalimab
   SHIRE HUMAN GENETIC THERAPIES, INC
      2018   Phase 3   EUCTR2017-000574-11-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
   Shire
      2019   Phase 3   NCT03627091   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   NCT03566823   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;New Zealand;Portugal;Slovakia;Spain;Turkey;Ukraine;United States
      2018   Phase 3   NCT03559517   Australia;Austria;Croatia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
   Shire Human Genetic Therapies, Inc.
      2019   Phase 3   EUCTR2017-000617-23-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000617-23-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000575-88-HR   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000575-88-GB   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000576-29-SK   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-PT   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-EE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-BG   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-000575-88-NL   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000575-88-LT   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000575-88-DE   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000575-88-AT   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000574-11-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000574-11-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000617-23-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000617-23-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000576-29-IE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      -   Phase 3   EUCTR2017-000575-88-PL   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      -   Phase 3   EUCTR2017-000574-11-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000574-11-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
OPC-6535
   Otsuka Pharmaceutical Co., Ltd.
      2009   Phase 2/Phase 3   NCT00989573   Japan;Korea, Republic of
      2006   Phase 2   NCT00317369   Japan
OPS-2071
   Otsuka Pharmaceutical Development & Commercialization, Inc.
      2020   Phase 2   EUCTR2019-000176-41-PL   Belgium;Canada;Germany;Italy;Poland;United States
      2020   Phase 2   EUCTR2019-000176-41-HU   Canada;Germany;Hungary;Italy;Poland;Russian Federation;Ukraine;United States
      -   Phase 2   EUCTR2019-000176-41-DE   Canada;Germany;Hungary;Italy;Poland;Russian Federation;Ukraine;United States
   Otsuka Pharmaceutical Development and Commercialization, Inc
      2020   Phase 2   EUCTR2019-000176-41-IT   Belgium;Canada;Germany;Hungary;Italy;Poland;United States
OPS-2071 150 MG
   Otsuka Pharmaceutical Development & Commercialization, Inc.
      2020   Phase 2   NCT03850509   Poland;United States
OPS-2071 300 MG
   Otsuka Pharmaceutical Development & Commercialization, Inc.
      2020   Phase 2   NCT03850509   Poland;United States
OPS-2071 600 MG
   Otsuka Pharmaceutical Development & Commercialization, Inc.
      2020   Phase 2   NCT03850509   Poland;United States
Optison
   University of Michigan
      2015   Phase 1/Phase 2   NCT02061163   United States
Oral contrast media application
   Massachusetts General Hospital
      2023   -   NCT06252493   United States
Oral prednisolone
   Assistance Publique - Hôpitaux de Paris
      2022   Phase 2/Phase 3   NCT05284136   France;Netherlands
Orencia
   Bristol-Myers Squibb International Corporation
      2008   -   EUCTR2006-003371-13-PL   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2008   -   EUCTR2006-003371-13-CZ   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-DK   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   Phase 3   EUCTR2006-003371-13-DE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
      2007   -   EUCTR2006-003371-13-BE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Poland;United Kingdom
Originator (legacy) drug
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2018   -   NCT03729674   Canada
Ossium VBM-MSC
   Amy Lightner
      2022   Phase 1/Phase 2   NCT05075811   United States
OSSM-001
   Ossium Health, Inc.
      2022   Phase 1   NCT05407766   -
Other biologic agents
   Takeda
      2015   -   NCT02674308   Austria;Belgium;Canada;Croatia;Denmark;Estonia;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
Other biologic therapies
   Janssen Scientific Affairs, LLC
      2021   -   NCT04372108   United States
Other biological agent
   Takeda
      2015   -   NCT02678052   Canada;United States
OVA-treg
   TxCell
      2014   Phase 2   EUCTR2014-001295-65-IT   Austria;Belgium;Germany;Italy
      2014   Phase 2   EUCTR2014-001295-65-DE   Austria;Belgium;Germany;Italy
      2014   Phase 2   EUCTR2014-001295-65-BE   Austria;Belgium;Germany;Italy
      2014   Phase 2   EUCTR2014-001295-65-AT   Austria;Belgium;Germany;Italy
Ovasave
   TxCell
      2014   Phase 2   NCT02327221   Austria;Belgium;France;Germany;Italy;United Kingdom
      2014   Phase 2   EUCTR2014-001295-65-IT   Austria;Belgium;Germany;Italy
      2014   Phase 2   EUCTR2014-001295-65-DE   Austria;Belgium;Germany;Italy
      2014   Phase 2   EUCTR2014-001295-65-BE   Austria;Belgium;Germany;Italy
      2014   Phase 2   EUCTR2014-001295-65-AT   Austria;Belgium;Germany;Italy
Oxadrop
   Mayo Clinic
      2006   Phase 1/Phase 2   NCT00587041   United States
Oxygen GAS FOR inhalation
   Ottawa Hospital Research Institute
      2024   Phase 1/Phase 2   NCT06109961   -
Ozanimod
   Bristol-Myers Squibb
      2023   Phase 2/Phase 3   NCT05470985   Australia;Belgium;Canada;France;Germany;Hungary;Poland;Spain;United Kingdom;United States
   CELGENE INTERNATIONAL II SàRL
      2018   Phase 3   EUCTR2017-004295-55-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-IT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002025-19-IT   Canada;Hungary;Italy;Poland;Ukraine;United States
   Celgene
      2018   Phase 3   NCT03467958   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Senegal;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   NCT03464097   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Senegal;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   NCT03440385   Australia;Austria;Brazil;Bulgaria;Canada;China;Colombia;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Senegal;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United States
      2018   Phase 3   NCT03440372   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czechia;Denmark;Finland;France;Georgia;Germany;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;Moldova, Republic of;Norway;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Celgene International II Sarl (CISII) awholly owned subsidiary of Celgene Corporation
      2015   Phase 2   EUCTR2015-002025-19-HU   Canada;Hungary;Italy;Poland;Ukraine;United States
   Celgene International II Sàrl (CIS II), a wholly owned subsidiary of Celgene Corporation
      2016   Phase 2   EUCTR2015-002025-19-PL   Canada;Hungary;Poland;Ukraine;United States
Ozanimod HCL
   Celgene International II Sarl
      2023   Phase 2;Phase 3   EUCTR2021-005019-30-HU   Australia;Belgium;Canada;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2023   Phase 2;Phase 3   EUCTR2021-005019-30-FR   Australia;Belgium;Canada;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2023   Phase 2;Phase 3   EUCTR2021-005019-30-DE   Australia;Belgium;Canada;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2021-005019-30-PL   Australia;Belgium;Canada;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2021-005019-30-BE   Australia;Belgium;Canada;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
   Celgene International II Sàrl
      2019   Phase 3   EUCTR2017-004295-55-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004295-55-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004295-55-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004294-14-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004294-14-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004293-33-FR   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2017-004292-31-RO   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004292-31-FR   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-SI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-SI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004293-33-SK   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-SI   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-SE   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-PT   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-PL   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-NL   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-LT   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-HU   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-GR   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-FI   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-ES   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-BG   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-AT   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004292-31-PL   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-NO   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-LV   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-IE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-HR   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-GB   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-ES   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-DK   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-DE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-CZ   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-BG   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-BE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-004295-55-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-004293-33-DE   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
Ozanimod hydrochloride
   CELGENE INTERNATIONAL II SàRL
      2018   Phase 3   EUCTR2017-004294-14-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Celgene International II Sàrl
      2016   Phase 1   EUCTR2016-003073-18-GB   United Kingdom
P28GST
   University Hospital, Lille
      2014   Phase 2   NCT02281916   France
Palifermin
   Stanford University
      2025   Phase 1/Phase 2   NCT06986382   United States
Pancreatin
   Department of Gastroenterology, Renmin Hospital of WuhanUniversity
      2024   Phase 1   ChiCTR2400086621   China
Pancrelipase
   Department of Gastroenterology Osaka City University Graduate School of Medicine
      2014   -   JPRN-UMIN000014205   Japan
Partial enteral nutrition
   NHS Greater Glasgow and Clyde
      2021   -   NCT04859088   United Kingdom
   The First Affiliated Hospital of Shantou University Medical College
      2022   -   ChiCTR2200058055   China
Pcdai
   Otani Tetsuya
      2024   Phase 3   JPRN-jRCT2071240040   Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Greece;Italy;Japan;New Zealand;Poland;Puerto Rico;South Korea;Spain;Taiwan;Turkey;United Kingdom;United States of America
   Rambam Health Care Campus
      2008   -   NCT01297907   Israel
PDA001
   Celularity Incorporated
      2013   Phase 1   NCT01769755   United States
Pectin
   Jinling Hospital, China
      2014   Phase 2   NCT02164877   China
Pegylated interferon alfa
   Vanderbilt-Ingram Cancer Center
      2006   -   NCT00897312   -
Pending
   Reistone Biopharma Company Limited
      2019   Phase 2   EUCTR2018-003303-19-PL   China;Poland;Ukraine;United States
Pentasa
   AstraZeneca K.K.
      -   Phase 3   EUCTR2014-004132-20-Outside-EU/EEA   Japan
   Ferring Pharmaceuticals
      2009   Phase 3   NCT00862121   Belgium;Denmark;France;Germany;Spain;Sweden;United Kingdom;United States
   Hamamatsu South Hospital, Centre for Gastroenterology and Inflammatory Bowel Disease Research
      2014   -   JPRN-UMIN000015770   Japan
   VU University Medical Center
      2005   Phase 4   NCT00167882   Netherlands
   Zeria Pharmaceutical Co.,LTD
      2005   Phase 3   JPRN-C000000300   Japan
   Zeria Pharmaceutical Co.,LTD.
      2005   Phase 2,3   JPRN-C000000301   Japan
Pentasa sachet
   Ferring Pharmaceuticals A/S
      2009   -   EUCTR2008-002100-26-GB   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002100-26-FR   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2009   -   EUCTR2008-002100-26-BE   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-002100-26-SE   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-002100-26-DK   Belgium;Denmark;France;Germany;Sweden;United Kingdom
      2008   -   EUCTR2008-002100-26-DE   Belgium;Denmark;France;Germany;Sweden;United Kingdom
Pentasa sachet 1 G prolonged release granules
   Ferring Laegemidler A/S
      2005   -   EUCTR2005-002472-15-SE   Sweden
Pentoxifylline
   University of Miami
      2017   Early Phase 1   NCT02953275   United States
Peptidic+probiotic
   Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2020   -   NCT04305535   Spain
Peptison liquid
   Wei Zhou
      2024   -   NCT06587178   China
Peripheral blood stem cell infusion
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
PF 06687234
   Pfizer
      2020   Phase 1   NCT03414788   United States
PF-00547659
   PFIZER SLU
      2011   -   EUCTR2010-023437-30-ES   Austria;Belgium;Bulgaria;Germany;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden
   PFIZER, S.L.U.
      2011   -   EUCTR2010-024638-48-ES   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
   Pfizer Inc.
      2013   Phase 2   EUCTR2012-002030-37-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;United Kingdom
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2012   Phase 2   EUCTR2010-024638-48-NO   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;United States
      2012   Phase 2   EUCTR2010-024638-48-DE   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
      2012   Phase 2   EUCTR2010-024638-48-BG   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
      2012   Phase 2   EUCTR2010-024638-48-BE   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
      2012   -   EUCTR2010-023437-30-PL   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;United States
      2012   Phase 2   EUCTR2010-023437-30-BG   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;United States
      2011   Phase 2   EUCTR2010-024638-48-SK   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
      2011   Phase 2   EUCTR2010-024638-48-SE   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
      2011   -   EUCTR2010-024638-48-PT   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
      2011   Phase 2   EUCTR2010-024638-48-NL   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Slovakia;South Africa;Spain;Sweden;United States
      2011   Phase 2   EUCTR2010-024638-48-AT   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
      2011   -   EUCTR2010-023437-30-SK   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;United States
      2011   Phase 2   EUCTR2010-023437-30-SE   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
      2011   Phase 2   EUCTR2010-023437-30-PT   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;United States
      2011   Phase 2   EUCTR2010-023437-30-NO   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
      2011   -   EUCTR2010-023437-30-NL   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;United States
      2011   -   EUCTR2010-023437-30-DE   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;United States
      2011   -   EUCTR2010-023437-30-BE   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;United States
      2011   -   EUCTR2010-023437-30-AT   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;South Africa;Spain;Sweden;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017, United States
      2012   Phase 2   EUCTR2010-024638-48-PL   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;United States
   Shire
      2011   Phase 2   NCT01298492   Austria;Belgium;Bulgaria;Canada;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
PF-00547659 SC injection
   Shire
      2011   Phase 2   NCT01276509   Austria;Belgium;Bulgaria;Canada;Croatia;France;Germany;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Serbia;Slovakia;South Africa;Spain;Sweden;United States
PF-04236921
   PFIZER INC.
      2011   -   EUCTR2010-023034-23-IT   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
   Pfizer
      2011   Phase 2   NCT01345318   Australia;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;New Zealand;Switzerland;United Kingdom;United States
   Pfizer Inc.
      2012   Phase 2   EUCTR2011-000722-30-CZ   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Romania;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2010-023034-23-CZ   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Romania;Sweden;Switzerland;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2014   -   EUCTR2011-000722-30-SE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-000722-30-AT   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2013   -   EUCTR2010-023034-23-SE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2013   -   EUCTR2010-023034-23-AT   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 2   EUCTR2011-000722-30-GB   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-000722-30-BE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2010-023034-23-BE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2011   Phase 2   EUCTR2011-000722-30-IE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2011   Phase 2   EUCTR2010-023034-23-IE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2011   -   EUCTR2010-023034-23-HU   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2011   -   EUCTR2010-023034-23-GB   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Sweden;Switzerland;United Kingdom;United States
      2011   -   EUCTR2010-023034-23-DK   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Romania;Sweden;Switzerland;United Kingdom;United States
      2011   -   EUCTR2010-023034-23-DE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Romania;Sweden;Switzerland;United Kingdom;United States
PF-04236921 SC injection
   Pfizer
      2011   Phase 2   NCT01287897   Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Romania;Sweden;Switzerland;United Kingdom;United States
PF-06651600
   Pfizer
      2018   Phase 2   NCT03395184   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
PF-06651600 50 MG
   PFIZER INC
      2018   Phase 2   EUCTR2017-003359-43-IT   Austria;Belgium;Croatia;Czech Republic;Germany;Hungary;Italy;Lithuania;Poland;Slovakia;Spain;United States
   Pfizer Inc.
      2018   Phase 2   EUCTR2017-003359-43-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-LT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lebanon;Lithuania;New Zealand;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001
      2018   Phase 2   EUCTR2017-003359-43-PL   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
PF-06651600 50MG
   Pfizer Inc.
      2018   Phase 2   EUCTR2017-003359-43-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
PF-06651600-15
   PFIZER INC
      2018   Phase 2   EUCTR2017-003359-43-IT   Austria;Belgium;Croatia;Czech Republic;Germany;Hungary;Italy;Lithuania;Poland;Slovakia;Spain;United States
   Pfizer Inc.
      2018   Phase 2   EUCTR2017-003359-43-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-LT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lebanon;Lithuania;New Zealand;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001
      2018   Phase 2   EUCTR2017-003359-43-PL   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
PF-06700841
   Pfizer
      2018   Phase 2   NCT03395184   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
PF-06700841 25 MG
   PFIZER INC
      2018   Phase 2   EUCTR2017-003359-43-IT   Austria;Belgium;Croatia;Czech Republic;Germany;Hungary;Italy;Lithuania;Poland;Slovakia;Spain;United States
   Pfizer Inc.
      2018   Phase 2   EUCTR2017-003359-43-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-LT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lebanon;Lithuania;New Zealand;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001
      2018   Phase 2   EUCTR2017-003359-43-PL   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
PF-06700841 5 MG
   PFIZER INC
      2018   Phase 2   EUCTR2017-003359-43-IT   Austria;Belgium;Croatia;Czech Republic;Germany;Hungary;Italy;Lithuania;Poland;Slovakia;Spain;United States
   Pfizer Inc.
      2018   Phase 2   EUCTR2017-003359-43-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-LT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lebanon;Lithuania;New Zealand;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001
      2018   Phase 2   EUCTR2017-003359-43-PL   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
PF-06700841-15
   PFIZER INC
      2018   Phase 2   EUCTR2017-003359-43-IT   Austria;Belgium;Croatia;Czech Republic;Germany;Hungary;Italy;Lithuania;Poland;Slovakia;Spain;United States
   Pfizer Inc.
      2018   Phase 2   EUCTR2017-003359-43-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-LT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lebanon;Lithuania;New Zealand;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001
      2018   Phase 2   EUCTR2017-003359-43-PL   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
PF2020-cell (UC-mscs) - allogeneic human umbilical cord mesenchymal stem cells
   CryoCord Sdn Bhd
      2022   Phase 1   NCT05039411   Malaysia
PGX-guided POST-operative pain management
   The Cleveland Clinic
      2018   -   NCT03455751   United States
Pharmacokinetics OF certolizumab pegol
   UCB Biopharma SRL
      2020   Phase 1   NCT04163016   Canada;France;Germany;Netherlands;Spain;Switzerland;United States
Phase1 : cded/modulen™IBD® + maintenance therapy
   Assistance Publique - Hôpitaux de Paris
      2022   Phase 3   NCT04777656   France
Phylloquinone
   University College Cork
      2008   Phase 4   NCT01235325   Ireland
Physician standard-OF-care
   Merck Sharp & Dohme Corp.
      2011   -   NCT01218360   Greece
Pioglitazone 15 MG
   GlaxoSmithKline
      2011   Phase 1   NCT01489943   United States
PK-model TO decide when TO dose vedolizumab and ustekinumab
   Odense University Hospital
      2025   Phase 4   NCT06788340   Denmark
PL 17901/0122
   Royal Liverpool & Broadgreen University Hospitals Trust
      2009   Phase 2   EUCTR2008-001137-99-GB   United Kingdom
PL 20532/0012
   Royal Liverpool & Broadgreen University Hospitals Trust
      2009   Phase 2   EUCTR2008-001137-99-GB   United Kingdom
Plantain NSP
   Provexis Plc
      2009   Phase 2   EUCTR2006-005526-23-GB   United Kingdom
Plaquenil
   Royal Liverpool & Broadgreen University Hospitals Trust
      2009   Phase 2   EUCTR2008-001137-99-GB   United Kingdom
Pnemovax
   Statens Serum Institut
      2013   -   EUCTR2012-002867-86-DK   Denmark
Pneumovax
   Cedars-Sinai Medical Center
      2005   -   NCT00829595   United States
   Statens Serum Institut
      2013   Phase 4   NCT01947010   Denmark
      2013   -   EUCTR2012-002867-86-DK   Denmark
Polaprezinc
   Kawasaki Medical School
      2011   -   JPRN-UMIN000005970   Japan
Polyethylene glycol 3350
   Children's Hospital of Philadelphia
      2018   Phase 2   NCT03476317   United States
   University of Pennsylvania
      2016   Phase 2   NCT02765256   United States
Polyethylene glycol preparation
   University Hospital, Toulouse
      2024   -   NCT06690632   France
Posaconazole delayed release oral tablet
   Cedars-Sinai Medical Center
      2022   Phase 4   NCT04966585   United States
Positron emission tomography
   Jonsson Comprehensive Cancer Center
      2016   Early Phase 1   NCT02925351   United States
Postoperative 3-month exclusive enteral nutrition
   Zhu Weiming
      2018   -   NCT04160325   China
PRA023
   Prometheus Biosciences, Inc.
      2021   Phase 2   EUCTR2021-000092-37-FR   Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Israel;Poland;Russian Federation;Ukraine;United States
      2021   Phase 2   EUCTR2021-000092-37-BE   Australia;Belgium;Canada;Czech Republic;Czechia;France;Georgia;Poland;United States
   Prometheus Biosciences, Inc. a subsidiary of Merck & Co., Inc.
      2021   Phase 2   EUCTR2021-000092-37-PL   Australia;Belgium;Canada;Czech Republic;Czechia;France;Poland;United States
      2021   Phase 2   EUCTR2021-000092-37-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;France;Poland;United States
PRA023 IV
   Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
      2021   Phase 2   NCT05013905   Australia;Belgium;Canada;Czechia;France;Georgia;Poland;Ukraine;United States
Pravastatin
   University of Virginia
      2004   -   NCT00599625   United States
PRE-filled syringe
      2014   Phase 2   EUCTR2013-002902-29-IE   Belgium;Canada;France;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
      2013   Phase 2   EUCTR2013-002902-29-GB   Belgium;Canada;France;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2022   Phase 2   EUCTR2021-002869-18-IT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom;United States
   ACADEMIC MEDICAL CENTER
      2015   Phase 4   EUCTR2013-002932-25-BE   Belgium;Netherlands
   AbbVie Deutschland GmbH & Co. KG
      2022   Phase 2   EUCTR2021-002869-18-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-GR   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-ES   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
      2022   Phase 2   EUCTR2021-002869-18-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Slovakia;Spain;Taiwan;Turkey;United Kingdom;United States
      2019   Phase 3   EUCTR2016-003191-50-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-003190-17-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001834-15-NL   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Spain;United States
      2015   Phase 2   EUCTR2015-001834-15-DE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001834-15-BE   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Spain;United States
      -   Phase 3   EUCTR2016-003191-50-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003190-17-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
   AstraZeneca AB
      2022   Phase 2;Phase 3   EUCTR2018-004346-42-FR   Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      2021   Phase 2   EUCTR2020-004527-16-IT   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;United States
   Belgian IBD research and development
      2019   Phase 4   EUCTR2018-004269-14-BE   Belgium
   Belgian IBD research and development (BIRD vzw)
      2021   Phase 3   EUCTR2021-000345-41-BE   Belgium
   Boehringer Ingelheim
      2021   Phase 2   EUCTR2019-001673-93-BE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2020   Phase 2   EUCTR2019-001673-93-AT   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim BV
      2022   Phase 2   EUCTR2019-001673-93-DK   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim España, S.A.
      2015   Phase 2   EUCTR2015-001834-15-ES   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Spain;United States
   Boehringer Ingelheim International GmbH
      2017   Phase 3   EUCTR2016-000612-14-HR   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-GR   Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-GB   Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000612-14-DE   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000612-14-CZ   Belarus;Bosnia and Herzegovina;Croatia;Czech Republic;European Union;Germany;Greece;Israel;Russian Federation;Serbia;Turkey;Ukraine;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2020   Phase 2   EUCTR2019-001673-93-DE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2014   Phase 2   EUCTR2013-002902-29-DE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
   Boehringer Ingelheim RCV GmbH & Co KG
      2020   Phase 2   EUCTR2019-001673-93-HU   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim S.A.
      2021   Phase 2   EUCTR2019-001673-93-ES   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim bv
      2015   Phase 2   EUCTR2013-002902-29-NL   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
   CHU Amiens Picardie
      2021   Phase 3   EUCTR2021-002047-29-FR   France
   Celltrion, Inc
      2020   Phase 3   EUCTR2019-001087-30-RO   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-SK   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-PL   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-LV   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-HU   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-HR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-GR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-FR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-ES   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-DE   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-CZ   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-BG   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-AT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   Charité Universitätsmedizin Berlin
      2018   Phase 4   EUCTR2017-005151-83-DE   Germany
   F. Hoffmann-La Roche Ltd
      2015   Phase 3   EUCTR2014-003855-76-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-003855-76-FR   Argentina;Australia;Brazil;Canada;Estonia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003855-76-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-003824-36-RO   Argentina;Australia;Austria;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003824-36-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003824-36-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   Ghent University Hospital
      2012   Phase 3   EUCTR2009-017998-37-BE   Belgium
   Gilead Sciences, Inc
      2016   Phase 2   EUCTR2015-001249-10-IS   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;New Zealand;South Africa;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001249-10-HU   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;New Zealand;South Africa;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001249-10-GB   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;Italy;New Zealand;South Africa;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001249-10-ES   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;New Zealand;South Africa;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001249-10-DE   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;New Zealand;South Africa;Spain;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001249-10-CZ   Australia;Canada;Czech Republic;Germany;Hungary;Iceland;New Zealand;South Africa;Spain;United Kingdom;United States
   Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)
      2012   -   EUCTR2011-003966-34-ES   Spain
      2011   Phase 3   EUCTR2011-003966-34-BE   Belgium;Spain
   JANSSEN CILAG INTERNATIONAL NV
      2023   Phase 3   EUCTR2021-006282-37-IT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-IT   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-002701-26-IT   Canada;France;Germany;Italy;Japan;Spain;Sweden;United States
   Janssen-Cilag International N.V.
      2020   Phase 3   EUCTR2018-002629-51-GB   Austria;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-SE   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-FR   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-002629-51-ES   France;Germany;Netherlands;Spain;Sweden;United States
      2018   Phase 3   EUCTR2017-004209-41-PL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-FR   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2016-002918-43-SK   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2018   Phase 3   EUCTR2016-002918-43-DK   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-SE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-PT   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-NL   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-GB   Belgium;Germany;Netherlands;Portugal;Spain;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-FR   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-ES   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-DE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-BE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 1   EUCTR2016-001956-22-PL   Belgium;Canada;France;Germany;Poland;United States
      2017   Phase 1   EUCTR2016-001956-22-DE   Belgium;Canada;France;Germany;Poland;United States
      2017   Phase 1   EUCTR2016-001956-22-BE   Belgium;Canada;France;Germany;Poland;United States
      -   Phase 1   EUCTR2016-001956-22-FR   Belgium;Canada;France;Germany;Poland;United States
   Janssen-Cilag International NV
      2023   Phase 3   EUCTR2021-006282-37-PT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-PL   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-NO   Austria;Belgium;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-006282-37-AT   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-NO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-003314-39-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Serbia;Singapore;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-PT   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-GR   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-FR   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-DE   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000491-10-BE   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2023   Phase 3   EUCTR2020-006165-11-DE   Australia;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-003314-39-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-PL   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-NL   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-HU   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000491-10-CZ   Australia;Belgium;Canada;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lebanon;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-SK   Australia;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-PL   Australia;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Lithuania;Malaysia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-NL   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-HR   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-ES   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-006165-11-BE   Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Greece;Hungary;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-HU   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-DE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-BE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004457-76-PL   Argentina;Belgium;France;Germany;Hungary;Japan;Poland;Russian Federation;Turkey;United States
      2021   Phase 3   EUCTR2019-004225-24-HU   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004225-24-DE   Belgium;Germany;Hungary;Japan;Poland;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004225-24-BE   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002629-51-CZ   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-NL   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-AT   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-PT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-GB   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2016-000634-21-FR   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-NL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-GB   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-CZ   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-SK   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-PL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-NL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LV   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-HR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-GR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-FR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-DE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Georgia;Germany;Greece;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-CZ   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-BE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-AT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000634-21-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-GB   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2021-006282-37-NL   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2021-006282-37-BE   Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-PL   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-Outside-EU/EEA   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-GB   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
   Roche Farma S.A en nombre de F. Hoffmann-La Roche Ltd
      2015   -   EUCTR2014-003824-36-ES   Argentina;Australia;Austria;Brazil;Canada;Estonia;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;New Zealand;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United States
   Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
      2015   Phase 3   EUCTR2014-003855-76-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   SCS Boehringer Ingelheim Comm.V
      2014   Phase 2   EUCTR2013-002902-29-BE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000482-31-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   UCB Celltech
      -   -   EUCTR2014-004381-24-Outside-EU/EEA   Australia;Canada;New Zealand;United States
   UCB Japan Co., Ltd.
      -   -   EUCTR2014-004400-30-Outside-EU/EEA   Japan
      -   -   EUCTR2014-004399-42-Outside-EU/EEA   Japan
      -   -   EUCTR2014-004354-34-Outside-EU/EEA   Japan
   UZ Leuven
      2019   Phase 4   EUCTR2019-002038-35-BE   Belgium
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany
Prebiotic
   University of California, Los Angeles
      2024   -   NCT06495658   United States
Prebiotics
   University of Alberta
      2020   -   NCT03950336   Canada
Precedentemente denominato MEDI2070 E AMG 139
   ALLERGAN LIMITED
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
Precision dosing with A dashboard
   Children's Hospital Medical Center, Cincinnati
      2021   Phase 2/Phase 3   NCT04974099   United States
Prednisolon
   Erasmus Medical Center
      2013   Phase 4   NCT01880307   Italy;Netherlands
   Hôpital Necker-Enfants Malades
      2005   Phase 4   NCT00265772   France
Prednisolon jenapharm
   4SC AG
      2010   -   EUCTR2008-005903-25-BG   Bulgaria;Germany
      2009   -   EUCTR2008-005903-25-DE   Bulgaria;Germany
Prednisolone
   Central Manchester University Hospitals Foundation Trust
      2011   Phase 2   EUCTR2010-022017-26-GB   United Kingdom
   Erasmus Medical Center
      2015   Phase 4   NCT02517684   Belgium;Denmark;Finland;Italy;Netherlands;Poland
   Merck Sharp & Dohme Corp.
      2003   Phase 3   NCT00796250   -
   University Hospital Birmingham
      2008   Phase 4   NCT00609752   United Kingdom
   University Hospital Tuebingen
      2025   Phase 2   NCT06953791   -
Prednisone
   AbbVie (prior sponsor, Abbott)
      2011   Phase 3   NCT01235689   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2010-020137-10-LT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   EUCTR2010-020137-10-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   EUCTR2010-020137-10-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-SE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-NL   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-020137-10-GB   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-DE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020137-10-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;United States
   Abbott GmBH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
   Abbott GmbH & Co. KG
      2010   Phase 3   EUCTR2010-020137-10-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-020137-10-ES   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom
   Icahn School of Medicine at Mount Sinai
      2016   Phase 4   NCT02324699   United States
   McMaster University
      2018   Phase 4   NCT03833596   Canada
   Shanghai Research Institute of Acupuncture and Meridian
      2016   Phase 1 study   ChiCTR-IIR-16007751   China
Prednisone/methylprenisolone
   Stanford University
      2025   Phase 1/Phase 2   NCT06986382   United States
Preparative regimen 4-6 weeks after leukapheresis
   Nationwide Children's Hospital
      2013   Phase 2   NCT02676622   -
Prevenar 13
   Statens Serum Institut
      2013   Phase 4   NCT01947010   Denmark
      2013   -   EUCTR2012-002867-86-DK   Denmark
Previously referred TO AS MEDI2070 and AMG 139, AGN-151-598
   ALLERGAN LIMITED
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   Allergan Limited
      2021   Phase 3   EUCTR2019-001866-14-ES   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Allergan Ltd.
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-RO   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-ES   Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2018-004346-42-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2019   Phase 2;Phase 3   EUCTR2018-004346-42-GB   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2019-001866-14-GB   Australia;Austria;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Astrazeneca AB
      2020   Phase 2;Phase 3   EUCTR2018-004346-42-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Probiotic
   The Baruch Padeh Medical Center, Poriya
      2013   Phase 4   NCT01765998   Israel
Probiotic - VSL#3
   University of Alberta
      2003   Phase 3   NCT00175292   Canada
Probiotic mixture
   Massachusetts General Hospital
      2017   -   NCT03266484   United States
Probiotics
   The Baruch Padeh Medical Center, Poriya
      2012   Phase 4   NCT01078935   -
Prochymal adult human mesenchymal stem cells
   Mesoblast, Inc.
      2007   Phase 3   NCT00543374   Canada;United States
Prochymal™ adult human mesenchymal stem cells
   Mesoblast, Inc.
      2006   Phase 2   NCT00294112   United States
Promethazine
   University of Pennsylvania
      2016   Phase 2   NCT02765256   United States
Prucalopride
   University of British Columbia
      2016   Phase 4   NCT02806206   Canada
PRV-6527
   Provention Bio, Inc.
      2018   Phase 2   NCT03854305   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
      2018   Phase 2   EUCTR2017-003017-25-PL   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
      2018   Phase 2   EUCTR2017-003017-25-HU   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
      2018   Phase 2   EUCTR2017-003017-25-ES   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
      2018   Phase 2   EUCTR2017-003017-25-DE   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
      2018   Phase 2   EUCTR2017-003017-25-AT   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
PTG-200
   Janssen-Cilag International NV
      2020   Phase 2   EUCTR2019-003335-37-DE   Argentina;Germany;Italy;Poland;Russian Federation;United States
Puri nethol
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
PURI-nethol
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   University of Edinburgh
      2007   Phase 4   EUCTR2006-005800-15-GB   United Kingdom
PURI-nethol 50 MG
   GETAID
      2015   Phase 4   EUCTR2014-002311-41-SE   France;Germany;Netherlands;Sweden;United Kingdom
Purinethol
   GETAID
      2018   Phase 4   EUCTR2014-002311-41-NL   Belgium;France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-DE   Australia;France;Germany;Netherlands;Sweden;United Kingdom
      2014   -   EUCTR2014-002311-41-FR   France;Sweden;United Kingdom
Purinethol - 50 MG compresse25 compresse
   UMBERTO I - POLICLINICO DI ROMA
      2017   Phase 4   EUCTR2016-000522-18-IT   Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Poland;United Kingdom
QAX567
   Gerhard Rogler
      2011   Phase 2   NCT01316601   Switzerland
QAX576
   Novartis Pharma AG
      2011   -   EUCTR2010-019973-13-DE   Germany;Switzerland
   Novartis Pharmaceuticals
      2011   Phase 2   NCT01355614   Germany;Switzerland
Qbeco
   Qu Biologics Inc.
      2013   Phase 1/Phase 2   NCT01809275   Canada
Qbeco-SSI
   Qu Biologics Inc.
      2018   Phase 2   NCT03472690   Canada
Quality-OF-life assessment
   Fred Hutchinson Cancer Research Center
      2012   Phase 2   NCT01570348   United States
Questionnaires
   Centre Hospitalier Universitaire Dijon
      2013   -   NCT02859675   France
   Hospices Civils de Lyon
      2011   -   NCT02504255   France
Rabbit
   Cedars-Sinai Medical Center
      2019   Phase 1/Phase 2   NCT04224558   United States
   WOLFSON DIGESTIVE DISEASES CENTRE
      2007   -   EUCTR2005-003337-40-IT   Italy;United Kingdom
Rabbit ANTI-human thymocyte immunoglobulin
   Barts Health NHS Trust
      2017   Phase 3   EUCTR2017-002545-30-GB   United Kingdom
Rabbit antithymocyte globulin
   European Group for Blood and Marrow Transplantation (EMBT)
      2006   -   EUCTR2005-003337-40-GB   United Kingdom
RAD001
   Novartis Pharma Services AG
      2005   Phase 2   EUCTR2005-001148-22-SK   Slovakia
Radiotracer injection
   Massachusetts General Hospital
      2023   -   NCT06252493   United States
Ranolazine
   Vanderbilt University Medical Center
      2022   Phase 2   NCT04456517   United States
Rapamycin
   The Second Hospital of Nanjing Medical University
      2015   -   NCT02675153   China
Raptiva 100 MG/ML powder and solvent FOR solution FOR injection
   Merck Serono International S.A.
      2009   -   EUCTR2007-001377-28-PT   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-NL   Austria;France;Germany;Netherlands;Portugal
      2008   Phase 4   EUCTR2007-001377-28-FR   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-DE   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-AT   Austria;France;Germany;Netherlands;Portugal
Rbatg
   European Group for Blood and Marrow Transplantation (EMBT)
      2006   -   EUCTR2005-003337-40-GB   United Kingdom
RCTB-401
   SBL Vaccin AB
      2005   -   EUCTR2005-002048-25-SE   Sweden
Received hormone maintenance therapy
   Fuzhou General Hospital
      2012   Phase 1/Phase 2   NCT02445547   China
Recombinant growth hormone
   Greater Glasgow & Clyde NHS
      2011   Phase 2   EUCTR2010-022215-19-GB   United Kingdom
Recombinant human insulin-like growth factor
   Greater Glasgow & Clyde NHS
      2011   Phase 2   EUCTR2010-022215-19-GB   United Kingdom
Remestemcel-L
   Mesoblast, Inc.
      2010   -   NCT01510431   United States
Remicade
   ACADEMIC MEDICAL CENTER
      2015   Phase 4   EUCTR2013-002932-25-BE   Belgium;Netherlands
   AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
      2009   -   EUCTR2008-006484-36-IT   Italy
   Academic Medical Center
      2019   Phase 4   EUCTR2018-002064-15-NL   Netherlands
      2014   -   EUCTR2013-001029-17-NL   Netherlands
      2013   Phase 4   EUCTR2013-002932-25-NL   Netherlands
   Academic Medical Center, department of Gastroenterology and hepatology
      2008   -   EUCTR2008-001131-35-NL   Netherlands
   CENTOCOR
      2010   -   EUCTR2010-018431-18-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;United Kingdom
   CUB- Hopital Erasme
      2016   Phase 4   EUCTR2015-004618-10-BE   Belgium
   Celltrion
      2014   Phase 3   NCT02096861   United States
   Celltrion, Inc.
      2014   Phase 3   EUCTR2013-004497-10-RO   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-NL   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-IT   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-HU   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-GB   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-ES   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-DK   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-BE   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Centocor B.V.
      2005   -   EUCTR2004-002815-10-SE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-GB   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002815-10-ES   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DK   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-DE   Denmark;Germany;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-002815-10-AT   Austria;Denmark;Germany;Spain;Sweden;United Kingdom
   Centocor BV
      2010   Phase 3   EUCTR2010-018431-18-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;United Kingdom
   Centocor, Inc.
      2002   -   NCT00261976   Argentina;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
   Department of medical gastroenterology S, Odense University Hospital
      2015   Phase 4   EUCTR2012-002702-51-SE   Denmark;Finland;Norway;Sweden
      2012   Phase 4   EUCTR2012-002702-51-DK   Denmark;Finland;Norway;Sweden
   Department of medical gastroenterology, Herlev Hospital
      2016   Phase 4   EUCTR2012-002702-51-NO   Denmark;Finland;Norway;Sweden
      2015   Phase 4   EUCTR2012-002702-51-FI   Denmark;Finland;Norway;Sweden
      2009   Phase 4   EUCTR2009-009926-94-DK   Denmark
   ErasmusMC
      2013   Phase 4   EUCTR2012-000645-13-BE   Belgium;Netherlands
      2012   -   EUCTR2012-000645-13-NL   Belgium;Italy;Netherlands
   GETAID
      2018   Phase 4   EUCTR2014-002311-41-NL   Belgium;France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-SE   France;Germany;Netherlands;Sweden;United Kingdom
      2015   Phase 4   EUCTR2014-002311-41-DE   Australia;France;Germany;Netherlands;Sweden;United Kingdom
      2014   -   EUCTR2014-002311-41-FR   France;Sweden;United Kingdom
   IBD Center LMU Munich
      2008   Phase 4   EUCTR2008-004926-18-DE   Germany
   Janssen Biologics B.V.
      2011   -   EUCTR2010-018431-18-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2011   -   EUCTR2010-018431-18-CZ   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2010   Phase 3   EUCTR2010-018431-18-NL   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2010   Phase 3   EUCTR2010-018431-18-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2010   -   EUCTR2010-018431-18-DE   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2010   -   EUCTR2010-018431-18-BE   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2010   -   EUCTR2010-018431-18-AT   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;United Kingdom
      2009   -   EUCTR2008-005237-30-NL   Canada;Netherlands;Sweden;United States
   Janssen Biologics BV
      2011   -   EUCTR2008-005237-30-SE   Belgium;France;Germany;Hungary;Italy;Netherlands;Sweden;United Kingdom;United States
   Jørgen Agnholt
      2013   Phase 3   EUCTR2013-000971-34-DK   Denmark
   Katholieke Universiteit Leuven
      2011   Phase 4   EUCTR2011-002061-38-BE   Belgium
   Merck Sharp & Dohme Corp.
      2003   -   NCT00705614   -
      2002   -   NCT00818272   Germany
   Novartis Pharma AG
      2011   -   EUCTR2010-019973-13-DE   Germany;Switzerland
   Pfizer
      2015   -   NCT02539368   Belgium;Czech Republic;Czechia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-NO   Denmark;Iceland;Norway
      2021   Phase 4   EUCTR2019-002942-19-IS   Denmark;Iceland
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;Iceland
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom
   Shradha Agarwal
      2011   -   NCT01438151   United States
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
   University of Edinburgh
      2015   -   EUCTR2014-002311-41-GB   Belgium;France;Germany;Sweden;United Kingdom
   University of Leuven
      2008   Phase 4   EUCTR2006-004784-58-DE   Belgium;France;Germany;United Kingdom
      2007   Phase 4   EUCTR2006-004784-58-BE   Belgium;France;Germany;United Kingdom
   University of Leuven Hospitals
      2009   Phase 4   EUCTR2006-004784-58-GB   Belgium;France;Germany;United Kingdom
   University of Leuven Hospitals, Division of Gastroenterology
      2009   Phase 4   EUCTR2008-007519-34-SE   Sweden
   University of Leuven, Division of Gastroenterology
      2007   Phase 4   EUCTR2006-006632-22-BE   Belgium
   Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie
      2013   -   EUCTR2011-001332-29-AT   Austria
   Zon MW
      2014   Phase 4   EUCTR2013-002651-15-NL   Netherlands
Remicade 100 MG
   CHRU de Lille
      2008   Phase 4   EUCTR2006-004784-58-FR   Belgium;France;Germany;United Kingdom
   Santeon
      2015   Phase 4   EUCTR2015-001954-14-NL   Netherlands
Remicade 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning
   Diakonhjemmet Hospital AS
      2014   Phase 4   EUCTR2014-002056-40-NO   Norway
Remisma
   CELLTRION INC.
      2019   Phase 3   EUCTR2019-001087-30-IT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
Remsima
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
   CUB- Hopital Erasme
      2016   Phase 4   EUCTR2015-004618-10-BE   Belgium
   Celltrion, Inc
      2019   Phase 3   EUCTR2019-001087-30-SK   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-PL   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-DE   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2019-001087-30-BG   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   Celltrion, Inc.
      2014   Phase 3   EUCTR2013-004497-10-RO   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-NL   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-IT   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-HU   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-GB   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-ES   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-DK   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004497-10-BE   Belgium;Brazil;Canada;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Department of medical gastroenterology S, Odense University Hospital
      2015   Phase 4   EUCTR2012-002702-51-SE   Denmark;Finland;Norway;Sweden
      2012   Phase 4   EUCTR2012-002702-51-DK   Denmark;Finland;Norway;Sweden
   Department of medical gastroenterology, Herlev Hospital
      2016   Phase 4   EUCTR2012-002702-51-NO   Denmark;Finland;Norway;Sweden
      2015   Phase 4   EUCTR2012-002702-51-FI   Denmark;Finland;Norway;Sweden
   GETAID
      2015   Phase 4   EUCTR2014-002311-41-SE   France;Germany;Netherlands;Sweden;United Kingdom
   Jørgen Agnholt
      2013   Phase 3   EUCTR2013-000971-34-DK   Denmark
   Mundipharma Pharmaceuticals B.V.
      2016   Phase 4   EUCTR2014-004904-31-BE   Belgium;Netherlands
      2015   Phase 4   EUCTR2014-004904-31-NL   Netherlands
   Taina Sipponen
      2016   Phase 4   EUCTR2016-001278-13-FI   Finland
   UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
      2016   Phase 4   EUCTR2016-002061-54-IT   Italy
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
Remsima 100 MG powder FOR solution FOR infusion
   GETAID
      2021   Phase 4   EUCTR2021-002369-17-FR   Belgium;France;Spain
Remsima 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning
   Diakonhjemmet Hospital AS
      2014   Phase 4   EUCTR2014-002056-40-NO   Norway
Remsima 120 MG solution FOR injection IN PRE-filled syringe
   GETAID
      2021   Phase 4   EUCTR2021-002369-17-FR   Belgium;France;Spain
Remsima and inflectra
   Janssen Biologics B.V.
      2009   -   EUCTR2008-005237-30-NL   Canada;Netherlands;Sweden;United States
Remsina
   Celltrion, Inc
      2019   Phase 3   EUCTR2019-001087-30-CZ   Austria;Belarus;Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
RHB-104
   RedHill Biopharma Limited
      2017   Phase 3   NCT03009396   Canada;Czechia;Israel;New Zealand;Poland;Serbia;United States
      2013   Phase 3   NCT01951326   Australia;Bulgaria;Canada;Czech Republic;Czechia;Israel;New Zealand;Poland;Serbia;Slovakia;United States
   RedHill Biopharma Ltd.
      2019   Phase 3   EUCTR2016-005199-90-SK   Australia;Canada;Czech Republic;Israel;New Zealand;Poland;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-SK   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-CZ   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-BG   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2015   Phase 3   EUCTR2015-001179-36-PL   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2015   Phase 3   EUCTR2014-004108-31-HU   Belgium;Czech Republic;Germany;Hungary;Ireland;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-004108-31-CZ   Czech Republic;Hungary;Ireland;Russian Federation;Ukraine;United Kingdom
Rhgh
   Greater Glasgow & Clyde NHS
      2011   Phase 2   EUCTR2010-022215-19-GB   United Kingdom
RHIL-11
   Wyeth is now a wholly owned subsidiary of Pfizer
      2002   Phase 2   NCT00040521   United States
Ribavirin
   Vanderbilt-Ingram Cancer Center
      2006   -   NCT00897312   -
Riboflavin sodium phosphate injection
   Xijing Hospital of Digestive Diseases
      2016   Phase 3   NCT02769494   China
Riboflavin supplementation
   University Medical Center Groningen
      2016   -   NCT02538354   Netherlands
Rifabutin
   RedHill Biopharma Ltd.
      2019   Phase 3   EUCTR2016-005199-90-SK   Australia;Canada;Czech Republic;Israel;New Zealand;Poland;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-SK   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-CZ   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 3   EUCTR2015-001179-36-BG   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2015   Phase 3   EUCTR2015-001179-36-PL   Australia;Bulgaria;Canada;Czech Republic;Israel;New Zealand;Poland;Romania;Serbia;Slovakia;United States
      2015   Phase 3   EUCTR2014-004108-31-HU   Belgium;Czech Republic;Germany;Hungary;Ireland;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-004108-31-CZ   Czech Republic;Hungary;Ireland;Russian Federation;Ukraine;United Kingdom
Rifabutin, clarithromycin, and clofazimine
   Medstar Health Research Institute
      2007   Phase 4   NCT00513552   United States
Rifaximin
   ALFA WASSERMANN
      2007   -   EUCTR2007-001014-17-IT   France;Germany;Hungary;Italy
   Assistance Publique - Hôpitaux de Paris
      2015   Phase 2   NCT02620007   France
   Mayo Clinic
      2019   Phase 2   NCT04254549   United States
   Northwestern University
      2019   Phase 2   NCT04154735   United States
   Salix Pharmaceuticals, Inc subsidiary of Valeant Pharmaceuticals International Inc
      2015   Phase 3   EUCTR2014-001645-24-CZ   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
   Salix Pharmaceuticals, Inc.
      2015   Phase 3   EUCTR2014-001645-24-PL   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
      2015   Phase 3   EUCTR2014-001645-24-DE   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
      2015   Phase 3   EUCTR2014-001644-38-PL   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
      2015   Phase 3   EUCTR2014-001644-38-DE   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
      2014   Phase 3   EUCTR2014-001645-24-HU   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
      2014   Phase 3   EUCTR2014-001645-24-FR   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
      2014   Phase 3   EUCTR2014-001644-38-HU   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
      2014   Phase 3   EUCTR2014-001644-38-FR   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
   Salix Pharmaceuticals, Inc. subsidiary of Valeant Pharmaceuticals International In
      2015   Phase 3   EUCTR2014-001644-38-CZ   Canada;Czech Republic;France;Germany;Hungary;Israel;Poland;Russian Federation;United States
   Scott Lee
      2008   Phase 2   NCT00603616   United States
   Sixth Affiliated Hospital, Sun Yat-sen University
      2017   Phase 3   NCT03185624   China
      2017   Phase 3   NCT03185611   China
Rifaximin delayed release 400 MG film coated tablet
   ALFASIGMA S.P.A.
      2019   Phase 2   EUCTR2017-002258-36-PL   Belgium;Germany;Italy;Netherlands;Poland;Spain
      2018   Phase 2   EUCTR2017-002258-36-NL   Belgium;Germany;Italy;Netherlands;Spain
      2018   Phase 2   EUCTR2017-002258-36-BE   Belgium;Germany;Netherlands;Spain
      2017   Phase 2   EUCTR2017-002258-36-ES   Germany;Spain
      2017   Phase 2   EUCTR2017-002258-36-DE   Belgium;Germany;Netherlands;Spain
Rifaximin delayed release tablets
   Alfasigma S.p.A.
      2017   Phase 2   NCT03537157   Italy
Rifaximin EIR
   Bausch Health Americas, Inc.
      2014   Phase 3   NCT02240121   United States
      2014   Phase 3   NCT02240108   United States
Rifaximin+omeprazole+miralax
   Seattle Children's Hospital
      2015   Phase 1/Phase 2   NCT02272868   United States
Rifaximin-EIR
   ALFA WASSERMANN
      2011   -   EUCTR2011-002821-24-IT   Italy
   ALFASIGMA S.P.A.
      2019   Phase 2   EUCTR2017-002258-36-PL   Belgium;Germany;Italy;Netherlands;Poland;Spain
      2018   Phase 2   EUCTR2017-002258-36-NL   Belgium;Germany;Italy;Netherlands;Spain
      2018   Phase 2   EUCTR2017-002258-36-BE   Belgium;Germany;Netherlands;Spain
      2017   Phase 2   EUCTR2017-002258-36-ES   Germany;Spain
      2017   Phase 2   EUCTR2017-002258-36-DE   Belgium;Germany;Netherlands;Spain
   Alfa Wassermann S.p.A.
      2008   -   EUCTR2007-001014-17-DE   France;Germany;Hungary;Italy
      2007   Phase 2   NCT00528073   France;Germany;Hungary;Israel;Italy;Poland;Russian Federation
      2007   Phase 2   EUCTR2007-001014-17-HU   France;Germany;Hungary;Italy
      2007   Phase 2   EUCTR2007-001014-17-FR   France;Germany;Hungary;Italy
Rifaximina
   ALFASIGMA S.P.A.
      2019   Phase 2   EUCTR2017-002258-36-PL   Belgium;Germany;Italy;Netherlands;Poland;Spain
      2018   Phase 2   EUCTR2017-002258-36-NL   Belgium;Germany;Italy;Netherlands;Spain
      2018   Phase 2   EUCTR2017-002258-36-BE   Belgium;Germany;Netherlands;Spain
      2017   Phase 2   EUCTR2017-002258-36-ES   Germany;Spain
      2017   Phase 2   EUCTR2017-002258-36-DE   Belgium;Germany;Netherlands;Spain
Risankizumab
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2020   Phase 3   EUCTR2020-002674-26-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie
      2024   Phase 2   NCT06548542   Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Germany;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Singapore;Slovakia;Slovenia;Spain;Switzerland;United Kingdom;United States
      2023   Phase 3   NCT05995353   Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Puerto Rico;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2021   -   NCT04846959   United States
      2020   Phase 3   NCT04524611   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 1   NCT04254783   Germany;Israel;United States
      2019   -   NCT03914261   Belgium;Israel;Spain;Switzerland;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 3   EUCTR2020-002674-26-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-003191-50-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2016-003190-17-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003191-50-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003190-17-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2016-003123-32-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003191-50-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003190-17-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003123-32-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2015-001834-15-DE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2016-003191-50-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003190-17-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003123-32-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States
   Alimentiv Inc.
      2024   -   NCT06249555   Canada;United States
   Otani Tetsuya
      2024   Phase 3   JPRN-jRCT2061230105   Canada;Israel;Japan;Taiwan;United States
   Shaare Zedek Medical Center
      2024   -   NCT06298188   Israel
Risankizumab 10 MG/ML
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2014   Phase 2   EUCTR2013-002902-29-DE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
Risankizumab 180 MG SC
   AbbVie
      2015   Phase 2   NCT02513459   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
Risankizumab 600 MG IV
   AbbVie
      2015   Phase 2   NCT02513459   Belgium;Canada;Germany;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
Risankizumab 90 MG/ML
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2014   Phase 2   EUCTR2013-002902-29-DE   Belgium;Canada;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
Risankizumab IV
   AbbVie
      2018   Phase 3   NCT03105102   American Samoa;Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   NCT03105128   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   NCT03104413   American Samoa;Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 2   NCT02031276   Belgium;Canada;France;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
Risankizumab SC
   AbbVie
      2023   Phase 3   NCT06063967   Argentina;Brazil;Canada;Chile;China;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Poland;Puerto Rico;Saudi Arabia;Serbia;Taiwan;Turkey;United Kingdom;United States
      2018   Phase 3   NCT03105102   American Samoa;Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   NCT03105128   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   NCT03104413   American Samoa;Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 2   NCT02031276   Belgium;Canada;France;Germany;Ireland;Korea, Republic of;Netherlands;Poland;Spain;United Kingdom;United States
Risankizumab-800CW 15 MG
   University Medical Center Groningen
      2024   Phase 1/Phase 2   NCT06606808   Netherlands
Risankizumab-800CW 25 MG
   University Medical Center Groningen
      2024   Phase 1/Phase 2   NCT06606808   Netherlands
Risankizumab-800CW 4.5 MG
   University Medical Center Groningen
      2024   Phase 1/Phase 2   NCT06606808   Netherlands
Risankizumab-800CW optimal dose
   University Medical Center Groningen
      2024   Phase 1/Phase 2   NCT06606808   Netherlands
Risedronate
   University of Alberta
      2010   Phase 4   NCT01215890   Canada
Ritlecitinib 50 MG
   Pfizer Inc.
      2018   Phase 2   EUCTR2017-003359-43-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-DE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-BE   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
      2018   Phase 2   EUCTR2017-003359-43-AT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
   Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001
      2018   Phase 2   EUCTR2017-003359-43-PL   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
Ritlecitinib 50MG
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2017-003359-43-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Hungary;Italy;Korea, Republic of;Lebanon;Lithuania;Poland;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Turkey;Ukraine;United Arab Emirates;United States
Rituximab
   CHU Amiens Picardie
      2021   Phase 3   EUCTR2021-002047-29-FR   France
   Paul Szabolcs
      2012   Phase 1/Phase 2   NCT00692939   United States
   Stanford University
      2025   Phase 1/Phase 2   NCT06986382   United States
Rizankisumab
   AbbVie Deutschland GmbH & Co. KG
      2017   Phase 3   EUCTR2016-003190-17-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Rizankizumab
   AbbVie Deutschland GmbH & Co. KG
      2017   Phase 3   EUCTR2016-003123-32-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
RO 549-0261/F04-02
   F. HOFFMANN - LA ROCHE LTD.
      2016   Phase 3   EUCTR2014-003824-36-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Italy;Korea, Democratic People's Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   F. Hoffmann-La Roche Ltd
      2015   Phase 3   EUCTR2014-003855-76-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-003855-76-FR   Argentina;Australia;Brazil;Canada;Estonia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003855-76-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003855-76-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-003824-36-RO   Argentina;Australia;Austria;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003824-36-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003824-36-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   Roche Farma S.A en nombre de F. Hoffmann-La Roche Ltd
      2015   -   EUCTR2014-003824-36-ES   Argentina;Australia;Austria;Brazil;Canada;Estonia;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;New Zealand;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United States
   Roche Farma S.A. en nombre de F. Hoffmann-La Roche Ltd
      2015   Phase 3   EUCTR2014-003855-76-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
RO 549-0261/F08-02
   F. HOFFMANN - LA ROCHE LTD.
      2016   Phase 3   EUCTR2014-003824-36-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Italy;Korea, Democratic People's Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   F. Hoffmann-La Roche Ltd
      2015   Phase 3   EUCTR2014-003824-36-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-003824-36-RO   Argentina;Australia;Austria;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003824-36-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United States
      2015   Phase 3   EUCTR2014-003824-36-EE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-003824-36-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   Roche Farma S.A en nombre de F. Hoffmann-La Roche Ltd
      2015   -   EUCTR2014-003824-36-ES   Argentina;Australia;Austria;Brazil;Canada;Estonia;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;New Zealand;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United States
RO549-0261/F04-02
   F. HOFFMANN - LA ROCHE LTD.
      2016   Phase 3   EUCTR2014-003855-76-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
RO5490261/F02
   F. Hoffmann-La Roche Ltd
      2018   Phase 1   EUCTR2017-003649-10-GB   Belgium;Germany;Poland;Spain;United Kingdom
      2018   Phase 1   EUCTR2017-003649-10-DE   Belgium;Germany;Poland;Spain;United Kingdom;United States
      2018   Phase 1   EUCTR2017-003649-10-BE   Belgium;Germany;Poland;Spain;United Kingdom
      -   Phase 1   EUCTR2017-003649-10-PL   Belgium;Germany;Poland;Spain;United Kingdom
   Roche Farma S.A. (Soc unipersonal) que realiza el ensayo en España y que actúa como represntante de FHoffmann-La Roche
      2018   Phase 1   EUCTR2017-003649-10-ES   Belgium;Germany;Poland;Spain;United Kingdom;United States
RO7790121
   Hoffmann-La Roche
      2025   Phase 3   NCT06819891   Australia;Canada;China;Colombia;France;Poland;United Kingdom;United States
      2025   Phase 3   NCT06819878   Belgium;Canada;Chile;China;France;Mexico;Poland;Puerto Rico;United Kingdom;United States
      2023   Phase 2   NCT05910528   Belgium;Bulgaria;Canada;France;Germany;Hungary;Poland;Slovakia;Spain;United States
Roadmab
   Children's Hospital Medical Center, Cincinnati
      2023   Phase 2/Phase 3   NCT05660746   United States
      2021   Phase 2/Phase 3   NCT04974099   United States
Rosuvastatin
   Department of lower gastroenterology, Hyogo College of Medicine
      2009   Phase 2   JPRN-UMIN000002074   Japan
   Stanford University
      2024   Early Phase 1   NCT06538649   United States
Rosuvastatin 10 MG
   GlaxoSmithKline
      2011   Phase 1   NCT01489943   United States
Routine drainage surgery
   Sixth Affiliated Hospital, Sun Yat-sen University
      2017   Phase 2/Phase 3   NCT03056664   -
Routine treatment OF CD
   Sixth Affiliated Hospital, Sun Yat-sen University
      2016   Phase 2/Phase 3   NCT02532738   -
RPC0163
   CELGENE INTERNATIONAL II SàRL
      2016   Phase 2   EUCTR2015-002025-19-IT   Canada;Hungary;Italy;Poland;Ukraine;United States
RPC1063
   CELGENE INTERNATIONAL II SàRL
      2018   Phase 3   EUCTR2017-004295-55-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-IT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2015-002025-19-IT   Canada;Hungary;Italy;Poland;Ukraine;United States
   Celgene
      2015   Phase 2   NCT02531113   Canada;Hungary;Italy;Poland;Ukraine;United States
   Celgene International II Sarl
      2023   Phase 2;Phase 3   EUCTR2021-005019-30-HU   Australia;Belgium;Canada;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2023   Phase 2;Phase 3   EUCTR2021-005019-30-FR   Australia;Belgium;Canada;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      2023   Phase 2;Phase 3   EUCTR2021-005019-30-DE   Australia;Belgium;Canada;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2021-005019-30-PL   Australia;Belgium;Canada;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2021-005019-30-BE   Australia;Belgium;Canada;France;Germany;Hungary;Israel;Italy;Poland;Spain;United Kingdom;United States
   Celgene International II Sàrl
      2016   Phase 1   EUCTR2016-003073-18-GB   United Kingdom
RPC1063 (equivalent TO ozanimod
   Celgene International II Sàrl
      2019   Phase 3   EUCTR2017-004295-55-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004295-55-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004295-55-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004294-14-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004294-14-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004293-33-FR   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2019   Phase 3   EUCTR2017-004292-31-RO   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004292-31-FR   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-SI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004295-55-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-SI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004294-14-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004293-33-SK   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-SI   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-SE   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-PT   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-PL   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-NL   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-LT   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-HU   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-GR   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-FI   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-ES   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-BG   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004293-33-AT   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-004292-31-PL   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-NO   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-LV   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-IE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-HR   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-GB   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-ES   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-DK   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-DE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-CZ   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-BG   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004292-31-BE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Moldova, Republic of;New Zealand;Norway;Poland;Puerto Rico;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-004295-55-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-004293-33-DE   Australia;Austria;Bulgaria;Canada;China;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;Ukraine;United States
RVG 05565
   Academic Medical Center, department of Gastroenterology and hepatology
      2008   -   EUCTR2008-001131-35-NL   Netherlands
RVG 07151
   University Medical Center Utrecht
      2009   -   EUCTR2009-013348-35-NL   Netherlands
RVG 114681
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
RVG 116648
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
RVG00859
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
RVT-3101
   Hoffmann-La Roche
      2023   Phase 2   NCT06370858   Belgium;Bulgaria;Canada;France;Germany;Hungary;Poland;Slovakia;Spain;United States
RYAH-medtech inhaler
   OMNI Medical Services, LLC
      2018   Phase 2   NCT03944447   United States
Saline
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   -
   Sanming First Affiliated Hospital of Fujian Medical University
      2014   Phase 4 study   ChiCTR-DDT-14004402   China
   Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
      2017   -   ChiCTR-INR-17012532   China
Salmon
   Children's Hospital Boston
      2004   -   NCT00114803   United States
Salofalk
   Dr. Falk Pharma GmbH
      2007   -   EUCTR2004-001213-34-GB   Czech Republic;United Kingdom
Salofalk 500 MG
   Disphar International B.V.
      2005   Phase 3   EUCTR2004-004083-77-SK   Czech Republic;Slovakia
      2004   -   EUCTR2004-004083-77-CZ   Czech Republic
Sandostatine
   Gastroenterology CHC Liege
      2011   Phase 2   EUCTR2010-023347-14-BE   Belgium
SAR441566
   Sanofi
      2024   Phase 2   NCT06637631   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;China;Croatia;France;Germany;Italy;Japan;Netherlands;Spain;Turkey;United States
Sargramostim
   Genzyme, a Sanofi Company
      2006   Phase 2   NCT00329537   Japan
      2006   Phase 3   NCT00295165   Australia;Brazil;Bulgaria;Canada;Israel;New Zealand;Romania;Russian Federation;South Africa;Ukraine;United States
      2004   Phase 3   NCT00206713   United States
      2004   Phase 3   NCT00206674   Argentina;Australia;Brazil;Canada;New Zealand;Russian Federation;Switzerland;Ukraine;United Kingdom
      2004   Phase 1/Phase 2   NCT00206661   United States
      2003   Phase 2   NCT00206700   Argentina;Australia;Brazil;Canada;New Zealand;Russian Federation;Switzerland;Ukraine;United Kingdom;United States
      2003   Phase 2   NCT00206596   Canada;United States
SB5
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
SC tulisokibart
   Merck Sharp & Dohme LLC
      2024   Phase 3   NCT06430801   Australia;Austria;Belgium;Canada;Chile;China;Colombia;Croatia;Denmark;Finland;France;Georgia;Germany;Greece;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
SC12267
   4SC AG
      2010   -   EUCTR2008-005903-25-BG   Bulgaria;Germany
      2009   Phase 2   NCT00820365   Bulgaria;Germany;Romania
      2009   -   EUCTR2008-005903-25-DE   Bulgaria;Germany
Search FOR exocrine pancreatic insufficiency AT week 0 and 12
   Hospices Civils de Lyon
      2019   -   NCT03915262   France
Selective immunosuppressive agents
   CHRU de Lille
      2008   Phase 4   EUCTR2006-004784-58-FR   Belgium;France;Germany;United Kingdom
Selective intensive induction therapy based ON ustekinumab clinical decision-making tools
   Sixth Affiliated Hospital, Sun Yat-sen University
      2023   Phase 4   NCT05861167   China
Selenium
   Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
      2020   Phase 0   ChiCTR2100048113   China
Semapimod
   Ferring Pharmaceuticals
      2003   Phase 2   NCT00741910   Germany;Israel;Netherlands;United States
      2002   Phase 2   NCT00740103   Belgium;Germany;Israel;Netherlands;United States
      2002   Phase 2   NCT00739986   Belgium;Germany;Israel;Netherlands;United States
      2002   Phase 2   NCT00038766   United States
Serum leucine-rich alpha-2 glycoprotein (LRG) levels
   Showa Inan General Hospital
      2020   -   NCT04535882   Japan
Seton placement
   Avobis Bio, LLC
      2021   Phase 2   NCT04847739   United States
Sezione * D.3.6.2.1 - valore: 400MG alla settimana 0, IN seguito 200MG ogni DUE settimane
   JANSSEN CILAG INTERNATIONAL NV
      2021   Phase 2   EUCTR2020-002701-26-IT   Canada;France;Germany;Italy;Japan;Spain;Sweden;United States
Shingrix
   University of Wisconsin, Madison
      2019   Phase 4   NCT03798691   United States
SHP647
   SHIRE HUMAN GENETIC THERAPIES, INC
      2019   Phase 3   EUCTR2017-000617-23-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000575-88-IT   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
   Shire Human Genetic Therapies, Inc.
      2019   Phase 3   EUCTR2017-000617-23-RO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000617-23-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000617-23-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000617-23-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000576-29-GR   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2019   Phase 3   EUCTR2017-000575-88-RO   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000575-88-HR   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000575-88-GB   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000574-11-RO   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-000574-11-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000617-23-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000576-29-SK   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-PT   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-HU   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-ES   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-EE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-BG   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-000576-29-BE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States
      2018   Phase 3   EUCTR2017-000575-88-NL   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000575-88-LT   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000575-88-DE   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000575-88-AT   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-000574-11-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000574-11-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2017-000574-11-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000617-23-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000617-23-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000617-23-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000576-29-IE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States
      -   Phase 3   EUCTR2017-000575-88-PL   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      -   Phase 3   EUCTR2017-000575-88-CZ   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States
      -   Phase 3   EUCTR2017-000574-11-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2017-000574-11-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States
SHR0302
   Reistone Biopharma Company Limited
      2019   Phase 2   NCT03677648   China;Poland;Ukraine;United States
      2019   Phase 2   EUCTR2018-003303-19-PL   China;Poland;Ukraine;United States
Sibofimloc
   Millennium Pharmaceuticals, Inc (a wholly owned subsidiary
      2019   Phase 2   EUCTR2019-000886-19-GB   Austria;France;Germany;Netherlands;United Kingdom;United States
   Millennium Pharmaceuticals, Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited)
      2020   Phase 2   EUCTR2019-000886-19-NL   Austria;France;Germany;Netherlands;United Kingdom;United States
      2020   Phase 2   EUCTR2019-000886-19-AT   Austria;France;Germany;Netherlands;United Kingdom;United States
   Takeda Development Center Americas,Inc.
      2019   Phase 2   EUCTR2019-000886-19-DE   Austria;France;Germany;Netherlands;United Kingdom;United States
Simethicone
   Sanming First Affiliated Hospital of Fujian Medical University
      2014   Phase 4 study   ChiCTR-DDT-14004402   China
Sivelestat
   Department of Surgery 2,Tokyo Women's Medical University
      2012   -   JPRN-UMIN000009631   Japan
Small bowel follow trough
   Universitaire Ziekenhuizen Leuven
      2005   Phase 2   NCT02247258   Belgium;Czech Republic;Greece
Smoflipid
   Mayo Clinic
      2018   -   NCT03773237   United States
Smoking cigarettes
   Meir Medical Center
      2010   Phase 1/Phase 2   NCT01040910   Israel
Smoking OF cannabis
   Meir Medical Center
      2010   Phase 1/Phase 2   NCT01040910   Israel
SOC corticosteroid - induction period
   Exeliom Biosciences
      2023   Phase 1   NCT05542355   Belgium;Poland
SOC corticosteroid - tapering
   Exeliom Biosciences
      2023   Phase 1   NCT05542355   Belgium;Poland
Sodium chloride
   ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
      2019   Phase 2   EUCTR2019-001948-21-FR   France
   University of Birmingham
      2019   Phase 1/Phase 2   NCT03681067   United Kingdom
Solid FOOD-based intervention
   NHS Greater Glasgow and Clyde
      2017   -   NCT03171246   United Kingdom
Somatropin
   Greater Glasgow & Clyde NHS
      2011   Phase 2   EUCTR2010-022215-19-GB   United Kingdom
Somatropin [rdna origin] FOR injection
   Nationwide Children's Hospital
      2007   Phase 2/Phase 3   NCT00511329   United States
Sonovue
   Gastroenterology MIDT
      2012   Phase 2   EUCTR2011-005886-19-DK   Denmark
      2012   Phase 2   EUCTR2011-005846-36-DK   Denmark
   Henning Glerup
      2011   Phase 2   EUCTR2010-024528-12-DK   Denmark
   Medical University of Vienna (MUW)
      -   -   EUCTR2015-002882-41-AT   Austria
SOY protein
   University of Campinas, Brazil
      2012   -   NCT01957423   Brazil
Soya bean OIL
   University of Dublin, Trinity College
      2011   Phase 4   NCT01792388   Ireland
Spesolilmab
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2020   Phase 2   EUCTR2019-001673-93-DE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
Spesolimab
   BOEHRINGER-INGELHEIM ITALIA S.P.A.
      2021   Phase 2   EUCTR2020-005770-99-IT   Aruba;Australia;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim
      2021   Phase 2   NCT05013385   Austria;Belgium;Canada;China;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Portugal;Sweden;Switzerland;Taiwan;United States
      2021   Phase 2   EUCTR2020-005770-99-NL   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2019-001673-93-BE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2020   Phase 2   NCT04362254   Austria;Belgium;Germany;Korea, Republic of;Netherlands
      2020   Phase 2   EUCTR2019-001673-93-AT   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim AB
      2021   Phase 2   EUCTR2020-005770-99-SE   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim B.V
      2021   Phase 2   EUCTR2020-005770-99-DK   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim BV
      2022   Phase 2   EUCTR2019-001673-93-DK   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2020   Phase 2   EUCTR2017-003090-34-DK   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim Ltd
      2021   Phase 2   EUCTR2020-005770-99-IE   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim Netherlands BV
      2019   Phase 2   EUCTR2017-003090-34-NL   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim Norway KS
      2022   Phase 2   EUCTR2020-005770-99-NO   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2020   Phase 2   EUCTR2019-001673-93-DE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2019   Phase 2   EUCTR2017-003090-34-DE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim Portugal, Lda
      2021   Phase 2   EUCTR2020-005770-99-PT   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim RCV GmbH & Co KG
      2020   Phase 2   EUCTR2019-001673-93-HU   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
      2019   Phase 2   EUCTR2017-003090-34-AT   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Boehringer Ingelheim S.A.
      2021   Phase 2   EUCTR2019-001673-93-ES   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   SCS Boehringer Ingelheim Comm.V
      2018   Phase 2   EUCTR2017-003090-34-BE   Austria;Belgium;Denmark;Germany;Hungary;Korea, Republic of;Netherlands;Spain
   Taguchi Aya
      2022   Phase 2   JPRN-jRCT2031210677   Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Portugal;Republic of Korea;Romania;Serbia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
ST10
   Shield Therapeutics
      2011   Phase 3   NCT01352221   Austria;United Kingdom
ST10-021
   Iron Therapeutics (Switzerland) AG
      2012   -   EUCTR2010-023589-39-DE   Austria;Germany;Hungary;United Kingdom
      2011   Phase 3   EUCTR2010-023589-39-GB   Austria;Germany;Hungary;United Kingdom
      2011   -   EUCTR2010-023589-39-AT   Austria;Germany;Hungary;United Kingdom
      -   -   EUCTR2010-023589-39-HU   Austria;Germany;Hungary;United Kingdom
STA-5326
   National Institute of Allergy and Infectious Diseases (NIAID)
      2005   Phase 2   NCT00250198   United States
   Synta Pharmaceuticals Corp.
      2004   Phase 1/Phase 2   NCT00088062   United States
STA-5326 mesylate
   Synta Pharmaceutical Corporation
      2006   -   EUCTR2005-002857-29-HU   Hungary
   Synta Pharmaceuticals Corp.
      2005   Phase 2   NCT00234741   United States
      2005   Phase 2   NCT00138840   Canada;United States
STA-6838, STA-5326 M, S38
   Synta Pharmaceutical Corporation
      2006   -   EUCTR2005-002857-29-HU   Hungary
Stable isotope infusions
   Indiana University
      2006   Phase 1   NCT00583232   United States
Standard 2 hours-infusion
   Asan Medical Center
      2011   Phase 4   NCT01346826   Korea, Republic of
Standard clear liquid diet
   Rhode Island Hospital
      2021   -   NCT05918562   United States
Standard infliximab intravenous therapy
   Asan Medical Center
      2023   Phase 4   NCT06051253   Korea, Republic of
Standard nutrition
   Tel-Aviv Sourasky Medical Center
      2020   Phase 3   NCT04398836   Israel
Standard OF care treatment
   Washington University School of Medicine
      2025   Phase 2   NCT06976853   United States
Standard STEP-UP care
   Maastricht University Medical Center
      2019   Phase 4   NCT03917303   Netherlands
Standart OF care
   Duzce University
      2021   Phase 3   NCT04921033   Turkey
Start adalimumab IN monotherapy
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2015   Phase 4   NCT03306446   Belgium;France
Stelara
   Charité Universitätsmedizin Berlin
      2018   Phase 4   EUCTR2017-005151-83-DE   Germany
   JANSSEN CILAG INTERNATIONAL NV
      2018   Phase 3   EUCTR2017-004209-41-IT   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002918-43-IT   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2016   Phase 2   EUCTR2016-000634-21-IT   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
   Janssen-Cilag International N.V.
      2020   Phase 3   EUCTR2018-002629-51-GB   Austria;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-SE   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-FR   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-002629-51-ES   France;Germany;Netherlands;Spain;Sweden;United States
      2018   Phase 3   EUCTR2017-004209-41-PL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-FR   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2016-002918-43-SK   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2018   Phase 3   EUCTR2016-002918-43-DK   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-SE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-PT   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-NL   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-GB   Belgium;Germany;Netherlands;Portugal;Spain;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-FR   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-ES   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-DE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-BE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 1   EUCTR2016-001956-22-PL   Belgium;Canada;France;Germany;Poland;United States
      2017   Phase 1   EUCTR2016-001956-22-DE   Belgium;Canada;France;Germany;Poland;United States
      2017   Phase 1   EUCTR2016-001956-22-BE   Belgium;Canada;France;Germany;Poland;United States
      2012   Phase 3   EUCTR2010-022760-12-NL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022760-12-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022758-18-BE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-IE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-HU   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-GB   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-DK   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-DE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-CZ   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-BG   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-AT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-NL   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-HU   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022759-42-GB   Australia;Brazil;Bulgaria;Canada;Croatia;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-DE   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-BG   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-IE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022758-18-GB   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-DK   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-DE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-CZ   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-AT   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      -   Phase 1   EUCTR2016-001956-22-FR   Belgium;Canada;France;Germany;Poland;United States
   Janssen-Cilag International NV
      2022   Phase 3   EUCTR2020-004457-76-HU   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-DE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-BE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004457-76-PL   Argentina;Belgium;France;Germany;Hungary;Japan;Poland;Russian Federation;Turkey;United States
      2021   Phase 3   EUCTR2019-004225-24-HU   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004225-24-DE   Belgium;Germany;Hungary;Japan;Poland;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004225-24-BE   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002629-51-CZ   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-NL   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-AT   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-PT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-GB   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2016-000634-21-FR   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-NL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-GB   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-CZ   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-SK   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-PL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-NL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LV   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-HR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-GR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-FR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-DE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Georgia;Germany;Greece;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-CZ   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-BE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-AT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000634-21-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-GB   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-PL   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-Outside-EU/EEA   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-GB   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
   UZ Leuven
      2019   Phase 4   EUCTR2019-002038-35-BE   Belgium
   Wolfson Medical Center
      2022   -   NCT04779762   Israel
Stelara - 45 MG soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) 0.5 ML (90 MG/ML) 1 flaconcino
   JANSSEN CILAG INTERNATIONAL NV
      2019   Phase 3   EUCTR2018-002629-51-IT   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
Stelara - 90 MG - soluzione iniettabile IN siringhe preriempite - USO sottocutaneo - siringa preriempita(vetro) 1 ML(90MG/ML) 1 siringa preriempita DA 1 ML
   BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      2021   Phase 2   EUCTR2020-004527-16-IT   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;United States
Stelara - 90 MG soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) 1.0 ML (90 MG/ML) 1 flaconcino
   JANSSEN CILAG INTERNATIONAL NV
      2019   Phase 3   EUCTR2018-002629-51-IT   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
Stelara 130 MG concentrate FOR solution FOR infusion
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2020   Phase 3   EUCTR2020-002674-26-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 3   EUCTR2020-002674-26-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 3   EUCTR2018-004614-18-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Eli Lilly and Company
      2020   Phase 3   EUCTR2018-004614-18-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Lilly S.A.
      2019   Phase 3   EUCTR2018-004614-18-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Stelara 130MG / 26ML concentrate FOR solution FOR infusion
   BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      2021   Phase 2   EUCTR2020-004527-16-IT   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;United States
Stelara 45 MG solution FOR injection
   Belgian IBD research and development
      2019   Phase 4   EUCTR2018-004269-14-BE   Belgium
Stelara 90 MG solution FOR injection IN PRE-filled syringe
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2020   Phase 3   EUCTR2020-002674-26-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 3   EUCTR2020-002674-26-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 3   EUCTR2018-004614-18-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Eli Lilly and Company
      2020   Phase 3   EUCTR2018-004614-18-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   GETAID
      2020   Phase 4   EUCTR2019-001337-13-FR   France
   Lilly S.A.
      2019   Phase 3   EUCTR2018-004614-18-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Stelara 90 MG solution FOR injection N PRE-filled syringue
   Belgian IBD research and development (BIRD vzw)
      2021   Phase 3   EUCTR2021-000345-41-BE   Belgium
Stelara, remicade, entyvio, humira, remsima, flixabi, inflectra
   Ced Service GmbH
      2017   -   NCT03108326   Germany
Stelara®
   Janssen-Cilag International NV
      2021   Phase 3   EUCTR2020-004457-76-FR   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
Stem cell transplant
   Nationwide Children's Hospital
      2013   Phase 2   NCT02676622   -
Stem cells
   CELLERIX S.A.
      2012   Phase 3   EUCTR2011-006064-43-IT   Austria;Belgium;Germany;Israel;Italy;Netherlands;Spain
   Kang Stem Biotech Co., Ltd.
      2015   -   NCT02926300   Korea, Republic of
      2014   Phase 1/Phase 2   NCT02000362   Korea, Republic of
   TiGenix, S.A. Unipersonal
      2012   Phase 3   EUCTR2011-006064-43-NL   Austria;Belgium;France;Germany;Israel;Italy;Netherlands;Spain
   Tigenix S.A.U.
      2008   Phase 3   NCT01378390   Austria;Netherlands;Spain
STEP-UP
   University of Roma La Sapienza
      2012   Phase 4   NCT01752790   Italy
Steroids
   University of Maryland, Baltimore
      2011   -   NCT02619552   United States
Stool simple
   Hospices Civils de Lyon
      2024   -   NCT06244849   France
SUB20016
   PIBD net
      2018   Phase 4   EUCTR2016-000522-18-GB   Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
Sugar extract
   Oslo University Hospital
      2011   Phase 2/Phase 3   NCT01496053   Norway
Sulfur hexafluoride
   Gastroenterology MIDT
      2012   Phase 2   EUCTR2011-005886-19-DK   Denmark
      2012   Phase 2   EUCTR2011-005846-36-DK   Denmark
   Henning Glerup
      2011   Phase 2   EUCTR2010-024528-12-DK   Denmark
   Mayo Clinic
      2017   Phase 4   NCT03235180   United States
   Medical University of Vienna (MUW)
      -   -   EUCTR2015-002882-41-AT   Austria
Sulphur hexafluoride
   Gastroenterology MIDT
      2012   Phase 2   EUCTR2011-005886-19-DK   Denmark
      2012   Phase 2   EUCTR2011-005846-36-DK   Denmark
   Medical University of Vienna (MUW)
      -   -   EUCTR2015-002882-41-AT   Austria
Surgery
   Clinical Research Group of inflammatory bowel disease in Japan
      2009   Phase 4   JPRN-UMIN000002604   Japan
   Department of Surgery 2,Tokyo Women's Medical University
      2012   -   JPRN-UMIN000009631   Japan
   Hyogo college of medicine
      2014   Phase 2   JPRN-UMIN000013369   Japan
   Jinling Hospital, China
      2011   -   NCT01540942   China
Suspension containing 250 embryonated, viable trichuris suis OVA (TSO)/15ML
   Dr. Falk Pharma GmbH
      2010   -   EUCTR2006-000720-13-DK   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-DE   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-CZ   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-AT   Austria;Czech Republic;Denmark;Germany;Switzerland
Suspension containing 250 embryonated, viable TSO/15ML
   Dr. Falk Pharma GmbH
      2010   -   EUCTR2006-000720-13-DK   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-DE   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-CZ   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-AT   Austria;Czech Republic;Denmark;Germany;Switzerland
Suspension containing 2500 embryonated, viable trichuris suis OVA (TSO)/15ML
   Dr. Falk Pharma GmbH
      2010   -   EUCTR2006-000720-13-DK   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-DE   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-CZ   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-AT   Austria;Czech Republic;Denmark;Germany;Switzerland
Suspension containing 2500 embryonated, viable TSO/15ML
   Dr. Falk Pharma GmbH
      2010   -   EUCTR2006-000720-13-DK   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-DE   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-CZ   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-AT   Austria;Czech Republic;Denmark;Germany;Switzerland
Suspension containing 7500 embryonated, viable trichuris suis OVA (TSO)/15ML
   Dr. Falk Pharma GmbH
      2010   -   EUCTR2006-000720-13-DK   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-DE   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-CZ   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-AT   Austria;Czech Republic;Denmark;Germany;Switzerland
Suspension OF 7500 embryonated, viable TSO/15ML
   Dr. Falk Pharma GmbH
      2010   -   EUCTR2006-000720-13-DK   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-DE   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-CZ   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-AT   Austria;Czech Republic;Denmark;Germany;Switzerland
Suspension OF adipose derived autologous adult stem cells
   CELLERIX S.A.
      2009   -   EUCTR2008-004286-25-DE   Austria;Belgium;Czech Republic;Germany;Netherlands;Spain
      2009   -   EUCTR2008-004286-25-BE   Austria;Belgium;Czech Republic;Germany;Netherlands;Spain
Synbiotic
   Mayo Clinic
      2006   Phase 1/Phase 2   NCT00587041   United States
   University of Alberta
      2021   -   NCT04804046   Canada
   University of Dundee
      2006   -   NCT00305409   United Kingdom
TA-650
   Mitsubishi Tanabe Pharma Corporation
      2012   Phase 3   NCT01580670   Japan
      2008   Phase 3   NCT00805766   Japan
Tacrolimus
   Department of Gastroenterology and Hepatology, Kyoto University
      2009   Phase 2   JPRN-UMIN000002796   Japan
   Fred Hutchinson Cancer Research Center
      2012   Phase 2   NCT01570348   United States
   Northwestern University
      2019   Phase 2   NCT04154735   United States
   University of Aberdeen
      2010   Phase 2   NCT01233570   United Kingdom
TAK-018
   Millennium Pharmaceuticals, Inc (a wholly owned subsidiary
      2020   Phase 2   EUCTR2019-000886-19-FR   France;Germany;United Kingdom;United States
      2019   Phase 2   EUCTR2019-000886-19-GB   Austria;France;Germany;Netherlands;United Kingdom;United States
   Millennium Pharmaceuticals, Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited)
      2020   Phase 2   EUCTR2019-000886-19-NL   Austria;France;Germany;Netherlands;United Kingdom;United States
      2020   Phase 2   EUCTR2019-000886-19-AT   Austria;France;Germany;Netherlands;United Kingdom;United States
   Takeda
      2020   Phase 2   NCT03943446   Austria;France;Germany;Netherlands;United Kingdom;United States
   Takeda Development Center Americas,Inc.
      2019   Phase 2   EUCTR2019-000886-19-DE   Austria;France;Germany;Netherlands;United Kingdom;United States
TAK-279
   Takeda
      2024   Phase 2   NCT06233461   Australia;Belgium;Bulgaria;Canada;China;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Romania;Slovakia;Spain;Switzerland;Taiwan;United Kingdom;United States
Tamibarotene
   R&R Inc.
      2006   Phase 2   NCT00417391   Japan
Tasty&healthy intervention group
   Shaare Zedek Medical Center
      2020   -   NCT04239248   Israel
TBC
   Provention Bio, Inc.
      2018   Phase 2   EUCTR2017-003017-25-ES   Austria;Germany;Hungary;Poland;Russian Federation;Spain;Ukraine
TD-1473
   Theravance Biopharma
      2018   Phase 2   NCT03635112   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
   Theravance Biopharma Ireland Limited
      2019   Phase 2   EUCTR2018-001272-37-PT   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001272-37-PL   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001272-37-HR   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001272-37-FR   Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2018-001272-37-AT   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001272-37-HU   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001272-37-GB   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001272-37-ES   Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2018   Phase 2   EUCTR2018-001272-37-DE   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001272-37-BG   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
   Theravance Biopharma UC Inc.
      2019   Phase 2   EUCTR2018-001272-37-RO   Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
   Theravance Biopharma US, Inc.
      2018   Phase 2   EUCTR2018-001272-37-GR   Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
TDM-based infliximab intravenous therapy
   Asan Medical Center
      2023   Phase 4   NCT06051253   Korea, Republic of
Teduglutide
   Shire
      2004   Phase 2   NCT00308438   Canada;United States
Teduglutide 0.05 dose
   Shire
      2003   Phase 2   NCT00072839   Canada;United States
Teduglutide 0.1 MG dose
   Shire
      2003   Phase 2   NCT00072839   Canada;United States
Teduglutide 0.2 MG
   Shire
      2003   Phase 2   NCT00072839   Canada;United States
Terbinafine
   Montreal Heart Institute
      2022   Phase 2   NCT05049525   Canada
Tetomilast
   Otsuka Pharmaceutical Co., Ltd.
      2006   Phase 2   NCT00317369   Japan
TEV-48574
   TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
      2023   Phase 2   EUCTR2022-002593-89-IT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Norway;Poland;Slovakia;Spain;United Kingdom;United States
   Teva Branded Pharmaceutical Products R&D, Inc.
      2023   Phase 2   EUCTR2022-002593-89-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2022-002593-89-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-SK   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-FR   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Norway;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2023   Phase 2   EUCTR2021-006881-19-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2022   Phase 2   NCT05499130   Austria;Belgium;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Moldova, Republic of;Norway;Poland;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 2   EUCTR2021-006881-19-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Norway;Poland;Serbia;Slovakia;Spain;Sweden;United Kingdom;United States
TEV-48574 dose regimen A
   Teva Branded Pharmaceutical Products R&D, Inc.
      2023   Phase 2   NCT05668013   Austria;Belgium;Bulgaria;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Norway;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
TEV-48574 dose regiment B
   Teva Branded Pharmaceutical Products R&D, Inc.
      2023   Phase 2   NCT05668013   Austria;Belgium;Bulgaria;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Norway;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
TH-SC01
   Jinling Hospital, China
      2020   Phase 1   NCT04939337   China
Thalidomide
   First Affiliated Hospital, Sun Yat-Sen University
      2013   Phase 2   NCT02501291   China
   IRCCS Burlo Garofolo
      2018   Phase 3   NCT03221166   Italy
      2008   Phase 3   NCT00720538   Italy
   Peking Union Medical College Hospital
      2016   -   ChiCTR-OPC-16008655   China
   Sixth Affiliated Hospital, Sun Yat-sen University
      2016   -   NCT02998827   -
      2016   Phase 0   NCT02956538   China
   The Second Affiliated Hospital of the Army Medical University PLA
      2025   -   ChiCTR2500100473   China
Thalidomide celgene - 50 MG capsula rigida - USO orale - blister (PVC/PE/aclar/ALU) 28 capsule
   IRCCS Burlo Garofolo
      2017   Phase 3   EUCTR2016-000786-24-IT   Italy
Thalidomide pharmion
   ISTITUTO PER L INFANZIA BURLO GAROFOLO
      2006   -   EUCTR2005-005414-20-IT   Italy
THC 5MG/ML and CBS 50MG/ML
   Meir Medical Center
      2013   Phase 1/Phase 2   NCT01826188   Israel
THE investigational medicinal product (IMP) will BE labeled AS PF-04236921 106 MG/vial, clonal SC lyophilized form, which IS equivalent TO PF-04236921 powder FOR injection, 106 MG/vial AS described IN THE enclosed CTA
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2011   Phase 2   EUCTR2011-000722-30-HU   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Romania;Sweden;Switzerland;United Kingdom;United States
      2011   Phase 2   EUCTR2011-000722-30-GR   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Romania;Sweden;Switzerland;United Kingdom;United States
      2011   Phase 2   EUCTR2011-000722-30-DK   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Romania;Sweden;Switzerland;United Kingdom;United States
      2011   -   EUCTR2010-023034-23-GR   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Ireland;Israel;Italy;New Zealand;Romania;Sweden;Switzerland;United Kingdom;United States
Thetanix
   4D Pharma
      2015   Phase 1   EUCTR2014-005666-29-GB   United Kingdom
Thiopurine
   Ernest Seidman
      2014   -   NCT02453607   Canada
   St Vincent's Hospital Melbourne
      2017   Phase 4   NCT03220841   Australia
Thiosix
   Amsterdam UMC location AMC
      2021   Phase 3;Phase 4   EUCTR2021-000469-33-NL   Netherlands
Thiotepa
   Paul Szabolcs
      2012   Phase 1/Phase 2   NCT00692939   United States
Threonine
   Nestlé
      2015   -   NCT02423460   Canada
THRX-139060
   Theravance Biopharma Ireland Limited
      2019   Phase 2   EUCTR2018-001272-37-PT   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001272-37-PL   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001272-37-HR   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001272-37-FR   Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2019   Phase 2   EUCTR2018-001272-37-AT   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001272-37-HU   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001272-37-GB   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001272-37-ES   Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2018   Phase 2   EUCTR2018-001272-37-DE   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001272-37-BG   Australia;Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
   Theravance Biopharma UC Inc.
      2019   Phase 2   EUCTR2018-001272-37-RO   Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
   Theravance Biopharma US, Inc.
      2018   Phase 2   EUCTR2018-001272-37-GR   Austria;Bulgaria;Croatia;France;Georgia;Germany;Greece;Hungary;Israel;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
Thymoglobulin
   Aaron Etra
      2017   Phase 2   NCT03219359   United States
Thymoglobuline
   Barts Health NHS Trust
      2017   Phase 3   EUCTR2017-002545-30-GB   United Kingdom
   WOLFSON DIGESTIVE DISEASES CENTRE
      2007   -   EUCTR2005-003337-40-IT   Italy;United Kingdom
Ticilimumab
   Vanderbilt-Ingram Cancer Center
      2006   -   NCT00897312   -
Time and attention + active fructooligosaccharide supplementation
   Rush University Medical Center
      2006   Phase 1/Phase 2   NCT00343642   United States
Tirzepatide
   Eli Lilly and Company
      2025   Phase 3   NCT06937099   Austria;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Turkey;United States
   University of Miami
      2025   Phase 4   NCT06774079   United States
   Washington University School of Medicine
      2025   Phase 2   NCT06976853   United States
TNF kinoid
   Neovacs
      2011   Phase 2   NCT01291810   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
TNF-alpha antagonists
   Assistance Publique - Hôpitaux de Paris
      2004   -   NCT00224562   France
TNF-K
   Neovacs SA
      2011   -   EUCTR2010-019996-32-HU   Belgium;Bulgaria;Germany;Hungary;Netherlands
      2011   -   EUCTR2010-019996-32-DE   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
      2011   Phase 2   EUCTR2010-019996-32-CZ   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
      2011   -   EUCTR2010-019996-32-BG   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
      2011   Phase 2   EUCTR2010-019996-32-BE   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
      -   -   EUCTR2010-019996-32-NL   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
TNF-kinoid
   Neovacs SA
      2011   -   EUCTR2010-019996-32-HU   Belgium;Bulgaria;Germany;Hungary;Netherlands
      2011   -   EUCTR2010-019996-32-DE   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
      2011   -   EUCTR2010-019996-32-BG   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
      2011   Phase 2   EUCTR2010-019996-32-BE   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
      -   -   EUCTR2010-019996-32-NL   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
Tnfa antagonist - adalimumab
   University of Calgary
      2023   Phase 4   NCT05928039   Canada
Tnfa antagonist - infliximab
   University of Calgary
      2023   Phase 4   NCT05928039   Canada
Tnfa kinoid
   Neovacs
      2008   Phase 1/Phase 2   NCT00808262   South Africa;Switzerland
TNFA-kinoid
   Neovacs SA
      2011   -   EUCTR2010-019996-32-HU   Belgium;Bulgaria;Germany;Hungary;Netherlands
      2011   Phase 2   EUCTR2010-019996-32-CZ   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
      2011   -   EUCTR2010-019996-32-BG   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
      2011   Phase 2   EUCTR2010-019996-32-BE   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
TO BE determined
   TiGenix, S.A.U.
      2017   Phase 3   EUCTR2017-000725-12-ES   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;United States
TO BE requested
   Landos Biopharma Inc.
      2020   Phase 2   EUCTR2018-005086-39-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-HU   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
      2019   Phase 2   EUCTR2018-005086-39-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
Tofacitinib
   Pfizer Inc
      2012   Phase 2   EUCTR2011-003622-27-CZ   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2013   Phase 2   EUCTR2011-003622-27-NL   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2013   Phase 2   EUCTR2011-003622-27-HR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2013   Phase 2   EUCTR2011-003622-27-AT   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-003622-27-HU   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-003622-27-BG   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
      2012   Phase 2   EUCTR2011-003622-27-DE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;Netherlands Antilles;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc.
      2012   Phase 2   EUCTR2011-001754-28-CZ   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-CZ   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc.235 East 42nd Street, New York, NY 10017
      2013   Phase 2   EUCTR2011-001754-28-HR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2013   -   EUCTR2011-001733-16-HR   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-NL   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-HU   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2011-001754-28-BG   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001754-28-AT   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-NL   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-HU   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;Norway;Slovakia;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-BG   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-AT   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Japan;Korea, Republic of;Netherlands;Romania;South Africa;Spain;Sweden;Ukraine;United States
   Pfizer Inc.235 East 42nd Street, New York, NY 10017, USA
      2012   Phase 2   EUCTR2011-001754-28-DE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
      2012   -   EUCTR2011-001733-16-DE   Australia;Austria;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Netherlands;South Africa;Spain;Sweden;Ukraine;United States
Tolerogenic dendritic cells
   Fundacion Clinic per a la Recerca Biomédica
      2015   Phase 1   NCT02622763   Spain
TOP down treatment IF patient AT high risk
   Region Örebro County
      2022   Phase 4   NCT05180175   Denmark;Iceland;Norway;Sweden
TOP-down
   University of Roma La Sapienza
      2012   Phase 4   NCT01752790   Italy
Total body irradiation
   Stanford University
      2025   Phase 1/Phase 2   NCT06986382   United States
Total-body irradiation
   Fred Hutchinson Cancer Research Center
      2012   Phase 2   NCT01570348   United States
Tpmt genotyping
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands
TQH3906 capsules
   Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
      2025   Phase 1   NCT06754891   China
Transfusion
   University Hospital, Akershus
      2019   Phase 1/Phase 2   NCT04164849   Norway
Treatment according TO current standards without knowledge OF serum infliximab and ANTI-infliximab AB status
   Copenhagen University Hospital at Herlev
      2009   Phase 4   NCT00851565   Denmark
Treatment with adalimumab
   Rabin Medical Center
      2007   -   NCT01144156   Israel
Triamcinolone
   University Medical Center Utrecht
      2009   -   EUCTR2007-005455-42-NL   Netherlands
Triangular test
   Centre Hospitalier Universitaire Dijon
      2013   -   NCT02859675   France
Trichuris suis eggs
   University of Aarhus
      2012   -   NCT03079700   -
Trichuris suis OVA
   Coronado Biosciences, Inc.
      2012   Phase 2   NCT01576471   United States
      2011   Phase 1   NCT01434693   United States
Trichuris trichiura eggs
   University of Aarhus
      2012   -   NCT02399683   -
Trilac
   Lebanese University
      2024   -   NCT06392061   Lebanon
Tripterygium glycosides
   Zhu Weiming
      2012   -   NCT01820247   China
Tris
   Iron Therapeutics (Switzerland) AG
      2012   -   EUCTR2010-023589-39-DE   Austria;Germany;Hungary;United Kingdom
      2011   Phase 3   EUCTR2010-023589-39-GB   Austria;Germany;Hungary;United Kingdom
      2011   -   EUCTR2010-023589-39-AT   Austria;Germany;Hungary;United Kingdom
      -   -   EUCTR2010-023589-39-HU   Austria;Germany;Hungary;United Kingdom
TRK-170
   Toray Industries Inc
      2012   -   EUCTR2011-000854-44-LV   Bulgaria;Czech Republic;Hungary;Latvia;Norway;Poland;Sweden
      2012   -   EUCTR2011-000854-44-CZ   Belgium;Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
      2012   -   EUCTR2011-000854-44-BG   Belgium;Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
      2011   -   EUCTR2011-000854-44-SE   Belgium;Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
      2011   -   EUCTR2011-000854-44-PL   Bulgaria;Czech Republic;Hungary;Latvia;Norway;Poland;Sweden
      2011   Phase 2   EUCTR2011-000854-44-NO   Belgium;Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
      2011   Phase 2   EUCTR2011-000854-44-BE   Belgium;Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
      -   -   EUCTR2011-000854-44-NL   Bulgaria;Czech Republic;Hungary;Latvia;Netherlands;Norway;Poland;Sweden
   Toray Industries, Inc
      2011   Phase 2   NCT01345799   Belgium;Bulgaria;Czech Republic;France;Hungary;Latvia;Netherlands;Norway;Poland;Romania;Serbia;Sweden;Ukraine
   Toray Industries, Inc.
      2011   -   EUCTR2011-000854-44-HU   Bulgaria;Czech Republic;Hungary;Latvia;Norway;Poland;Sweden
TRX103
   Tr1X, Inc.
      2025   Phase 1/Phase 2   NCT06721962   United States
Trypsin
   Department of Gastroenterology, Renmin Hospital of WuhanUniversity
      2024   Phase 1   ChiCTR2400086621   China
   Renmin Hospital of Wuhan University
      2022   Phase 4   ChiCTR2200058343   China
TSO 250
   Dr. Falk Pharma GmbH
      2010   -   EUCTR2006-000720-13-DK   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-DE   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-CZ   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-AT   Austria;Czech Republic;Denmark;Germany;Switzerland
TSO 2500
   Dr. Falk Pharma GmbH
      2010   -   EUCTR2006-000720-13-DK   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-DE   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-CZ   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-AT   Austria;Czech Republic;Denmark;Germany;Switzerland
TSO 7500
   Dr. Falk Pharma GmbH
      2010   -   EUCTR2006-000720-13-DK   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-DE   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-CZ   Austria;Czech Republic;Denmark;Germany;Switzerland
      2010   -   EUCTR2006-000720-13-AT   Austria;Czech Republic;Denmark;Germany;Switzerland
TU-100
   Tsumura USA
      2011   Phase 2   NCT01388933   United States
Tulisokibart
   Merck Sharp & Dohme LLC
      2024   Phase 3   NCT06651281   Poland;United States
TV-5600
   Teva Pharmaceutical Industries Ltd.
      2008   -   EUCTR2008-004276-49-NL   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2008-004276-49-IT   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-GB   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-FR   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-ES   Belgium;France;Italy;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-004276-49-BE   Belgium;France;Italy;Netherlands;Spain;United Kingdom
UC-mscs BY peripheral intravenous infusion
   Fuzhou General Hospital
      2012   Phase 1/Phase 2   NCT02445547   China
Ultrasound elastography
   Mayo Clinic
      2017   Phase 4   NCT03235180   United States
Ultrasound imaging
   Children's Hospital Medical Center, Cincinnati
      2020   -   NCT03492944   United States
Ultrasound microbubble contrast agent
   Children's Hospital Medical Center, Cincinnati
      2020   -   NCT03492944   United States
Ultrasound vascularity
   Mayo Clinic
      2017   Phase 4   NCT03235180   United States
Undetermined
   EA Pharma Co., Ltd.
      2019   Phase 2   EUCTR2018-002109-70-HU   Czech Republic;Hungary;Japan;Poland
      2019   Phase 2   EUCTR2018-002109-70-CZ   Czech Republic;Czechia;Hungary;Japan;Poland;Russian Federation
Upadacitinib
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2018   Phase 3   EUCTR2017-001240-35-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie
      2024   Phase 3   NCT06332534   Australia;Belgium;Brazil;Bulgaria;China;France;Greece;Italy;Japan;Korea, Republic of;New Zealand;Poland;Puerto Rico;Spain;Taiwan;United Kingdom;United States
      2019   -   NCT04159597   -
      2018   Phase 3   NCT03345823   American Samoa;Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   NCT03345849   American Samoa;Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   NCT03345836   American Samoa;Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;Estonia;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2020   Phase 3   EUCTR2017-001240-35-FR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001240-35-SI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001240-35-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001226-18-SI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001226-18-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001225-41-SI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001225-41-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2017-001225-41-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-LV   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Russian Federation;Serbia;Singapore;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-001240-35-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001240-35-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Denmark;Egypt;Estonia;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001226-18-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-LV   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-ES   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Portugal;Russian Federation;Serbia;Singapore;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States
      2018   Phase 3   EUCTR2017-001225-41-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-001225-41-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2015-003759-23-NO   Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-SK   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-NL   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-GB   Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-DK   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
      2016   Phase 2   EUCTR2015-003759-23-DE   Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Netherlands;New Zealand;Norway;Slovakia;Spain;United Kingdom;United States
   Otani Tetsuya
      2024   Phase 3   JPRN-jRCT2071240040   Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Greece;Italy;Japan;New Zealand;Poland;Puerto Rico;South Korea;Spain;Taiwan;Turkey;United Kingdom;United States of America
   Sixth Affiliated Hospital, Sun Yat-sen University
      2024   Phase 1   NCT06902987   China
      2023   -   NCT06922331   China
      2023   -   NCT06095596   China
   Takeda
      2025   Phase 3   NCT06227910   Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Xiang Gao
      2024   -   NCT06780683   China
Upadaticitib
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2018   Phase 3   EUCTR2017-001225-41-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
Ursodeoxycholic acid
   Ghent University Hospital
      2014   Phase 4   EUCTR2014-003141-10-BE   Belgium
Ursofalk
   Ghent University Hospital
      2014   Phase 4   EUCTR2014-003141-10-BE   Belgium
US TAP bupivacaine/epinephrine
   Cedars-Sinai Medical Center
      2015   -   NCT02538679   -
Ustekinumab
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2020   Phase 3   EUCTR2020-002674-26-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   AbbVie
      2020   Phase 3   NCT04524611   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 3   EUCTR2020-002674-26-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-002674-26-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2020-002674-26-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
   Affiliated Hospital of Nanjing University of Chinese Medicine
      2024   -   ChiCTR2400089219   China
   Alimentiv Inc.
      2024   -   NCT06249555   Canada;United States
   BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      2021   Phase 2   EUCTR2020-004527-16-IT   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;United States
   Belgian IBD research and development
      2019   Phase 4   EUCTR2018-004269-14-BE   Belgium
   Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
      2021   Phase 3   NCT05299931   Belgium
      2020   Phase 3   NCT04245215   Belgium
   Boehringer Ingelheim
      2021   Phase 2   NCT04978493   Belgium;Czechia;Denmark;Germany;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States
   Centocor BV
      2009   -   EUCTR2008-000649-77-NL   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-000649-77-GB   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-000649-77-FR   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-000649-77-ES   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-000649-77-DE   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-000649-77-BE   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2008-000649-77-AT   Austria;Belgium;France;Germany;Netherlands;Spain;United Kingdom
   Centocor, Inc.
      2008   Phase 2   NCT00771667   Australia;Austria;Belgium;Canada;France;Germany;Israel;Netherlands;New Zealand;Spain;United Kingdom;United States
   Charité Universitätsmedizin Berlin
      2018   Phase 4   EUCTR2017-005151-83-DE   Germany
   Drum Tower Hospital Affiliated to Nanjing University School of Medicine
      2022   Phase 4   ChiCTR2200055424   China
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 3   EUCTR2018-004614-18-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Eli Lilly and Company
      2020   Phase 3   EUCTR2018-004614-18-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2018-004614-18-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   NCT03926130   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2018-004614-18-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   General Hospital of Eastern Millitary Command
      2024   -   ChiCTR2400087670   China
   Graduate School of Medical Sciences, Kyushu University
      2017   -   JPRN-UMIN000028139   Japan
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2020   Phase 4   NCT04496063   France
   Hospices Civils de Lyon
      2022   -   NCT03712826   France
   JANSSEN CILAG INTERNATIONAL NV
      2019   Phase 3   EUCTR2018-002629-51-IT   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-IT   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-IT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002918-43-IT   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2016   Phase 2   EUCTR2016-000634-21-IT   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
   JANSSEN-CILAG INTERNATIONAL N.V.
      2011   -   EUCTR2010-022759-42-IT   Australia;Brazil;Bulgaria;Canada;Croatia;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-IT   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;South Africa;Spain;United Kingdom;United States
   Janssen Cilag S.A.S.
      2018   -   NCT03606499   France
   Janssen Korea, Ltd., Korea
      2019   -   NCT03942120   Korea, Republic of
   Janssen Research & Development, LLC
      2022   -   NCT05242458   United States
      2021   Phase 3   NCT05092269   Argentina;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Poland;Spain;Turkey;United Kingdom;United States
      2021   Phase 4   NCT05029921   China
      2021   Phase 3   NCT04673357   Belgium;Germany;Hungary;Israel;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 2   NCT04655807   Canada;France;Germany;Italy;Japan;Spain;Sweden;United States
      2018   Phase 2/Phase 3   NCT03466411   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czechia;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, The Former Yugoslav Republic of;Malaysia;Netherlands;New Zealand;North Macedonia;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2017   -   NCT03362736   Brazil
      2017   Phase 1   NCT02968108   Belgium;Canada;France;Germany;Poland;United States
      2016   Phase 2   NCT02877134   Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United Kingdom;United States
   Janssen Scientific Affairs, LLC
      2021   -   NCT04372108   United States
      2018   Phase 3   NCT03464136   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
   Janssen-Cilag International N.V.
      2020   Phase 3   EUCTR2018-002629-51-GB   Austria;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-SE   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-FR   Austria;Czech Republic;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2018   Phase 3   EUCTR2018-002629-51-ES   France;Germany;Netherlands;Spain;Sweden;United States
      2018   Phase 3   EUCTR2017-004209-41-PL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-FR   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-BE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2016-002918-43-SK   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2018   Phase 3   EUCTR2016-002918-43-DK   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-SE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-PT   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-NL   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-GB   Belgium;Germany;Netherlands;Portugal;Spain;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-FR   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-ES   Belgium;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-DE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 3   EUCTR2016-002918-43-BE   Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2017   Phase 1   EUCTR2016-001956-22-PL   Belgium;Canada;France;Germany;Poland;United States
      2017   Phase 1   EUCTR2016-001956-22-DE   Belgium;Canada;France;Germany;Poland;United States
      2017   Phase 1   EUCTR2016-001956-22-BE   Belgium;Canada;France;Germany;Poland;United States
      2012   Phase 3   EUCTR2010-022760-12-NL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022760-12-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022758-18-BE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-IS   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-IE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-HU   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-GB   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-FR   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-ES   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-DK   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-DE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-CZ   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-BG   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;European Union;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022760-12-AT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-NL   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-IS   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-HU   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022759-42-GB   Australia;Brazil;Bulgaria;Canada;Croatia;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-ES   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-DE   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022759-42-BG   Australia;Brazil;Bulgaria;Canada;Croatia;European Union;Germany;Hungary;Iceland;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Russian Federation;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-IS   Austria;Belgium;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Italy;Spain;United Kingdom
      2011   -   EUCTR2010-022758-18-IE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-HU   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022758-18-GB   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   Phase 3   EUCTR2010-022758-18-ES   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-DK   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-DE   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-CZ   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;European Union;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022758-18-AT   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Hungary;Iceland;Ireland;Israel;Italy;Japan;Korea, Republic of;New Zealand;Serbia;South Africa;Spain;United Kingdom;United States
      -   Phase 1   EUCTR2016-001956-22-FR   Belgium;Canada;France;Germany;Poland;United States
   Janssen-Cilag International NV
      2022   Phase 3   EUCTR2020-004457-76-HU   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-DE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004457-76-BE   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004457-76-PL   Argentina;Belgium;France;Germany;Hungary;Japan;Poland;Russian Federation;Turkey;United States
      2021   Phase 3   EUCTR2019-004225-24-HU   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004225-24-DE   Belgium;Germany;Hungary;Japan;Poland;United Kingdom;United States
      2021   Phase 3   EUCTR2019-004225-24-BE   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      2021   Phase 3   EUCTR2018-002629-51-CZ   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-NL   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2018-002629-51-AT   Austria;Czech Republic;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-PT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2;Phase 3   EUCTR2017-002195-13-GB   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2016-000634-21-FR   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-NL   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-GB   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004209-41-CZ   Australia;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-SK   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-PL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Türkiye;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-NL   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LV   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-LT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-HR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-GR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-FR   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-ES   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-DE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Georgia;Germany;Greece;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-CZ   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-BE   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;India;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2018   Phase 2;Phase 3   EUCTR2017-002195-13-AT   Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;China;Colombia;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Lebanon;Lithuania;Netherlands;New Zealand;North Macedonia;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;South Africa;Spain;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-000634-21-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-GB   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-000634-21-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-PL   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-Outside-EU/EEA   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
      -   Phase 3   EUCTR2019-004225-24-GB   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States
   Janssen-Cilag Ltd.
      2017   -   NCT03495973   Sweden
      2017   Phase 3   NCT03107793   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
   Lilly S.A.
      2019   Phase 3   EUCTR2018-004614-18-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Mikami Yohei
      2019   -   JPRN-jRCT1031190056   -
   Moroi Rintao
      2018   Phase 3   JPRN-jRCTs021200013   -
   NYU Langone Health
      2022   Phase 4   NCT04629196   United States
   National Institute of Allergy and Infectious Diseases (NIAID)
      2017   Phase 1/Phase 2   NCT03167437   United States
   Nishikawa Kazuko
      2022   Phase 3   JPRN-jRCT2031220186   Belgium;France;Germany;Hungary;Japan;Poland;United States Of America
      2021   Phase 3   JPRN-jRCT2031200345   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom Of Great Britain And Northern Irela;United States Of America
   Numaguchi Hirotaka
      2021   Phase 2   JPRN-jRCT2031200406   Canada;France;Germany;Italy;Japan;Spain;United States Of America
   Peking Union Medical College Hospital
      2020   -   NCT05386290   China
   Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
      2023   Phase 4   ChiCTR2300070321   China
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2024   -   NCT05387031   China
      2023   -   NCT05705856   China
   Shanghai Tenth People's Hospital
      2023   Phase 4   ChiCTR2300075237   China
   Shenzhen Hospital of Southern Medical University
      2024   Phase 0   ChiCTR2400093919   China
   Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
      2024   -   ChiCTR2300079034   China
   Takeda
      2024   Phase 4   NCT06045754   Canada;United States
   The First Affiliated Hospital of Anhui Medical University
      2023   Phase 4   ChiCTR2300078772   China
   The Second Affiliated Hospital of the Army Medical University PLA
      2025   -   ChiCTR2500100473   China
   Tohoku University Hospital, Division of Gastroenterology
      2018   -   JPRN-UMIN000030884   Japan
   Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
      2023   -   ChiCTR2300079089   China
   UZ Leuven
      2019   Phase 4   EUCTR2019-002038-35-BE   Belgium
   University Medical Center Groningen
      2025   Phase 1   NCT05725876   Netherlands
   University of California, San Diego
      2013   -   NCT02103361   United States
   Wolfson Medical Center
      2022   -   NCT04779762   Israel
   Xian-Janssen Pharmaceutical Ltd.
      2023   -   NCT06082986   China
   Xijing Hospital, Air Force Military Medical University
      2022   Phase 4   ChiCTR2200060604   China
Ustekinumab - standard dosage
   Second Affiliated Hospital of Wenzhou Medical University
      2020   -   NCT06935942   China
      2020   -   NCT06935929   China
Ustekinumab 130 MG IV
   Janssen Research & Development, LLC
      2011   Phase 3   NCT01369355   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
Ustekinumab 4.5 MG/KG
   Centocor, Inc.
      2004   Phase 2   NCT00265122   Belgium;Canada;United States
Ustekinumab 90 MG
   Centocor, Inc.
      2004   Phase 2   NCT00265122   Belgium;Canada;United States
Ustekinumab 90 MG (SC) group 1
   Janssen-Cilag Ltd.
      2018   Phase 3   NCT03782376   Austria;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
Ustekinumab 90 MG (SC) group 2
   Janssen-Cilag Ltd.
      2018   Phase 3   NCT03782376   Austria;Czechia;France;Germany;Italy;Korea, Republic of;Netherlands;Russian Federation;Spain;Sweden;United Kingdom;United States
Ustekinumab 90 MG SC Q12W
   Janssen Research & Development, LLC
      2011   Phase 3   NCT01369355   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
Ustekinumab 90 MG SC Q8W
   Janssen Research & Development, LLC
      2011   Phase 3   NCT01369355   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Iceland;Ireland;Israel;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;United Kingdom;United States
Ustekinumab and semi enteral nutrition
   Xiang Gao
      2024   -   NCT06912815   China
Ustekinumab and upadacitinib
   Sixth Affiliated Hospital, Sun Yat-sen University
      2024   Phase 4   NCT06520397   China
Ustekinumab IV infusion
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Ustekinumab SC injection
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Usual current care
   Hospital Galdakao-Usansolo
      2020   -   NCT04188990   Spain
UTTR1147A
   GENENTECH, INC.
      2019   Phase 2   EUCTR2017-004997-32-IT   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Genentech, Inc.
      2019   Phase 2   NCT03650413   Bulgaria;China;France;Georgia;Germany;Greece;Hungary;Ireland;Israel;Italy;Moldova, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2016   Phase 1   NCT02749630   Canada;Germany;United Kingdom
UTTR1147A, IL22-FC, IL-22FC
   Genentech, Inc.
      2019   Phase 2   EUCTR2017-004997-32-NL   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-004997-32-HU   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-004997-32-GB   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2017-004997-32-DE   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-004997-32-IE   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
   Roche Farma, S.A por delegación de Genentech, Inc.
      2018   Phase 2   EUCTR2017-004997-32-ES   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Uvadex
   Therakos
      2005   -   EUCTR2004-002693-37-DE   Germany
      2005   Phase 2   EUCTR2004-002693-37-BE   Austria;Belgium;Germany
      2004   -   EUCTR2004-002693-37-AT   Austria;Germany
Uvadex and uvar XTS photopheresis system
   National Institute of Allergy and Infectious Diseases (NIAID)
      2003   Phase 1   NCT00056355   United States
V565
   VHsquared Ltd
      2017   Phase 2   EUCTR2016-002939-15-SK   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Netherlands;Norway;Poland;Slovakia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002939-15-NO   Austria;Canada;Czech Republic;Germany;Hungary;Netherlands;Norway;Poland;Serbia;Slovakia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002939-15-NL   Austria;Canada;Czech Republic;Germany;Hungary;Netherlands;Norway;Poland;Serbia;Slovakia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002939-15-HU   Austria;Canada;Czech Republic;Germany;Hungary;Netherlands;Norway;Poland;Serbia;Slovakia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002939-15-GB   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Netherlands;Norway;Poland;Slovakia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002939-15-DE   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Netherlands;Norway;Poland;Slovakia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002939-15-CZ   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Netherlands;Norway;Poland;Slovakia;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002939-15-AT   Austria;Canada;Czech Republic;Germany;Hungary;Netherlands;Norway;Poland;Serbia;Slovakia;Ukraine;United Kingdom;United States
   VHsquared Ltd.
      2016   Phase 2   NCT02976129   Austria;Canada;Czech Republic;Czechia;Germany;Hungary;Netherlands;Norway;Poland;Serbia;Slovakia;Ukraine;United Kingdom;United States
      2015   Phase 1   NCT03010787   United Kingdom
Vaccine
   Klara M. Pósfay Barbe
      2014   Phase 4   NCT01908283   Switzerland
Vancomycin
   Children's Hospital of Philadelphia
      2018   Phase 2   NCT03476317   United States
   University of Pennsylvania
      2016   Phase 2   NCT02765256   United States
Vedolizumab
   Aaron Etra
      2017   Phase 2   NCT03219359   United States
   Alimentiv Inc.
      2024   Phase 4   NCT06257706   Australia;Belgium;Canada;Czechia;Denmark;France;Germany;Italy;Netherlands;Poland;Portugal;United Kingdom;United States
      2024   -   NCT06249555   Canada;United States
   Centre Hospitalier Universitaire de Saint Etienne
      2024   Phase 4   NCT06180382   France
      2016   Phase 4   NCT02768532   France
   FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
      2016   Phase 4   EUCTR2015-003270-32-IT   Italy
   Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
      2018   Phase 4   EUCTR2018-002925-47-ES   Spain
   Geert D'Haens
      2015   Phase 4   NCT02646683   Belgium;Hungary;Netherlands
   Icahn School of Medicine at Mount Sinai
      2016   Phase 4   NCT02324699   United States
   MILLENNIUM PHARMACEUTICALS, INC.
      2011   -   EUCTR2009-016488-12-IT   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands
      2009   -   EUCTR2008-002783-33-IT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
   Marc Schwartz
      2018   Phase 2   NCT02834754   United States
   Millennium Pharmaceuticals, Inc.
      2011   Phase 3   EUCTR2009-016488-12-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands;Slovakia
      2011   -   EUCTR2009-016488-12-NL   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands
      2011   -   EUCTR2009-016488-12-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;New Zealand;Norway;Poland;Slovakia;South Africa;Turkey;United States
      2011   -   EUCTR2009-016488-12-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands;Slovakia
      2011   Phase 3   EUCTR2009-016488-12-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands;Slovakia
      2011   -   EUCTR2009-016488-12-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;New Zealand;Norway;Poland;Slovakia;South Africa;Turkey;United States
      2010   Phase 3   NCT01224171   Canada;Puerto Rico;United States
      2010   -   EUCTR2009-016488-12-HU   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Netherlands
      2009   Phase 3   EUCTR2008-002784-14-PT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002784-14-MT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-IE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-GR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-FR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-EE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   -   EUCTR2008-002783-33-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-PT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-MT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002783-33-IS   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-IE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-GR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002783-33-GB   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002783-33-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-EE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
      2009   -   EUCTR2008-002783-33-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002783-33-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002783-33-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
      2008   Phase 3   NCT00783692   Canada;Puerto Rico;United States
      2008   -   EUCTR2008-002783-33-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-002783-33-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2007   Phase 2   NCT00619489   Canada
   Peking Union Medical College Hospital
      2020   -   NCT05386290   China
   Pontifícia Universidade Católica do Paraná
      2020   -   NCT04362735   -
   Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine
      2022   Phase 4   ChiCTR2200063233   China
   Shaare Zedek Medical Center
      2017   -   NCT02862132   Denmark;Finland;Ireland;Israel;Slovenia;United Kingdom;United States
   Shenzhen Hospital of Southern Medical University
      2024   Phase 0   ChiCTR2400093919   China
   Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
      2024   -   ChiCTR2300079034   China
   Sixth Affiliated Hospital, Sun Yat-sen University
      2023   -   NCT06095596   China
   TAKEDA DEVELOPMENT CENTER AMERICAS INC.
      2021   Phase 3   EUCTR2020-004301-31-IT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
   Takeda
      2025   Phase 3   NCT06227910   Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Republic of;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2024   Phase 4   NCT06045754   Canada;United States
      2021   Phase 3   NCT04738942   Japan
      2019   -   NCT04002180   Japan
      2018   Phase 1   NCT03329209   China
      2018   Phase 2   NCT03196427   Belgium;Canada;France;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   NCT03138655   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 4   NCT02764762   Canada;United States
      2017   Phase 4   NCT02559713   United States
      2016   Phase 4   NCT02760615   United States
      2016   Phase 4   NCT02743806   Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   NCT02630966   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2015   -   NCT02678052   Canada;United States
      2015   -   NCT02674308   Austria;Belgium;Canada;Croatia;Denmark;Estonia;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2015   Phase 3   NCT02425111   Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Poland;United States
      2014   Phase 3   NCT02038920   Japan
      2009   Phase 3   NCT00790933   Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Israel;Korea, Republic of;Malaysia;United States
   Takeda Development Center Americas, Inc.
      2023   Phase 3   EUCTR2021-000630-34-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-GR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2023   Phase 3   EUCTR2021-000630-34-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HU   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2021-000630-34-HR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004301-31-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-SK   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-LT   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-HU   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004301-31-ES   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-Outside-EU/EEA   Australia;Canada;China;Israel;Japan;Korea, Republic of;United Kingdom;United States
      -   Phase 3   EUCTR2021-000630-34-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004301-31-PL   Australia;Belgium;Canada;China;Croatia;Czech Republic;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
      -   Phase 3   EUCTR2020-004301-31-Outside-EU/EEA   Australia;Belgium;Canada;China;Croatia;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2020-004301-31-CZ   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Slovakia;Spain;United Kingdom;United States
   Takeda Development Centre Americas Inc.
      2018   Phase 2   EUCTR2017-002182-21-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Americas, Ltd.
      2017   Phase 2   EUCTR2017-002182-21-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe Limited
      2017   Phase 4   EUCTR2016-000678-40-BG   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-LV   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-HU   Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
      2016   Phase 4   EUCTR2016-000678-40-EE   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda Development Centre Europe Ltd
      2009   Phase 3   EUCTR2008-002784-14-IS   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
   Takeda Development Centre Europe Ltd.
      2010   Phase 3   EUCTR2008-002784-14-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2008-002784-14-GB   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-CZ   Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom
      2009   Phase 3   EUCTR2008-002784-14-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   Phase 3   EUCTR2008-002784-14-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2008   Phase 3   EUCTR2008-002784-14-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe ltd.
      2009   Phase 3   EUCTR2008-002784-14-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe, Ltd.
      2018   Phase 2   EUCTR2017-002182-21-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002182-21-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002182-21-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 4   EUCTR2015-000852-12-BE   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-NL   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-GB   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-FR   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
      2016   Phase 4   EUCTR2015-000852-12-ES   Belgium;Canada;France;Italy;Netherlands;Spain;United Kingdom;United States
   Takeda Pharmaceutical Company Limited
      2019   -   JPRN-jRCT1080224753   Japan
      2014   Phase 3   JPRN-jRCT2080222352   Japan
   Universita degli Studi di Genova
      2016   Phase 4   NCT02820493   -
   University of Miami
      2017   Early Phase 1   NCT02953275   United States
   Yonsei University
      2021   Phase 3   NCT04919252   Korea, Republic of
Vedolizumab 300 MG
   Shikamura Mitsuhiro
      2023   Phase 3   JPRN-jRCT2071230036   China;Greece;Hungary;Italy;Japan;Korea;Poland
      2022   Phase 3   JPRN-jRCT2071210031   Australia;Belgium;Bosnia;China;Croatia;Czech Republic;Germany;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russia;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 3   JPRN-jRCT2031200371   -
   Washington University School of Medicine
      2018   Phase 4   NCT03142321   United States
Vedolizumab intravenous injection
   Takeda
      2014   Phase 2   NCT02913508   -
Vedolizumab IV
   AMC MEDICAL RESEARCH B.V.
      2017   Phase 3   EUCTR2015-000555-24-IT   France;Italy;Netherlands;Spain
   Academic Medical Center Amsterdam
      2016   Phase 4   EUCTR2015-000555-24-NL   France;Italy;Netherlands;Spain
      2016   Phase 4   EUCTR2015-000555-24-FR   France;Netherlands;Spain
      2016   Phase 4   EUCTR2015-000555-24-ES   Netherlands;Spain
   Academic Medical Center, Gastroenterology
      2015   Phase 4   EUCTR2014-005376-29-BE   Belgium;Netherlands
   Shikamura Mitsuhiro
      2021   Phase 3   JPRN-jRCT2031200371   -
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2015-000481-58-IT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2014-003509-13-IT   Belgium;Canada;Czech Republic;Hungary;Italy;Poland;United States
   Takeda
      2025   -   NCT06856135   United States
      2025   Phase 4   NCT06581328   United States
      2025   Phase 3   NCT06100289   Belgium;Bulgaria;Denmark;Ireland;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Romania;Serbia;Spain;Switzerland;Taiwan;Turkey;United States
      2023   Phase 3   NCT05837897   China
      2023   Phase 3   NCT05442567   Australia;Belgium;Canada;China;Croatia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Poland;Slovakia;United Kingdom;United States
      2022   Phase 3   NCT04779320   Australia;Belgium;Canada;China;Croatia;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States
      2021   Phase 4   NCT04804540   India
      2017   Phase 3   NCT03234907   China
   Takeda Development Centre Europe Limited
      2016   Phase 4   EUCTR2016-000678-40-CZ   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine
   Takeda Development Centre Europe Ltd
      2015   Phase 3   EUCTR2014-003509-13-PL   Belgium;Canada;Czech Republic;Hungary;Poland;United States
      2015   Phase 3   EUCTR2014-003509-13-HU   Belgium;Canada;Czech Republic;Hungary;Poland;United States
      2015   Phase 3   EUCTR2014-003509-13-CZ   Belgium;Canada;Czech Republic;Hungary;Poland;United States
      2015   Phase 3   EUCTR2014-003509-13-BE   Belgium;Canada;Czech Republic;Hungary;Poland;United States
   Takeda Development Centre Europe, Ltd.
      2018   Phase 2   EUCTR2017-002231-41-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2017-002231-41-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2017   Phase 2   EUCTR2017-002231-41-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      -   Phase 2   EUCTR2017-002231-41-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States
   Takeda Pharmaceutical Company Limited
      2016   Phase 3   JPRN-jRCT2080223165   Japan;Refer to Othersection
Vedolizumab IV 300 MG
   Takeda
      2016   Phase 3   NCT02611817   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Pharmaceutical Company Limited
      2016   Phase 3   JPRN-jRCT2080223331   Japan;Refer to Othersection
Vedolizumab SC
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2015-000482-31-IT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Montenegro;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-IT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda
      2025   Phase 4   NCT06581328   United States
      2025   Phase 3   NCT06405087   -
      2025   Phase 3   NCT06100289   Belgium;Bulgaria;Denmark;Ireland;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Romania;Serbia;Spain;Switzerland;Taiwan;Turkey;United States
      2016   Phase 3   NCT02620046   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000482-31-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-RO   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000482-31-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-000481-58-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
Vedolizumab SC 108 MG
   Takeda
      2016   Phase 3   NCT02611817   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Takeda Pharmaceutical Company Limited
      2016   Phase 3   JPRN-jRCT2080223331   Japan;Refer to Othersection
      2016   Phase 3   JPRN-jRCT2080223165   Japan;Refer to Othersection
Vedolizumab subcutaneous injection
   Takeda
      2014   Phase 2   NCT02913508   -
Vedolizumab, entyvio
   Amsterdam UMC
      2022   Phase 4   EUCTR2022-000837-17-NL   Netherlands
Vehice control
   Celularity Incorporated
      2010   Phase 2   NCT01155362   United States
Verapamil
   University of Alberta
      2010   Phase 1   NCT01261286   Canada
Viagra
   University College London / University College London Hospitals NHS Foundation Trust
      2006   -   EUCTR2006-002494-48-GB   United Kingdom
Vialebex
   ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
      2019   Phase 2   EUCTR2019-001948-21-FR   France
Vidofludimus calcium
   Immunic AG
      2019   Phase 2   EUCTR2018-001895-39-RO   Bulgaria;Croatia;Czech Republic;Czechia;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-NL   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-HR   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-CZ   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001895-39-BG   Bulgaria;Croatia;Czech Republic;Germany;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Ukraine;United Kingdom;United States
Vigantol OEL TM
   Imperial College London
      2008   -   EUCTR2008-001467-10-GB   United Kingdom
      2008   -   EUCTR2008-001466-93-GB   United Kingdom
      2008   Phase 4   EUCTR2007-006692-37-GB   United Kingdom
Visilizumab
   Facet Biotech
      2005   Phase 2   NCT00267722   United States
      2005   Phase 2   NCT00267709   United States
   PDL BioPharma, Inc
      2005   -   EUCTR2004-004388-31-DE   Germany
   PDL BioPharma, Inc.
      2005   -   EUCTR2004-004387-72-DE   Germany
   Protein Design Labs, Inc.
      2005   -   EUCTR2004-004387-72-AT   Austria;Germany
Vitamin D
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2013   Phase 4   NCT02010762   Netherlands
   Federal University of Juiz de Fora
      2016   Phase 4   NCT02704624   Brazil
   Gudangdong General Hospital, Guangdong Academy of Medical Sciences
      2018   -   ChiCTR1800015174   China
   Nanjing University School of Medicine
      2019   Early Phase 1   NCT04134065   -
   Penn State University
      2009   Phase 1   NCT00742781   United States
   Stanford University
      2021   Phase 1   NCT04828031   United States
   University of Aarhus
      2005   Phase 2/Phase 3   NCT00132184   Denmark
   University of British Columbia
      2010   Phase 4   NCT01187459   Canada
   University of Dublin, Trinity College
      2011   Phase 4   NCT01792388   Ireland
Vitamin D drops
   Second Affiliated Hospital of Wenzhou Medical University
      2020   Early Phase 1   NCT04308850   China
Vitamin D3
   Boston Children's Hospital
      2020   -   NCT04331639   United States
      2017   Phase 3   NCT03162432   United States
   Jantchou Prevost
      2020   Phase 3   NCT03999580   Canada
   Massachusetts General Hospital
      2020   -   NCT04225819   United States
   McMaster University
      2014   -   NCT02615288   -
   University Hospital, Basel, Switzerland
      2022   Phase 3   NCT04991324   Switzerland
   University of California, San Francisco
      2012   -   NCT01877577   United States
   University of Dublin, Trinity College
      2012   Phase 4   NCT01369667   Ireland
   University of Saskatchewan
      2013   -   NCT01864616   Canada;Saudi Arabia
Vitamin D3 3000 UI daily
   St. Justine's Hospital
      2012   Phase 2   NCT01692808   Canada
Vitamin D3 4000 UI daily
   St. Justine's Hospital
      2012   Phase 2   NCT01692808   Canada
Vitamin D3 800 UI/DAY then 800 UI/DAY
   St. Justine's Hospital
      2016   Phase 3   NCT02186275   Canada
Vitamin D3: 3000 or 4000 UI/DAY then 2,000 UI/DAY
   St. Justine's Hospital
      2016   Phase 3   NCT02186275   Canada
Vitamin E 800IU
   University Health Network, Toronto
      2002   Phase 2   NCT00152841   Canada
Vitamin K 10 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Vitamin K1
   University College Cork
      2008   Phase 4   NCT01235325   Ireland
Vorinostat
   National Institute of Allergy and Infectious Diseases (NIAID)
      2017   Phase 1/Phase 2   NCT03167437   United States
VSL#3
   Charles University, Czech Republic
      2014   -   NCT01765439   Czech Republic;Czechia
   Children's Mercy Hospital Kansas City
      2009   Phase 3   NCT00944736   United States
   Federico II University
      2012   Phase 4   NCT01632462   Italy
   Hadassah Medical Organization
      2009   Phase 4   NCT00367705   Israel
   Orphan Australia
      2005   Phase 4   NCT00114465   Australia
   Samsung Medical Center
      2010   Phase 3   NCT01548014   Korea, Republic of
VTX-958
   Ventyx Biosciences, Inc.
      2023   Phase 2   EUCTR2022-003365-38-SK   Australia;Brazil;Bulgaria;Canada;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Slovakia;United States
      2023   Phase 2   EUCTR2022-003365-38-PL   Australia;Brazil;Bulgaria;Canada;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Slovakia;United States
      2023   Phase 2   EUCTR2022-003365-38-LT   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
      2023   Phase 2   EUCTR2022-003365-38-HU   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
      2023   Phase 2   EUCTR2022-003365-38-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Slovakia;Spain;United States
      -   Phase 2   EUCTR2022-003365-38-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
VTX958
   Ventyx Biosciences, Inc
      2022   Phase 2   NCT05688852   Australia;Brazil;Bulgaria;Canada;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Slovakia;United States
   Ventyx Biosciences, Inc.
      2023   Phase 2   EUCTR2022-003365-38-SK   Australia;Brazil;Bulgaria;Canada;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Slovakia;United States
      2023   Phase 2   EUCTR2022-003365-38-PL   Australia;Brazil;Bulgaria;Canada;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Slovakia;United States
      2023   Phase 2   EUCTR2022-003365-38-LT   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
      2023   Phase 2   EUCTR2022-003365-38-IT   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
      2023   Phase 2   EUCTR2022-003365-38-HU   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
      2023   Phase 2   EUCTR2022-003365-38-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Slovakia;Spain;United States
      -   Phase 2   EUCTR2022-003365-38-BG   Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;India;Israel;Italy;Lithuania;Moldova, Republic of;Poland;Serbia;Slovakia;Spain;United States
Warfarin 10 MG
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States
Water
   Academic Medical Center
      2014   Phase 3   EUCTR2013-002838-20-BE   Belgium;Netherlands
   Universitary Hospital Príncipe de Asturias
      2021   Phase 4   EUCTR2021-000985-14-ES   Spain
Water preparation
   University Hospital, Toulouse
      2024   -   NCT06690632   France
WFI
   Neovacs
      2011   Phase 2   NCT01291810   Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
Whey protein
   All India Institute of Medical Sciences, New Delhi
      2005   Phase 1   NCT00838149   India
   University of Campinas, Brazil
      2012   -   NCT01957423   Brazil
Whole body protein turnover
   University of Texas Southwestern Medical Center
      2006   -   NCT00286689   United States
WMT
   The Second Hospital of Nanjing Medical University
      2016   -   NCT02897661   China
Xanthohumol
   National University of Natural Medicine
      2020   Phase 2   NCT04590508   United States
Zasocitinib
   Takeda
      2025   Phase 2   NCT06764615   -
Zessly
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;Spain
      2020   Phase 4   EUCTR2020-001811-26-NL   Belgium;Netherlands;Spain
Zoledronic acid
   McGill University Health Center
      2004   Phase 3   NCT00798473   Canada
ZP1848
   MDS Pharma Services
      2009   Phase 1/Phase 2   NCT01429922   United States